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Even a relatively short polypeptide of 75 amino acids has more unique sequence 
possibilities than the number of atoms in the observable universe. Given the 
vastness of this protein sequence space, the fraction of this space that has ever 
been sampled by nature is tiny, and the fraction still observable in nature is even 
smaller. There are (currently) fewer than 150,000,000 non-redundant protein 
sequences in RefSeq, which represent only ~2000 different protein folds. This 
work aimed to understand the evolutionary mechanisms that gave rise to these 
folds and to determine the frequency at which this repertoire of folds can be 
expanded. It has been proposed that the limited protein repertoire is a 
consequence of ancient proteins being built from a distinct set of building blocks, 
called subdomains. Representing some of the earliest peptides, subdomains would 
have contributed a basic motif of structure or function that would have acted as a 
scaffold around which an autonomously-folding domain could be built. These 
primordial subdomains could have associated with one another giving rise to 
proteins with new structure and function, which were eventually encoded on full 
length genes; a mechanism referred to as subdomain assembly.  This research 
tried to recapitulate subdomain assembly by recombining subdomain sized 
fragments of modern proteins.  
The method Incremental Truncation for the Creation of Hybrid enzYmes 
(ITCHY) was used to recombine randomly sized fragments from every Escherichia 
coli open reading frame. An ITCHY library of ~10,000,000 chimeric genes was 
constructed and screened for soluble and functional proteins. The library 
potentially contained combinations of any sized fragment of any two E. coli ORFs. 
A plasmid-based solubility selection (pSALect) was used to search the library for 
folded proteins. This method did not identify any hybrid proteins which were able 
to be solubly over-expressed and purified. Auxotroph rescue experiments were 
performed to select for functional hybrids. The ITCHY library was used to 
transform 107 conditionally auxotrophic strains of E. coli each with a single gene 
knockout. Six chimeric proteins were found which could rescue different 
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knockout strains. One of these proteins – a hybrid of MioC and SgbE, which 
rescued the strain E. coli ∆cysN – was able to be expressed and purified.  
Through biophysical characterisation the hybrid SgbE147/MioC82 was found 
to have distinct secondary structural elements, as well as apparently forming a 
dimer in solution. The secondary structure of SgbE147/MioC82 appears to have 
high thermal stability, while the protein as a whole may have areas of disorder. 
The sequence of the hybrid indicates that one of the parental fragments is a β-⍺-β 
motif, one of the most ancient subdomains.  
This work represents an advancement of previously established techniques as it 
describes the most comprehensive library of its type produced to date. The hybrid 
SgbE147/MioC82 is one of the first functional proteins produced de novo from a 
random recombination approach that does not utilise rational design in any way. 
The generation of a novel protein which is both soluble and functional provides 
evidence that subdomain assembly was a viable route to the earliest folded 
domains. It also suggests that modern genomes retain the potential to generate 
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1.1 The protein repertoire 
Proteins can be defined in three ways: by their amino acid sequence, their three 
dimensional (3D) structure, or their function (Kolodny et al., 2013). These 
properties are all interconnected. The amino acid sequence defines the atoms 
within the structure and how these atoms are bonded, the 3D structure describes 
how the atoms are arranged in space, and these two properties define the function 
of the protein. Only considering amino acid sequence, the number of potential 
proteins is staggering. Even in a relatively short sequence of 100 amino acids, with 
20 naturally occurring amino acids the theoretical sequence space is 20100, which 
far exceeds the number of atoms in the universe (Dill, 1999). 
At its core, evolution is the diversification and refinement of amino acid 
sequences, resulting in modified structure, function and application of the 
proteins available to a given species. Evolution has led to a distinct repertoire of 
proteins observed within nature today. However, the observed protein repertoire 
is a miniscule subset of the almost infinite set of all potential sequence. There are 
~108 known protein sequences in the RefSeq database (Pruitt et al., 2006), from 
104 domain families (Finn et al., 2015), representing only 103 distinct folds (Fox et 
al., 2013) (where a fold is defined as a group of structurally similar protein 
superfamilies). Understanding the mechanisms that led to the observed repertoire 
of proteins in nature is key to the understanding of evolution as a whole. 
1.2 Evolution of new proteins 
Fundamentally, new proteins can evolve from two origins; by modification of 
an existing protein encoding gene, or via de novo gene birth (Sabath et al., 2012). 
Until recently, de novo gene birth from previously non-coding regions of DNA 
was thought to be implausible. However a number of recent studies have shown 
this to be far more common than originally thought (Begun et al., 2006; Cai et al., 
2008; Levine et al., 2006). Within the phylogenetic branches leading to Archaea 
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and Proteobacteria, there is bioinformatic evidence for at least 240 genes and 320 
genes, respectively, that have arisen de novo (Cai et al., 2008). Most proteins 
however, originate through diversification from common ancestors (Tautz et al., 
2011), via the accumulation of sequence changes. Many proteins can tolerate 
sequence changes without undergoing significant structural changes, as long as 
the physical and chemical properties of the protein remain unchanged. In many 
cases, proteins with little sequence identity share the same fold and function. It is 
relatively well accepted that proteins with 30% sequence identity will share the 
same fold (Rost, 1999), and less sequence identity is required in many cases. For 
example DNA and RNA polymerases have very similar structures, and perform a 
very similar function (catalysing chain elongation reactions guided by a single 
stranded DNA template, proceeding in a 5’–3’ direction), yet share few sequence 
motifs key for catalysis in each (Patel & Loeb, 2000).  
1.2.1 Mechanisms of protein diversification 
There are a number of mechanisms that have contributed to the diversification 
of the protein repertoire; the most prominent being duplication (Figure 1.1), 
divergence (Figure 1.2), and recombination (Figure 1.3) (Lupas et al., 2001). Each 
type of event plays a different yet significant role in the evolution of proteins.  
1.2.1.1 Duplication 
Duplication events are thought to be the most common process in protein 
evolution (Lupas et al., 2001). In eukaryotes gene duplication is thought to occur 
and fix in genes at a rate of 0.01 per gene per million years (Lynch & Conery, 
2000). Whether a whole gene or only a fragment of a gene is being duplicated, 
these events can lead to a variety of outcomes, including new gene functions and 
altered expression patterns (Ohno, 1970; Sidow, 1996). Duplication of a gene has 
the effect of relieving functional pressure on a protein domain, because the 
original copy is still able to fulfil its functional role. This allows mutations to 
accumulate in the duplicated copy without the risk of negatively affecting the host 
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organism if a particular event is deleterious. There are three potential outcomes 
from the evolution of duplicate genes: (1) a copy of the gene becomes non-
functional due to one or more inactivating mutations (Walsh, 1995); (2) 
mutations may lead to a new, beneficial function that can be selected for (Force et 
al., 1999); or (3) both copies of the genes become semi-functional resulting in the 
two copies being required to fulfil the role of the original gene (Lynch & Force, 
2000).  
There are a number of mechanisms by which gene duplication can occur: 
unequal crossing over, retroposition, and chromosomal (or genome) duplication 
(Zhang, 2003). Unequal crossover occurs during mitosis and is a consequence of 
sequence similarity at duplicate break points. It results in the duplicate genes 
being linked on one chromosome. Gene duplication can be partial, complete, or 
multi-gene (Smith, 1976). Duplications frequently occur between separated 
sequence repeats; for example, the most common such event in Salmonella 
enterica occurs between copies of the rrn cistrons (Anderson & Roth 1977). 
Retroposition is the result of messenger RNA (mRNA) being retrotranscribed into 
complementary DNA (cDNA) and then inserting itself back into the genome. In 
this scenario, the replicated genes are typically distant from one another (Long, 
2001). Chromosomal or genome duplication is thought to occur following DNA 
replication due to failed disjunction of the daughter chromosome (Li, 1997). 
Duplication events have been shown to be the most common type of mutation in 
bacterial populations, with roughly 10% of S. enterica cells in culture carrying a 








Figure 1.1 Summary of evolution by gene duplication. Beginning with a single copy of 
a gene, expressing an active protein (1), gene duplication occurs so that two copies of 
the gene exist, each expressing an active protein (2). Diversification can lead to three 
different outcomes: inactivating mutations in one copy of the gene lead to loss of 
function in one gene (3) (this often results in the duplicated gene being lost from the 
genome); mutations of one gene copy lead to modifications of the expressed protein 
producing a new protein with new functions (4); both copies of the gene are mutated 
such that both copies are required to fulfil the function of the original single copy (5). 	
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1.2.1.2 Divergence 
Divergence is the accumulation of mutations over time leading to the formation 
of a new protein (Figure 1.2) . This could occur following a duplication event, or it 
could be that a particular protein accumulates one set of mutations in one species, 
and another in a second species, resulting in two distinct proteins. Divergence 
could be the result of a number of factors including point mutations, insertions 
and deletions, and further duplication of domains (Lupas et al., 2001). In 
combination these events can lead to large families of closely related proteins such 
as G protein-coupled receptors (Horn et al., 2001).  
At the other extreme, recent evidence also suggests that single point mutations 
can lead to structurally distinct proteins. “Metamorphic proteins” can adopt 
multiple, distinct conformations with different functions, generally as a result of 
environmental changes such as pH and redox state (Murzin, 2008). However the 
proteins Mad2 (Mapelli et al., 2007) and chemokine lymphotactin (Ltn) (Tuinstra 
et al., 2008) are each able to adopt two distinct folds at equilibrium. Point 
Figure 1.2 Summary of evolution by divergence. A gene expresses the protein 
"Protein A" (1). Over time the gene accumulates point mutations, however, 
initially this does not result in any change in protein structure of function (2). 
Once the right mutations occur the gene expresses a new protein "Protein B" 
which may have altered structure and/or function (3). The transition from "Protein 
A" to "Protein B" may take one, or many point mutations, and the newly 
expressed protein may be completely inactive. 	
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mutations, which destabilise one of the Ltn folds, trap the protein in one 
conformation (Tuinstra et al., 2008). This highlights the potential for new 
evolutionary trajectories if these mutations were to occur in vivo. This would lead 
to proteins with high sequence identity, with little or no structural homology, an 
atypical evolutionary step.  
1.2.1.3 Non-homologous recombination 
As described above homologous recombination plays a role in duplication of 
genes and gene fragments. Non-homologous recombination (NHR) is also an 
important factor in protein evolution and seems a likely mechanism to generate 
new folds (Cui et al., 2002). Examples of NHR include retroposition, deletions, 
inversions, translocations, exon shuffling, non-homologous end joining, and 
transposable elements (Kegel et al., 2006; Long et al., 2003b; Lupas et al., 2001).  
Exon shuffling occurs within introns, and results in novel combinations of 
exons (Long et al., 2003a). An example of exon shuffling is the chimeric gene 
jingwei, from Drosophila teissieri. The gene is the result of retroposition of alcohol 
dehydrogenase into intron three of yellow emperor. The chimeric protein has a 
function distinct from its parental genes, playing a role in hormone/pheromone 
metabolism (Ding et al., 2012). Exon shuffling is also able to generate mid-domain 
breaks – chimeras where sequence is inserted within a domain, not between 
domains – which are less frequent in other duplication events (Rogers & Hartl, 
2012).  
Two examples of NHR insertion mechanisms are transposable elements and 
horizontal gene transfer. Transposable elements are sequences of DNA that can 
randomly insert themselves into host DNA (McClintock, 1950). In humans, 533 
protein-coding regions contain transposable elements (~4% of human genes) 
(Nekrutenko & Li, 2001). Horizontal gene transfer refers to the process by which 
genetic material is transferred from one organism to another via non-reproductive 
methods. The newly acquired DNA is incorporated into the host genome via 
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homologous or non-homologous recombination, and potentially provides a 
selective advantage to the host (Ochman et al., 2000). While there are many 
examples of entire genes being transferred from one species to another (for 
example antibiotic resistance genes (de la Cruz & Davies, 2000)), there is also 
evidence for horizontal gene transfer contributing to the formation of new genes. 
Trichomonas vaginalis appears to have acquired N-acetyl neuramate lyase in a 
transfer event. Following which, a 24 amino acid leader sequence was fused to the 
gene, causing the newly evolved protein to be secreted, where the original protein 
is cytosolic (de Koning et al., 2000).  
Non-homologous end joining (NHEJ) is an important mechanism for joining 
segments of unrelated DNA. When double stranded breaks occur in bacterial 
DNA, they are typically repaired by homologous recombination (HR) using the 
conserved protein RecA (Michel & Leach, 2012). However, in the absence of a 
second copy of DNA to perform HR, some bacteria utilise NHEJ, which relies on a 
number of proteins including various Ku proteins and LigD (Weller et al., 2002; 
Della et al., 2004). NHEJ can lead to the combination of unrelated DNA (Daniel et 
al., 2004) and is potentially the most likely mechanism for the emergence of de 
novo proteins from extant proteins (Figure 1.3).  
 
Non-homologous recombination appears to accelerate protein evolutionary 
rates. NHR events are more likely to be deleterious to a protein, but can sample 
Figure 1.3 De novo gene assembly by NHEJ. Following a DSB 
event bacteria may employ NHEJ to repair the DNA. It is 
possible that if two DSB events have occurred two unrelated 
genes may undergo NHR to form a new gene.	
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protein sequence and structure space in a way that events such as point mutations 
cannot (Cui et al., 2002). NHR events are attributed to the evolution of E. coli 
from Salmonella. The phenotypic differences between these organisms are 
attributed to NHR events, not point mutations (Lawrence, 1997). Furthermore the 
rate of evolution attributed to major genetic shifts is 31,000 bases/million 
compared to 22,000 bases/million for point mutations. This shows that despite a 
high rate of deleterious events resulting from major shifts, NHR still contributes 
greatly to evolutionary trajectories (Bogarad & Deem, 1999).  
1.3 The role of subdomains in evolution 
The evolutionary mechanisms above are generally applicable to the emergence 
of a new protein from an existing protein, as highlighted in the examples given. In 
this context, existing genes are the starting point or building blocks for evolution. 
A domain could diverge, duplicate, or recombine with another domain to form a 
new protein. Some folds and domains can be traced back over 3.5 billon years to 
the ‘Last Universal Common Ancestor” (LUCA), however, the mechanisms which 
allowed these proteins to emerge from an almost infinite sequence space are still 
being elucidated. It has been theorised that domains arose from pre-existing 
peptides (Lupas et al., 2001; Söding & Lupas, 2003), referred to as subdomains, 
which were active in the ‘RNA world’. In the RNA world hypothesis it is proposed 
that replication and catalysis was performed by RNA enzymes, with polypeptides 
acting as co-factors (Gilbert, 1986). The pool of peptide co-factors is proposed to 
represent a library of subdomains used as the building blocks to form early 




Subdomains are polypeptides between ~25 and 100 amino acids in length that 
encode for some selectable unit of super-secondary structure (Ostermeier et al., 
2000). It has been shown that subdomain sized fragments which are similar in 
sequence and structure are found within topologically distinct domains. The 
presence of the same subdomain within distinct domains suggests they predate the 
folded protein they were found in (Alva & Lupas, 2018). The discovery of the β-a-
β nucleotide binding motif represented the first description of a subdomain 
(Buehner et al., 1973; Rossmann et al., 1974). It was later shown that extant 
proteins containing this motif were a result of divergence from a common 
ancestor, rather than convergence, providing evidence for this motif as an ancient 
building block (Laurino et al., 2016). Like the β-a-β motif, many of the 
subdomain fragments currently identified have known functions which would 
have been significant in an RNA world. These subdomains include: the P-loop 
(mononucleotide-binding) (Walker et al., 1982); the helix-turn helix motif 
(nucleic-acid binding) (Brennan & Matthews, 1989); and the KH motif (RNA 
binding) (Grishin, 2001).  
More recently a study used a computational approach to construct a 
‘vocabulary’ of subdomains. The researchers identified limited areas with high 
sequence and structure similarities within globally diverse protein folds (Alva, 
Söding & Lupas, 2015). The approach identified a total of 40 subdomains, 
Figure 1.4 From the RNA world to modern proteins. A simple overview of the 
transitions from an RNA world (1) to the Modern protein landscape (3), via the use 
of polypeptide co-factors as protein building blocks (2).	
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including all 16 previously identified subdomains. One of the subdomains 
identified was the β-hammerhead motif, which was found in eight proteins with 
four distinct folds. This work suggested that it was not only likely that subdomains 
played an important role in the emergence of ancient domains, but were still 
detectable in extant proteins.  
1.3.1 Subdomains as building blocks 
In order to move from peptides reliant on RNA enzymes, to autonomously-
folding, catalytically active proteins, an increase in complexity of the peptides was 
required. This increased complexity could be achieved in three ways: repetition, 
accretion, and recombination.  
1.3.1.1 Repetition 
As discussed in section 1.2.1.1, duplication is an important mechanism by 
which new proteins can arise from existing domains, and this is equally the case 
for the emergence of ancient folds from shorter peptides. The observation of 
internal sequence symmetry in ferredoxin led to peptide repetition being 
proposed as the origin of proteins as early as 1966 (Eck & Dayhoff, 1966).  
The majority of studies aiming to recapitulate protein fold evolution have 
utilised repetition of super-secondary structure elements. One such study aimed 
to generate a tetratricopeptide repeat (TPR) protein from the repetition of an 
ancestral peptide (Zhu et al., 2016). TPRs typically comprise 1–20 repeats and 
yield many well folded structures (Main et al., 2003). In TPRs the repeating motif 
is a helical hairpin (Das et al., 1998). The helical hairpin motif is found in a variety 
of proteins, including non-repetitive protein structures and is considered a 
subdomain (Alva et al., 2015). The helical hairpin from a non-repetitive protein, 
RPS20, was isolated and amplified to see if the formation of the TRP domain 
could be recapitulated with a non-TRP forming helical hairpin (Figure 1.5). 
Without modifications, the repeated RPS20 helical hairpin was not able to form a 
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TRP domain, instead it was a disordered, but soluble protein. The introduction of 
3–5 point mutations in the motif (different mutation sets, lead to the same result) 
resulted in the protein forming a TRP domain (Zhu et al., 2016). The experiment 
highlighted how repetition of subdomains could allow new protein domains to 
emerge, and showed how a small amount of genetic drift allows for a single motif 
to reside within completely distinct protein architectures.  
 
Repetition of subdomain motifs has also been recapitulated in the TIM (βa)8-
barrel (Eight βa units) (Höcker et al., 2001; Bharat et al., 2008), outer membrane 
β-barrels of bacterial organelles (4–12 β-hairpin repeats) (Arnold et al., 2007), and 
most comprehensively in the β-propeller (Smock et al., 2016). β-propeller proteins 
consist of 4–12 repeating blades. Smock et al. (2016) used ancestral sequence 
reconstruction to recapitulate the evolutionary trajectory of the modern lectin β-
propeller. Two inferred ancestral proteins were identified that represent single 
blade motif. These blade motifs were individually able to self-assemble into 
functional pentameric propellers. The two motifs were duplicated 5-fold and fused 
in tandem respectively, to further replicate its evolutionary trajectory. Fusion 
Figure 1.5 Formation of the repetitive TRP 
domain from a non-repeating helical hairpin 
motif. The helical hairpin motif from the 
protein RPS20 is non-repetitive. This motif 
was amplified and replicated to try and 
recapitulate the evolution of the TRP 
domain. The introduction of 3–5 point 
mutations allowed RPS20 to adopt the TPR 
fold.	
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resulted in a 4-fold increase in functional activity (glycoprotein binding). Further 
work was done to diversify the protein by adding in non-identical motifs (also 
from the ancestral library). It was shown that foldability was the key factor 
influencing the activity of the propeller. One of the key points from this 
experiment is that the interaction of small polypeptides can lead to a functional 
oligomer, and that the duplication and fusion of the gene encoding the 
polypeptide is a selectable evolutionary trajectory, as it can lead to increased 
activity. This concept is important for the work presented in this thesis, as it is one 
of the main ideas of subdomain driven evolution. 
1.3.1.2 Accretion 
In the context of the evolution of proteins from subdomains, accretion would 
involve the addition of heterologous amino acid sequences around the 
subdomain. The subdomain would act as a scaffold, retaining the selectable 
structure/function, allowing the evolution of the accessory protein sequence. 
Subdomain accretion is less well studied than duplication, with the most eminent 
example in the study of a three β-strand segment of cold shock protein A (cspA). 
The three β-strand subdomain was used as a bait protein for the fusion of E. coli 
genomic DNA fragments. The combination of the three β-strand subdomain and 
genomic DNA resulted in a protein with novel structure, which still retained the 
structural identity of the cspA fragment within the overall protein architecture. 
This showed that cspA appears to be a structurally stable subdomain, able to 
direct the folding of surrounding residues (de Bono et al., 2005).  
Further studies utilised different bait peptides and sources for fusion partners. 
Reichmann & Winter (2006) found similar results as above using a fragment from 
hen egg lysozyme as bait, fusing again to fragments of E. coli genomic DNA 
fragments. Like the de Bono (2005) study, the most successful fusions were 
through recombination with a fragment of a protein coding sequence. The closest 
example to evolution by accretion was in a study using a bait made from two 
segments of an immunoglobulin VK domain, fused to fragmented human mRNA 
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(Fischer, Reichmann & Winter, 2004). The most folded chimera was a fusion with 
an section of antisense sequence. The previous examples involved fusions with 
evolutionarily optimised fragments of proteins, while this fusion represents an 
essentially random addition of sequence resulting in a structured protein. 
Other work also aimed to add heterologous amino acids to a potential 
subdomain. Setiyaputra et al. (2011) showed that the three-quarter (β⍺)8 barrel, 
trPRAI, was another candidate for a subdomain-like scaffold. Setiyaputra et al. 
(2011) found a three-quarter-sized (β⍺)8 barrel fragment that was almost as 
thermostable as the full-length parent. (β⍺)8 barrels are the most common enzyme 
fold in nature (Sterner & Höcker, 2005), and they were thought to have evolved 
from the dimerisation of two half barrels (Höcker et al., 2001). However, the 
discovery of the thermostable trPRAI suggested a different evolutionary 
mechanism. Setiyaputra et al (2011) to proposed that trPRAI represented an 
evolutionary intermediate in the evolution of the (β⍺)8 barrel from (β⍺)2 quarter 
barrels. This proposition was based on evidence from previous work (Nagano et 
al., 2002; Richter et al., 2010), coupled to the ancient origins of (β⍺)8 (they existed 
prior to the LUCA) (Caetano-Anollés et al., 2007). It was proposed that (β⍺)8 
barrels evolved in a world which contained a diverse pool of (β⍺)2  subdomains, 
which evolved into, half-, quarter-, and three-quarter-barrels by transient 
associations, and eventual gene fusion (Setiyaputra et al., 2011). In previous work 
that lead to the study presented in this thesis, Saraswat (2014) attempted to fuse 
random segments of trPRAI to random segments of a distantly related (β⍺)8 
barrel, Kvb. with the aim of fusing (β⍺)2 subdomains from two different (β⍺)8 
barrels. Soluble proteins were discovered, albeit with evidence of partial disorder, 
meaning structural evidence for subdomain fusion was not measurable.	
1.3.1.3 Recombination 
Subdomain driven evolution of domains would have occurred in an 
environment enriched for subdomain peptides encoded by micro-genes. These 
peptides could form transient interactions, assembling non-covalently into 
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different oligomeric states. Some of these interactions may be beneficial – 
providing a stable protein scaffold, or a function. Beneficial interactions could 
provide a selective advantage, which in-turn could lead to the positive selection of 
cells that inherited all of the micro-genes required to produce the right 
combination of peptides. Fusion of the micro-genes could then stabilise the 
co-expression of these associating peptides leading to the formation of putative 
genes. Further recombination could lead to further shuffling of the micro-genes, 
increasing the diversity of the emerging proteins (Figure 1.6).  
 
Figure 1.6 Subdomain assembly. It has been proposed that subdomains are 
could act as the building blocks for the emergence of new proteins. In a peptide 
world, the beneficial interactions of multiple subdomains could have led to fusion 
of the micro-genes encoding them. These newly formed genes could have then 
recombined and diverged to generate greater protein diversity, eventually 
leading to the repertoire of proteins observed in nature today.	
 16 
1.4 Project outline 
This project aimed to recapitulate subdomain assembly, and therefore to 
determine whether the recombination of subdomain sized peptides was a viable 
mechanism for the evolution of protein folds and domains. As discussed above a 
number of experiments have successfully recapitulated evolution of particular pre-
determined folds from individual subdomains. However, no previous studies have 
been able to implement experiments which would replicate the potential for 
random recombination of subdomains from a large pool of subdomain sized 
peptides (like the conditions proposed in the RNA world hypothesis). Research 
has shown that subdomains can be identified in the sequence and structure of 
extant proteins (Alva et al., 2015), therefore, this research hoped to use modern 
proteins as a source of subdomains. The overall goal was to randomly recombine 
subdomain sized fragments from every open reading frame of E. coli to replicate 
subdomain assembly.  
Furthermore, this work aimed to extend the bounds of the protein repertoire, 
by inventing new proteins, and potentially new protein folds. The SCOPe database 
classifies a fold as a group of structurally similar protein superfamilies (Fox et al., 
2013). The number of distinct folds is in the magnitude of 103 suggesting the 
sequence space sampled by nature has been constrained in some way (given the 
possible sequence combinations are infinite). This work tried to determine if it 
was possible to invent new folds by recombining modern-day subdomains. This 
meant that the work will not only probe whether new folds are possible, but 
whether nature sampled all of the possible folds within a sequence space 
constrained by a set of pre-determined subdomains. This study aimed to 
determine the rate at which new proteins and folds are generated by the fusion of 
subdomains, and whether this exceeds the rate of evolution of new proteins by 
other methods.  
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1.4.1 ITCHY 
This study required a method capable of combining fragments of every gene 
from E. coli in a parallel fashion with the possibility to generate massive levels of 
diversity (~1013 possible clones). The method Incremental Truncation for the 
Creation of Hybrid enzYmes (ITCHY) was utilised to complete this work. ITCHY 
recombines randomly-truncated fragments of two genes. The recombined genes 
can be completely non-homologous, making ITCHY a powerful method for 
generating recombinant chimeric genes. The first ITCHY methods generated 
truncated fragments of genes on different plasmids before using restriction digests 
and gel extraction to isolate the fragments of both genes and ligating them 
together (Ostermeier et al., 1999). The loss of DNA through gel extraction and the 
relatively low efficiency of ligating two fragments together limited the library sizes 
of this early version of ITCHY. The method was developed to utilise a single 
plasmid system to join randomly-truncated fragments of two parental genes, 
producing a variety of hybrid products. The parental genes were individually 
cloned into the plasmid prior to linearization, truncation and ligation steps (Lutz 
et al., 2001; Ostermeier & Benkovic, 2001). Single plasmid ITCHY methods were 
used to generate fusions of human thymidine kinase 2 and deoxyribonucleoside 
kinase from Drosophila melanogaster. Chimeras were identified from the fusion 
library that had increase activity over the parents or novel activity which neither of 
the parents possessed (Gerth & Lutz, 2007).  
Similar methods have been developed to produce recombinant libraries. The 
method Sequence Homology-Independent Protein RECombination (SHIPREC) 
has been used to generate, for example, hybrids of two P450 proteins from 
different species (Sieber, Martinez & Arnold, 2001). The technique Expression of 
Soluble Protein by Random Incremental Truncation (ESPRIT) uses similar 
truncation methods to ITCHY to generate gene fragments. The ESPRIT fragments 
are not hybridised, but unlike ITCHY can be from any part of the gene, not only a 
5ʹ or 3ʹ terminal fragment. The ESPRIT method also incorporates a solubility 
selection to screen for soluble fragments (Yumerefendi et al., 2010). 
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At their core the various ITCHY protocols have 3 main steps: gene 
combination, truncation, and recombination. During the combination step, 2 
genes are combined into a single construct. In Figure 1.7 this is achieved by 
manually cloning the two genes into a plasmid. Truncation is achieved using: 
exonuclease III – digests DNA in the 3ʹ–5ʹ direction – leaving single stranded 
overhangs; mung bean nuclease – removes single stranded overhangs; and Klenow 
fragment, which polishes the DNA ends leaving blunt ends for ligation. A ligation 
step recombines the fragments of the two genes into a single ORF.  
The biggest problem with the ITCHY workflow as presented in Figure 1.7, is the 
need to individually clone the two genes into a plasmid. This cloning step 
drastically reduces the scalability of the method. Because this study aimed to 
recombine randomly-sized fragments from every E. coli open reading frame, there 
was a need to extend ITCHY. The work presented expanded on the work of Gerth 
Figure 1.7 Single plasmid ITCHY. Summary of a typical ITCHY experiment. Two genes 
are cloned into a single plasmid, the plasmid is linearised with a restriction enzyme that 
cleaves between them, and the ends digested with ExoIII, then treated with mung bean 
nuclease, and Klenow fragment, before the DNA is ligated to form an intact plasmid. 
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& Lutz (2007) whose work combined fragments of two genes from two separate 
parental plasmids – referred to in this study as two-plasmid ITCHY. The specifics 
of this method are discussed in Chapter 3.2 and Chapter 3.3; briefly however, the 
combination step utilises overlap extension PCR to combine two unrelated genes 
on two separate plasmids into a single construct. 
This two-plasmid ITCHY protocol had been described previously for the 
simplest case, in which there was a single parent in each plasmid (Gerth & Lutz, 
2007). In this work the method was expanded; every ORF from E. coli was cloned 
into the parental plasmids giving the potential for ~1013 unique clones. The source 
of the E. coli ORFs was the ASKA collection. The ASKA collection is a complete 
set of E. coli K-12 ORFs (>4200 ORFs), which have been individually cloned into 
the expression vector pCA24N using SfiI restriction sites between a His-tag and 











1.5 Specific Aims 
The specific aims of this thesis were: 
1) Generate a library of chimeric proteins by combining subdomain sized 
fragments from every protein of E. coli. The aim was to construct a library that 
mimicked the fusion of peptides in the primordial subdomain world (Figure 
1.6). 
 A) Optimise the ITCHY protocol for use with a library of parental genes. 
 B) Optimise an "All versus All" ITCHY experiment with the potential to  
 combine fragments of any two E. coli genes. 
 C) Assess the ITCHY libraries for use in large-scale screening experiments. 
2) Screen the library for soluble or functional proteins. Solubility and function 
are two selectable characteristics key to the survival of a protein through an 
evolutionary path. 
 A) Utilise the pSALect selection system to screen for soluble hybrids. 
 B) Utilise conditionally auxotrophic strains of E. coli to screen the library 
 for functional proteins.  
3)  Characterise soluble and functional proteins to determine the biophysical 
characteristics of each, and determine the role of subdomains in the formation 
of the proteins. 
 A) Determine whether hybrid proteins appear to form stable secondary 
 and tertiary structure using methods such as circular dichroism and     
 SEC-MALS. 
 B) Use sequence information and predictive tools to determine whether 





































The methods recorded in this chapter are a generalised view of the method 
used. Where required specific details were included in the associated chapter the 
method was applicable. 
Unless otherwise stated, all growth media was obtained from Formedium and 
all buffer salts and reagents were obtained from Sigma Aldrich. All enzymes were 
purchased from New England Biolabs (NEB) unless otherwise stated. 
All work was undertaken under the approval code GMO08/UO004 following 
guidelines set by the Ministry for Primary Industries and the University of Otago.  
2.2 Bacterial culturing 
Unless otherwise stated the bacterial strain used in experiments was the E. coli 
strain, E. cloni 10G. E. coli was routinely cultured in LB medium supplemented 
with the required antibiotics and grown at 37°C with orbital shaking at 220 rpm.  
Overnight cultures were typically grown at a volume of 4.5 mL in a sterile test 
tube for 16 h. Overnight cultures were inoculated by transferring cells from 
glycerol stocks, or picking colonies from agar plates, using a sterile loop. 
Cells were grown on agar plates at 37°C overnight, or until the appearance of 
colonies. Cells were stored on plates at 4°C for up to two weeks.  
2.2.1 Media 
Unless otherwise stated, media was prepared in MilliQ (MQ) water, and 
sterilized by autoclave or by filtration with a 0.22 µm sterile filter. Supplements 
were added to media following autoclaving. With the exception of M9 minimal 
medium plates, solid agar media was made by adding 15 g/L of bacteriological 
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agar to the medium prior to autoclaving. Approximately 20 mL of medium was 
poured into sterile petri dishes and allowed to cool. Agar plates were stored at 
4°C.  
2.2.1.1 Luria broth medium 
LB and LB agar were used as standard of the culturing of E. coli. LB medium 
was prepared to by suspending 25 g Luria broth pre-mixed medium in 1 L of 
water (Sambrook et al., 1989). 
2.2.1.2 Terrific broth (TB) medium 
TB was used for the expression of proteins from E. coli. TB medium was 
prepared by adding 36 g Terrific broth pre-mixed medium and 8 mL of 50% (w/v) 
glycerol in 1 L of water (Sambrook et al., 1989). 
2.2.1.3 Auto-induction medium (AIM) 
AIM was used for the expression of proteins from E. coli. AIM was prepared by 
suspending 56 g AIM pre-mixed medium and 8 mL of 50% (w/v) glycerol in 1 L of 
water. 
2.2.1.4 M9 minimal medium 
M9 minimal medium agar was used for the growth of conditionally auxotrophic 
strains of E. coli. A 5x M9 minimal medium was prepared by suspending 56.4 g of 
5x M9 minimal salts base in 1 L of water. Agar was prepared separately by 
suspending 15 g of bacteriological agar in 750 mL of water. Following autoclaving 
of both the M9 solution and the agar, 200 mL of 5x M9 minimal medium was 
added to the agar, and further supplemented with MgSO4 (final concentration 2 
mM), CaCl2 (final concentration 0.1 mM) and glucose (final concentration 0.4% 
(w/v)). The M9 agar was made up to 1 L and the plates were poured (Sambrook et 
al., 1989). 
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2.2.1.5 Super optimal broth with catabolite repression medium 
SOC medium was used for the recovery of cells following electroporation. It was 
prepared by suspending 20 g bacto tryptone, 5 g Bacto yeast extract, 5 g NaCl, 
0.19 g KCl, 0.95 g MgCl2, and 1.2 g MgSO4 in 980 mL of water. After autoclaving, 
20 mL of sterile 1 M glucose is added to the medium.   
2.2.2 Supplements 
Supplements were filter sterilised and added to media after the medium was 
autoclaved and cooled to below 50°C. 
2.2.2.1 Antibiotics 
Carbenicillin (Carb), Chloramphenicol (Cm), and Kanamycin (Kn) were used 
in selective media. Carb was dissolved in MQ water to make a 1000x stock and 
used at a final concentration of 100 μg/mL. Cm was dissolved in 99% analytical 
grade ethanol to make a 1000x stock and used at a final concentration of 
34 μg/mL. Kn was dissolved in MQ water to make a 1000x stock and used at a 
final concentration of 30 μg/mL. 
2.2.2.2 IPTG 
Isopropyl β-D-1-thiogalactopyranoside (IPTG) was used to induce the 
expression proteins under the control of the lac operator. Stock solutions were 
made to 0.5 M in MQ water and filter sterilised, then used at a final concentration 
of 0.5 mM. 
2.2.3 Glycerol stocks 
Bacterial strains were kept long term as glycerol stocks at -80°C. Glycerol stocks 
were prepared by growing an overnight culture of the desired strain in LB (+ the 
required antibiotic if the cells contain a plasmid). The culture was mixed with 1:1 
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with 500 μL of 40% (w/v) glycerol. The mixture was snap frozen with liquid 
nitrogen and stored.  
2.3 DNA techniques 
2.3.1 Agarose gel electrophoresis 
Agarose gels were prepared to 1% w/v agarose in TAE buffer (Tris base, 40 mM, 
acetic acid, 20 mM, EDTA, 1 mM) and heated in a microwave until the agarose 
dissolved. Ethidium bromide was added to a final concentration of 0.5 µg/mL. If 
DNA was to be purified from the agarose gel, SYBR Safe DNA Gel Stain 
(Invitrogen) (0.01 %(v/v)) was added to the agarose gel solution instead of 
ethidium bromide. The agarose gels were cast using a horizontal system (Bio-Rad) 
and allowed to set. The gel was transferred to a gel tank and submerged in TAE 
buffer. Samples were mixed at a 1:5 ratio with 6x loading dye (KAPA Biosystems) 
and loaded into the lanes of the gel. Samples were run alongside a KAPA universal 
DNA ladder (KAPA Biosystems). Gels were run at 110 kV for 27 min (EPS301 
Electrophoresis Power Supply, Amersham Biosciences), or until desired 
separation had occurred. Gels were imaged under UV illumination using a BioRad 
XR+ geldoc set to automatic exposure.  
2.3.2 DNA purification 
2.3.2.1 Plasmid purification 
Plasmids were purified from 4 mL overnight cultures grown in Luria Broth with 
the appropriate antibiotic. Plasmids were purified using a Macherey-Nagel 
NucleoSpin plasmid preparation kit, as per the kit instructions. The protocol was 
modified by eluting DNA in 25 µL of elution buffer after incubation of the 
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column and buffer at 70°C for 2 min, and centrifuged as per protocol, then the 
elution was repeated as above with a second 25 µL volume of elution buffer.  
2.3.2.2 PCR product purification and DNA cleanup 
DNA, from PCR and ligation reactions, was purified using the Macherey-Nagel 
Nucleospin Gel and PCR cleanup kit, as per kit instructions (“PCR clean-up”, 
page 17). The protocol was modified by eluting DNA in 25 µL of elution buffer 
after incubation of the column and buffer at 70°C for 2 min, and centrifuged as 
per protocol, then the elution was repeated as above with a second 25 µL volume 
of elution buffer. 
2.3.2.3 Agarose gel extraction 
PCR DNA was routinely purified by gel extraction: DNA was separated by 
agarose gel electrophoresis (2.2.1). DNA was visualised using a blue light 
transilluminator and the DNA of interested was excised from the gel using a clean 
scalpel blade. DNA was purified from the gel using Nucleospin Gel and PCR 
cleanup kit, as per kit instructions (“Agarose gel extraction, page 19). The protocol 
was modified by eluting DNA in 25 µL of elution buffer after incubation of the 
column and buffer at 70°C for 2 min, and centrifuged as per protocol, then the 
elution was repeated as above with a second 25 µL volume of elution buffer. 
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2.3.3 Polymerase chain reaction  
PCR was routinely used to amplify plasmid DNA from a pure DNA and as a 
screening tool to amplify plasmid DNA from within bacterial colonies. Typically, 
DNA was amplified in 0.2 µL tubes, using KAPA-Taq ready-mix + dye (KAPA 
biosystems) (for screening), or Phusion polymerase (for molecular cloning) in a 
Bio-Rad T100 thermal cycler. PCR reactions typically comprised: 1x KAPA-Taq 
ready-mix + dye, DNA template (volume varied as per below), 0.2 µM forward 
primer, 0.2 µM reverse primer, made up to 25 µL in nuclease free water. A list of 
primers used in this study is shown in Table 2.3. Primers were synthesised by 
Invitrogen or Macrogen (South Korea). 
2.3.3.1 PCR from purified DNA 
When using pure plasmid as a template, 10–20 ng of template DNA was used in 
the reaction. The PCR reactions were set up as per 2.3.3, and thermal cycling was 
completed as per Table 2.2. 
2.3.3.2 Colony PCR screening 
Colonies were routinely screened for plasmid DNA using colony PCR. 
Template DNA was prepared by picking a colony of interest from an agar plate 
with a sterile pipette tip and mixing it into 60 µL of sterile MQ water in a 0.2 µL 
tube. The tip (with cell residue) was then used to streak a fresh agar plate to grow a 
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copy of the screened colony. The cell/water mix was heated at 95°C for 5 min. The 
PCR reactions were set up as per 2.3.3, and thermal cycling was completed as per 
Table 2.2. 
2.3.4 Restriction endonuclease reactions 
Restriction enzymes were regularly used to digest plasmid DNA. As a standard 
protocol, restriction digest reactions were incubated overnight (~16 h). The 
restriction enzymes used, and their associated incubation temperatures and cut 
recognition sites are shown in Table 2.4. All enzymes used were compatible with 
CutSmart buffer (NEB). A typical reaction included ~2 µg of DNA, ~10 U of 
enzyme and 1x CutSmart buffer, in a 50 µL total volume in nuclease free MQ 
water. All restriction enzymes, apart from SfiI, were heat inactivated. Due to the 
heat tolerance of the SfiI enzyme, DNA digested with SfiI was purified by agarose 
gel extraction or PCR clean-up protocol prior to use in further experiments. 
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2.3.5 Measuring DNA concentration 
The concentration of DNA was determined using a DeNovix DS-11 
spectrophotometer. Elution buffer from Nucleospin kit was used as a blank before 
1 μL samples of DNA were used to determine the concentration. 
2.3.6 Ligation reactions 
T4 DNA ligase was used to recircularise plasmid DNA and for restriction digest 
cloning. A typical ligation reaction included ~50 ng of vector DNA at a 1:3 molar 
ratio with insert DNA (if inserting a DNA fragment). Reactions occurred in 1 x T4 
DNA ligase buffer, with 400 U of T4 DNA ligase, in a total reaction volume of 20 
µL. The reaction mixture was incubated for ~16 h at 16°C. To achieve greater 
ligation efficiency, the reaction temperature was cycled between 10°C and 30°C 
with a 30 s hold time at each temperature for ~16 h (Lund et al., 1996). 
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2.3.7 Transformation of E. coli cells 
2.3.7.1 Electrocompetent cell preparation 
 In a test tube, 4 mL of LB was inoculated with the E. coli strain required for 
transformation. The 4 mL cultures were grown overnight at 37°C with shaking. A 
3 mL sample of the overnight culture was used to inoculate 500 mL of LB in a flask 
and grown at 37°C, with shaking, until the OD600 of the culture reached ~0.35–0.4 
(3–4 h growth). The cells were chilled on ice for 20 min. Cells were split evenly 
into ~45 mL aliquots in 12 pre-chilled, 50 mL, sterile, conical bottomed, centrifuge 
tubes (Falcon). Cells were pelleted by centrifugation at 3000 rpm for 15 min (F50C 
rotor, Beckman Coulter Avanti J-26 XP centrifuge). The supernatant was 
decanted, and cells were gently resuspended and pooled into 4 tubes in a total of 
~160 mL pre-chilled sterile water.  Cells were pelleted again by centrifugation at 
3000 rpm for 15 min.  The supernatant was decanted, and cells were gently 
resuspended in ~40 mL pre-chilled sterile water per tube. Cells were pelleted by 
centrifugation at 3000 rpm for 15 min, the supernatant decanted, and cells were 
resuspended and pooled in a single 50 mL tube in a total of ~40 mL of chilled, 
sterile 10% (v/v) glycerol. Cells were pelleted by centrifugation at 3000 rpm for 15 
min. The supernatant was decanted, and the cells were resuspended to a final 
volume of ~1.25 mL in 10% (v/v) glycerol. The cells were split into 50 µL aliquots 
and either used immediately, or snap frozen using liquid nitrogen and stored 
at -80°C. 
2.3.7.2 Transformation of electrocompetent cells 
Cells were transformed by DNA using electroporation. As a standard 50 µL of 
electrocompetent cells were mixed with either ~10 ng of plasmid DNA, or         
10–500 ng of purified ligated DNA. The cell/DNA mixture was transferred into a 
sterile 2 mm MicroPulser electroporation cuvette (Bio-Rad). The cells were 
electroporated at 2.5 kV (MicroPulser electroporator, Bio-Rad) and 500 uL of 
SOC medium was immediately added to the cells, which were then transferred to 
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a 1.7 mL micro-centrifuge tube, and allowed to recover at 37°C, with shaking for 
1 h. Depending on the expected efficiency, 5–100 µL of the recovery culture was 
plated onto agar plates containing the appropriate selective medium 
2.3.8 QuikChange mutagenesis of pSALect-NotI 
The pSALect-NotI primer was modified for use in the ITCHY protocol by the 
use of QuikChange mutagenesis. The overall principle is shown in Figure 3.2. The 
mutagenic primers QCpSAL.for, and QCpSAL.rev were designed to add the 
nucleotides 5ʹ-TGCGGCCGG-3ʹ into pSALect-NotI. The entire pSALect-NotI 
plasmid was amplified in the following conditions: 1 x Phusion HF buffer, 5 ng of 
pSALect-NotI template, 0.6 µM QCpSAL.for primer, 0.6 µM QCpSAL.rev primer, 
200 µM dNTP mix, 3% (v/v) dimethylsulfoxide (DMSO), 1 U Phusion 
polymerase. The construct was amplified at a temperature of 72°C, for a total of 18 
PCR cycles (cycles as per Table 2.2) 
Following PCR amplification, 10 U of the restriction enzyme DpnI was added 
to the reaction mix and the solution was incubated for 16 h at 37°C to digest the 
parental DNA fragment.  
Up to 5 µL of the DpnI digested DNA was used to transform E. cloni 10G cells 
as per 2.3.7.2. Up to 100 µL of the recovered cells were plated on an LB-Cm agar 
plate and grown overnight at 37°C. Colonies were picked and screened by 
sequencing for the inserted DNA. 
2.3.9 Library generation general methods 
This project required the use of a number of plasmid based ORF libraries. A 
number of steps were taken to maximise the size and coverage of these libraries. 
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2.3.9.1 Subcloning of the ASKA collection 
The ASKA collection (Kitagawa et al., 2005) was subcloned from pCA24N, into 
both pSALect-FseI and pSALect-NotI. The ORFs from the ASKA collection were 
isolated from a frozen glycerol stock of all ASKA members pooled into one 
culture. To eliminate bias towards individual ORFs, four overnight cultures were 
set up in LB-Cm medium, each inoculated individually from the pooled ASKA 
collection stock. Following growth, the plasmid DNA was isolated from each 
culture (as per 2.3.2.1). Plasmid DNA (15 µL) was digested using the restriction 
enzyme SfiI, in a total reaction volume of 50 µL (See 2.3.4). The entire sample was 
separated using agarose gel electrophoresis and SYBR safe stain. Because the ORFs 
in the ASKA collection are a variety of sizes, the separated DNA appeared as a 
smear on the gel. All DNA less than 5000 bp was excised from the gel and purified 
using agarose gel DNA extraction. The dissolved gel was split into four separate 
DNA purification columns to maximise the recovered DNA. Following elution of 
the purified DNA, the purified ASKA ORFs were pooled. To increase the 
concentration of the DNA for ligation, the pooled ORF DNA was lysophilised. 
The lysophilised DNA was resuspended in 20 µL of sterile MQ water. pSALect-
FseI and pSALect-NotI were also digested with SfiI and purified by agarose gel 
extraction. Ligation reactions were then setup (as per 2.3.6) with 10 µL of the 
resuspended ORF DNA added to two separate reaction mixes containing either 
SfiI digested pSALect-FseI or SfiI digested pSALect-NotI. The ligated DNA was 
purified (as per 2.3.2.2) and 7 µL was used to transform E. cloni 10G 
electrocompetent cells.  
Following recovery from electroporation, the entire 500 µL recovery cultures 
were spread on LB-Cm agar prepared in 500 cm2 square culture dishes (~250 mL 
of agar per plate) (Thermo-Scientific). 
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2.3.9.2  Transformant pooling 
Following transformation of cells with the library of interest, the transformants 
were pooled into a single culture. This was achieved by adding liquid LB medium 
(including antibiotic) onto the surface of an agar plate with the transformant 
colonies. A sterile spreader was used to resuspend the cells in the liquid medium, 
and the cell suspension was then transferred to a sterile tube. Enough liquid 
medium was added such that 1–2 mL of cell suspension was removed. Some of the 
liquid medium added was absorbed by the agar, so the exact volume added varied. 
If transformants from a single library were spread on multiple plates, then the cell 
suspension from each was pooled. Pooled cells were separated into 500 µL 
aliquots and freezer stocks were prepared (as per 2.2.3). 
2.3.9.3 Estimating library size 
The size of the generated libraries was calculated by spreading an aliquot (2–
20 μL) of cells transformed by the library onto an agar plate of the same selective 
medium as the library preparation, and counting the number of colony forming 
units per millilitre (CFU/mL) of the culture. With a knowledge of the volume of 
culture spread in the preparation of the library compared to the volume spread on 
the counted plate, the CFU within the library could be calculated. 
2.3.10 DNA sequencing 
Sequencing of plasmid DNA and PCR products was carried out by Genetic 
Analysis Services (GAS, University of Otago, http://gas.otago.ac.nz/) or Macrogen 
(South Korea) (https://dna.macrogen.com/eng/). 
GAS required submission of premixed samples of primer (3.2 pmol) and 
template DNA (1 ng/100 bp of PCR products; 150 ng of plasmid DNA ) in a total 
volume of 5 µl. 
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Macrogen required submission of at least 2 µg of template DNA (100 ng/µl). 
Primers were supplied separately at a concentration of 10 pmol/µl.  
Sequencing results were analysed by aligning the experimental chromatograms 
with the target sequence using the software SnapGene (www.snapgene.com/). 
2.4 ITCHY library preparation 
ITCHY libraries were generated using a protocol modified from Patrick & 
Gerth (2014). Briefly: 1) ORFs from the ASKA collection were joined on the same 
pSALect construct by overlap extension PCR; 2) The two genes of each construct 
were truncated using nucleases; 3) The truncated genes were fused by 
recircularization of the plasmids (Figure 3.2). 
2.4.1 Generation of double-ORF constructs by overlap-
extension PCR 
The plasmids pSALect-FseI and pSALect-NotI each containing the ORFs of 
interest were purified. The purified plasmids may represent a single ORF in each 
plasmid, or many different ORFs cloned into each plasmid (as described in 
2.3.8.1). 
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Separately, pSALect-FseI and pSALect-NotI were linearized by restriction 
enzyme digest with FseI or NotI-HF respectively. The linearised plasmid pools 
were purified using the Nucleospin PCR cleanup kit. The linear DNA was used to 
setup initial overlap-extension PCRs as follows: 1x KAPA-Taq polymerase ready-
mix + dye, 10 ng linear pSALect-FseI:ORF, 10 ng linear pSALect-NotI:ORF, 4% 
(v/v) DMSO, made up to total reaction volume of 50 µL with sterile MQ water. 
The thermal cycling method for this PCR is shown in Table 2.5. 
 
The products from the overlap extension PCR should contain two ORFs per 
plasmid construct. To amplify the double-ORF constructs 0.2 µL of 100 µM P1v2 
primer and 0.2 µL of 100 µM P2v2 primer were added to the reaction mix. These 
primers were designed to amplify across the entire construct, regardless of the 
ORFs present. The constructs were amplified by PCR using the thermal cycle 
shown in Table 2.6. 
DpnI (10 U) was added to the reaction mix and the reaction was incubated for 
16 h at 37°C to digest parental plasmid DNA. DNA from eight 50 µL reactions 
was typically pooled at this point, in order to accumulate enough DNA for the 
following steps of the ITCHY protocol. The pooled DNA was purified using the 
Nucleospin PCR cleanup kit. The concentration of the DNA was determined. 
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2.4.2 Time dependent exonuclease III digestion 
Exonuclease III (ExoIII) reactions were set up as follows: 1x NEBuffer I (NEB), 
4–5 μg of purified DNA from 2.4.1, 30 mM NaCl, in a total reaction volume of 100 
μL was mixed in a thin wall, 0.2 mL PCR tube and kept at 22°C in a heat block. 
ExoIII (100 U/μg of DNA) was added to the reaction mix. After 2 min, a 2 μL 
aliquot was removed from the reaction mix and added to a 500 μL of ice cold NTI 
buffer (NucleoSpin PCR clean-up kit) to stop the reaction. Every 15 s, 2 μL 
aliquots were removed from the reaction and added to the NTI buffer. After 15 
min, any remaining reaction mix was added to the NTI buffer. 
The DNA was purified using the NucleoSpin PCR Clean-up kit. The 
concentration of the DNA was determined. 
2.4.3 Mung bean nuclease digestion 
Mung bean nuclease was used to remove the single-stranded DNA left from the 
exoIII digestion. The reactions were set up as follows: 1x mung bean nuclease 
buffer (NEB), all of the DNA from 2.4.2, 1.5 U of mung bean nuclease per 
microgram of DNA, in a total volume of 60 μL. The reaction mix was incubated at 
30°C for 30 min. The reaction was stopped by the addition of 5 volumes of NTI 
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buffer. The NucleoSpin PCR purification kit was used to purify the DNA. The 
concentration of the DNA was determined.  
2.4.4 End polishing 
The Klenow fragment of DNA polymerase was used to polish the ends of the 
truncated DNA by removing 3ʹ overhangs and filling in 5ʹ overhangs,	leaving 
blunt ends ready for ligation. The Klenow reaction was prepared as follows: 1x 
NEBuffer 2 (NEB), dNTPs (final concentration 100 μM), all the DNA from 2.4.3, 
1 U of Klenow DNA polymerase per microgram of DNA, in a total reaction 
volume of 60 μL. The reaction mix was incubated at 25°C for 15 min. The reaction 
was stopped by adding EDTA to a final concentration of 10 mM and heating at 
75°C for 20 min. 
The DNA was purified using the NucleoSpin PCR clean-up kit and DNA 
concentration was determined. A typical yield was ~1 μg of DNA. 
2.4.5  Ligation 
Ligation was used to recircularise the truncated DNA from the ITCHY 
protocol, resulting in the fusion of two fragments from two ORFs. A single 
ligation mix was set up to recircularise the DNA from the ITCHY protocol as 
follow: 1x T4 DNA ligase buffer, all of the DNA from 2.4.4 (~1 μg), 1000 U T4 
DNA ligase, made up to a total reaction volume of 150 μL. The reaction was 
incubated overnight in a thermal cycler with the temperature cycling between 
10°C and 30°C, with 30 s hold times at each temperature. 
The DNA was then purified using the NucleoSpin PCR clean-up kit. The DNA 
was eluted into a total of 40 μL, via two 16 μL elution steps. 
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2.4.6 Transformation 
Electro-competent E. cloni 10G cells were transformed by the ligated DNA via 
electrophoresis. To generate the biggest possible libraries the entire pool of ligated 






recovery	culture	was	spread	on	separate	500 cm2 square culture dishes of LB-
Cm agar. Following growth, the cells were collected as described in 2.3.8.2. 
2.5 Restriction enzyme digest library 
preparation 
An overview of this protocol is shown in Figure 3.11. 
2.5.1 Purification of the ORFs from the ASKA collection 
The ORFs from the ASKA collection were isolated and purified as per 2.3.9.1. 
Four overnight cultures were set up in LB-Cm medium, each inoculated 
individually from the pooled ASKA collection glycerol stock. Following growth, 
the plasmid DNA was isolated from each culture (as per 2.3.2.1). Four 
simultaneous digestions were set up where 15 µL of the plasmid DNA was 
digested using the restriction enzyme SfiI, in a total reaction volume of 50 µL (See 
2.2.4). The samples were individually separated using agarose gel electrophoresis 
and SYBR safe stain. Because the ORFs in the ASKA collection are a variety of 
sizes, the separated DNA appeared as a smear on the gel. All DNA less than 5000 
bp was excised from the gels and purified using agarose gel DNA extraction. The 
gel segments from each reaction were dissolved and the solution was split into 4 
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separate DNA purification columns per digestion reaction. Following elution of 
the purified DNA, the purified ASKA ORFs were pooled. The purified DNA was 
lysophilised and then resuspended in 30 µL of sterile MQ water.  
2.5.2 Fragmentation of the ASKA ORFs 
Purified ORFs from the ASKA collection were fragmented by digestion with the 
restriction enzymes AluI or BstUI. Restriction digests were undertaken as 
described in 2.3.4. The fragments were purified using Nucleospin PCR cleanup 
kit. The concentration of the DNA was determined. 
2.5.3 Ligation of DNA fragments 
The ORF fragments were first ligated together to generate new ORFs flanked by 
the overhanging SfiI sites generated during purification of the ASKA ORFs. A 
ligation reaction was set up (as per 2.3.6) with 50 ng of fragment DNA (either 
from AluI digestion, BstUI digestion, or a mixture of both) and 400 U of T4 DNA 
ligase. After 4 h, 50 ng of (previously SfiI digested and agarose gel purified) 
pSALect-FseI vector was added to the ligation reaction. The ligation reaction was 
allowed to continue for a further 16 h. Ligated DNA was purified using the 
Nucleospin PCR cleanup kit. 
2.5.4 Generating the transformant library 
Purified, ligated DNA was used to transform electrocompetent E. cloni 10G (as 
described 2.3.7.2). Ligated DNA (4 µL) was used to transform five 50 µL aliquots 
of competent cells. Following recovery, the entire culture was spread on selective 
medium (as described 2.3.9.1) and grown at 37°C for 16 h. Transformed colonies 
were collected and stored at -80°C (as described 2.3.9.2).  
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2.6 Folding selection of hybrid libraries 
The plasmid pSALect allows for selection of folding based on the survival of 
cells on medium containing β-lactam antibiotics. All cells containing the pSALect 
plasmid should survive in medium containing the antibiotic chloramphenicol, due 
to the constitutive expression of a chloramphenicol resistance gene. However, 
only cells expressing a soluble ORF of interest (under the control of a second 
constitutively active promoter in the plasmid) will be able to survive in medium 
containing the antibiotic carbenicillin (this mechanism is discussed in 
Chapter 4.2). Therefore, by plating cells containing the hybrid libraries in pSALect 
(from 2.4 and 2.5) on LB-Carb agar, surviving cells should be expressing folded 
hybrid protein from the pSALect plasmid. 
Folded hybrid libraries were generated by thawing a freezer stock of a hybrid 
library and spreading the entire culture on a 500 cm2 square culture dishes of 
LB-Carb agar. The cells which grew on this selective medium were collected and 
stored as described in 2.3.9.2.  
2.6.1.1 pSALect-positive fraction of libraries 
The percentage of clones in a library that could survive pSALect selection was 
determined by comparing the number of cells surviving on LB-Cm agar to the 
number of cells surviving on LB-Carb agar. These experiments were undertaken 
as follows: 4 mL of LB-Cm was inoculated with a scraping of cells from a hybrid 
library (pre-selection by pSALect). The culture was grown at 37°C until the OD600 
of the culture reached ~0.6. A sample of the culture was diluted by a factor of 
10,000 and 1,000,000, in sterile MQ water. 50 μL of the 10,000-fold diluted cells 
was spread onto three LB-Cm plates, and 50 μL of the 1,000,000-fold diluted cells 
was spread onto three LB-Carb plates. The plates were incubated at 37°C for 16 h. 
The CFU on each plate was counted, and the percentage of cells surviving 
pSALect selection was determined. 
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2.7 Auxotroph rescue 
Members of the ITCHY library were tested for their ability to rescue 107 
conditionally auxotrophic strains of E. coli that are unable to grow in M9 minimal 
medium + 0.4% (w/v) glucose (Patrick et al., 2007). Each strain had a single gene 
knockout. The strains were each transformed with the random members of 
ITCHY library and screened to determine if any ITCHY clones allowed the 
bacteria to grow on M9 minimal medium + 0.4% (w/v) glucose solid agar 
medium, and therefore, the overcome the auxotrophic phenotype. The genes 
knocked out in the 107 strains are shown in Table 2.7, where they are catagorised 
based on the cellular function of the proteins they encode.  
2.7.1 Transformation of the auxotrophic strains 
Each of the 107 conditionally auxotrophic strains were made electrocompetent 
by scaling down the method used in 2.3.7.1. Briefly: for each strain 40 mL of 
LB-Cm medium was inoculated with 100 μL of cells from an overnight culture. 
The cells were grown in a flask at 37°C with shaking until the OD600 reached ~0.4. 
The cells were chilled on ice for 20 min, then pelleted by centrifugation at 3000 
rpm for 15 min. The supernatant was decanted, and cells were washed with 25 mL 
of pre-chilled sterile water. The cells were pelleted by centrifugation at 3000 rpm 
for 15 min, the supernatant decanted, and the wash step repeated. The cells were 
pelleted by centrifugation at 3000 rpm for 15 min, the supernatant decanted, and 
the cells were washed with 25 mL of pre-chilled sterile 10% (w/v) glycerol. The 
cells were pelleted by centrifugation at 3000 rpm for 15 min. The supernatant was 
decanted, and the cells resuspended in pre-chilled sterile 10% (w/v) glycerol to a 
final volume of 200 μL. The cells were separated into 50 μL aliquots. 
Each of the 107 knockout strains was transformed (as per 2.3.7.2) individually 
with 20 ng of purified pSALect:[ITCHY library pool], and 20 ng of purified 
pSALect:metC as a control. SOC (1mL) was added to recover cells. Following 
recovery, the cells were pelleted by centrifugation at 3000 rpm for 10 min. The 
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supernatant was decanted, and the cells were resuspended in 1 mL of M9 minimal 
medium + 0.4% (w/v) glucose. The cells were pelleted by centrifugation at 
3000 rpm for 10 min, and the supernatant was decanted. The cells were 
resuspended a second time in 1 mL of M9 minimal medium + 0.4% (w/v) glucose, 
and pelleted by centrifugation at 3000 rpm for 10 min. The supernatant was 
decanted and cells were resuspended in 200 μL of M9 minimal medium + 0.4% 
(w/v) glucose. The cell suspension (198 μL) was spread on M9 minimal medium + 
0.4% (w/v) glucose agar and grown in a humidified container at 37°C for 30 days. 
The number of plated cells was estimated by spreading 2 μL of cell suspension on 
an LB-Cm agar plate and determining the CFU/mL of the transformed culture. 
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2.7.2 Selection of rescuing clones 
Colonies which formed on the selective medium in 2.7.1 were used to re-streak 
M9 minimal medium + 0.4% (w/v) glucose agar plates, and grown at 37°C. Cells 
which grew on the re-streak plates were used to inoculate overnight cultures of 
LB-Cm medium for the preparation of pure plasmid and freezer stocks.  
2.7.3 Retransformation test 
 Pure plasmid of rescuing clones (attained in 2.7.2), was used to transform 
electro-competent cells of the strain that it apparently rescued. As per 2.7.1 the 
transformed cells were washed twice in M9 minimal medium + 0.4% (w/v) 
glucose prior to spreading on M9 minimal medium + 0.4% (w/v) glucose agar.  
2.8 Protein purification and analysis 
2.8.1 SDS-PAGE 
SDS-PAGE (sodium dodecyl-sulfate polyacrylamide gel electrophoresis) was 
used to analyse the approximate molecular weight and concentration of protein 
samples. As standard, 12% resolving, and 5% stacking gels were used which were 
prepared (Table 2.8) and run as described in Sambrook & Russell (2001). 
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Acrylamide/Bis (40% w/v) was obtained from Bio-Rad. Ammonium persulfate 
(APS) and TEMED were added last to the reaction mixture and gels cast 
immediately.  
Gels were cast and run using the Mini-PROTEAN Tetra Cell system (Bio-Rad). 
Gels were run in 1x SDS-PAGE buffer (25 mM Tris-HCl, 192 mM glycine, 
0.1% (w/v) SDS.  
Samples were pre-mixed 1:4 with 5x sample buffer (250 mM Tris-HCl, pH 6.8, 
10% (w/v) SDS, 30% (w/v) glycerol, 5% (v/v) β-mercaptoethanol, 0.05% (w/v) 
bromophenol blue) prior to loading.  
Gels were run at 200 V for 45 min alongside a 5 μL of Precision Plus Protein 
standard (Bio-Rad) using an electrophoresis power supply pack (EPS301, 
Amersham Biosciences). 
Gels were stained with Coomassie blue stain (0.1% (w/v) Coomassie brilliant 
blue R-250 (Bio-Rad) in MQ water: methanol: acetic acid (5:5:2) (v/v/v)), and 
destained (30% (v/v) methanol, 10% (v/v) acetic acid in MQ water), prior to 
imaging (Bio-Rad Gel Doc XR+). 
2.8.2 Protein expression 
All proteins were expressed under the same conditions in TB or AIM liquid 
medium. The expression medium (with appropriate antibiotic) was inoculated 
with a 1000-fold dilution of cells from the desired overnight culture. The 
expression culture was grown at 37°C with shaking until the OD600 reached ~0.6. If 
using AIM, the culture was not further treated and grown at 18°C for 24 h with 
shaking. If using TB, the culture was supplemented with IPTG (final 
concentration 500 μM), and the culture was grown at 18°C for 24 h with shaking. 
Cells were pelleted by centrifugation at 3000 rpm for 15 min. Cell pellets were 
stored at -20°C. 
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2.8.3 Protein purification 
All purifications used the TN buffer: 40 mM Tris-HCl pH 7.7, 300 mM NaCl. 
All proteins were expressed with an N-terminal His6-Tag, so initial purification 
was undertaken using immobilized metal affinity chromatography (Talon-Co 
resin).  
2.8.3.1 Metal affinity purification using Talon resin 
Preparation of clarified lysate: 
Cell pellet was resuspended (per gram) in 5 mL of TN buffer supplemented with 
1x BugBuster (Novagen), lysozyme 0.5 mg/mL (final), 2.5 U Benzonase 
(ThermoScientific), and 20 uL protease inhibitor cocktail (Sigma-Aldrich). The 
mixture was incubated at room temperature for 30 min with shaking at 100 rpm. 
The insoluble debris was pelleted by centrifugation at 13,000 rpm for 20 min at 
4°C (JA17 rotor, Beckman Coulter Avanti J-26 XP centrifuge). The supernatant 
was clarified by filtration through a 0.45 μm filter. 
Talon resin purification: 
Per 1 L of expression culture, 3 mL of Talon resin suspension (1.5 mL bed 
volume) was used.  
The resin was pelleted by centrifugation at 700 x g for 2 min (Swing bucket 
rotor, Eppendorf 5810 R centrifuge). The supernatant was discarded, and the resin 
resuspended in 10 bed volumes of TN buffer. This wash step was repeated two 
more times. 
The clarified lysate was added to the resin and the mixture was gently agitated 
at 4°C for 60 min. The resin was pelleted by centrifugation at 700 x g for 5 min, 
and the supernatant was removed and stored as the unbound fraction. The resin 
was washed by resuspension in 10 bed volumes of TN buffer and gently agitated at 
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4°C for 10 min. The resin was pelleted by centrifugation at 700 x g for 5 min, and 
the supernatant was discarded. This wash step was repeated two more times. 
The resin was resuspended in 1 bed volume of TN buffer, and transferred to a 
gravity flow column with the end cap in place. The resin was allowed to settle 
before the end cap was removed, and the buffer was allowed to drain until it was 
near the top of the resin. 5 bed volumes of TN buffer was added to the column and 
the flow-through was collected (Wash 1). 5 bed volumes of TN buffer + 7 mM 
imidazole was added to the column and the flow-through was collected (Wash 2). 
The protein was eluted by adding 4.5 mL of TN buffer + 150 mM imidazole to the 
column and the flow-through was collected in 1.5 mL fractions (Elution 1, 2, and 
3).  
Samples of whole cell lysate, clarified lysate, unbound fraction, wash fractions, 
and elution fractions, were analysed by SDS-PAGE. 
Samples containing the purified protein of interest, were pooled, and buffer 
exchanged into TN buffer, and concentrated. Buffer exchange and concentration 
were completed by centrifugation at 4000 x g using the appropriate molecular 
weight cut-off Amicon Ultra centrifugal filter unit.  
2.8.3.2 HisPur 96-well plate purification 
Equilibration of HisPur plate: 
Water (400 μL) was added to each well of the HisPur plate, and the plate and 
sample collection tray were centrifuged at 100 x g for 1 min. The flow-through 
was discarded. TN buffer (400 μL )was added to each well, and the plate and 
sample collection tray centrifuged at 100 x g for 1 min. The flow-through was 
discarded, and the previous wash step was repeated. The flow through was 




Preparation of soluble lysate: 
For purification via HisPur 96-well plates 1 mL expression cultures were 
prepared in deep well 96-well plates (2 mL well volume) using AIM and grown as 
described in 2.8.2 except with shaking at 1200 rpm. Cells were pelleted as per 2.8.2 
and frozen for a minimum of 30 min. The cells were lysed as described in 2.8.3.1 
in a volume of 100 μL and shaking at 1200 rpm.  
The insoluble debris was pelleted by centrifugation of the plate at 1900 x g for 
30 min. The soluble lysates were carefully transferred to wells of a pre-equilibrated 
HisPur plate. The resin + soluble lysate was allowed to sit for 15 min. The plate 
was then centrifuged at 100 x g for 1 min. The sample collection tray was kept as 
the “unbound” protein. The plate was washed three times by the addition of 400 
μL TN buffer and centrifugation at 100 x g for 1 min.  
TN buffer + 150 mM imidazole to a volume of 110 μL, was added to each well of 
the HisPur plate, and the plate was incubated for 15 min at room temperature. 
The protein was eluted into a fresh sample collection tray by centrifugation of the 
plate at 100 x g for 1 min.  
Protein samples were analysed by SDS-PAGE.  
2.8.3.3 Size exclusion chromatography 
Purification of proteins by size exclusion chromatography was performed using 
a Superdex 16/600, 200pg column (GE Life Sciences) and an ÄKTA prime or 
ÄKTA Pure protein purification system. 
The flow rate for all steps was set to 0.7 mL/min with a pressure limit of 
0.3 MPa. 
All water and solutions were filtered through a 0.1 μm filter and degassed prior 
to use. 
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Protein samples were prepared by concentrating the sample to a volume of 
<1 mL, and following centrifugation at 10,000 x g for 10 min to remove protein 
aggregate. 
The pumps and column was equilibrated with a minimum of two column 
volumes of MQ water (260 mL) followed by two column volume of TN buffer 
(260 mL). The sample was injected into a 2 mL sample loop and loaded onto the 
column by switching the machine to “inject” for a total volume of 15 mL.  
Fractions (3 mL) were collected, starting 30 mL after the sample was loaded and 
ending 130 mL after loading of sample. 
The fractions correlating to peaks in the absorbance at 280 nm were analysed by 
SDS-PAGE and the fractions of interest were pooled and concentrated. 
Following purification, the column was cleaned with two column volumes of 
water and stored in 20% (v/v) ethanol. 
2.8.4 SEC-MALS 
All water and solutions were filtered through a 0.1 μm filter and degassed prior 
to use. 
Protein samples were prepared by concentrating the sample to ~10 mg/mL, and 
centrifuging the sample at 10,000 x g for 10 min to remove protein aggregate. 
The flow rate for the experiment was set at 0.4 mL/min and the pressure limit to 
3 MPa. 
SEC-MALS experiments were undertaken using a Dawn 8+ MALS detector 
(Wyatt), a Superdex 30 Increase 10/300 GL column (GE Life Sciences), and an 
ÄKTA Purifier. 
The MALS detector was purged with 40 mL of 20% (v/v) ethanol. The lines and 
pumps were then flushed with MQ water followed by TN buffer. The 
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pre-equilibrated column (equilibrated with 2 column volumes of MQ water 
(48 mL) and 2 column volumes of TN buffer (48 mL), was attached to the system. 
The RI detector flow cell was purged for a minimum of 90 min, until a steady 
baseline was reached. A volume of 200 μL of protein sample was injected into an 
equilibrated 500 μL sample loop and loaded onto the column.  
The data were collected and analysed the “Astra” software package. During 
analysis, detectors that collected poor quality data were excluded from the final 
analysis. 
Following data collection, the column and MALS were cleaned with two 
column volumes of water and stored in 20% (v/v) ethanol.   
2.8.5 Thermal shift assays 
Thermal shift assays were performed using the Roche LightCycler 480 II. 
Protein denaturation was detection through binding of the fluorophore, SYPRO 
Orange (Roche) to exposed hydrophobic residue. The excitation wavelength was 
set at 465 nm, and the emission wavelength was set at 580 nm. The program 
settings were set as per Table 2.9. 
 
Sample condition were setup as follows: 1x TN Buffer, 5x SYPRO Orange dye, 
10 μM protein sample. Experiments were set up in LightCycler 480 Multiwell 
plates (Roche). All samples were set up in triplicate 
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2.8.6 Circular dichroism spectroscopy 
Circular dichroism (CD) spectra were collected using a Jasco J-1500 CD 
spectrometer according to the manufacturer’s instructions. Prior to the collection 
of the data the sample compartment device was purged with nitrogen gas at a flow 
rate of 5 L/min for a minimum of 30 min.  
Spectra were collected from 185–260 nm in a 0.1 cm quartz cuvette. Data pitch 
was set at 0.1 nm, scanning speed was set at 50 nm/min, the digital integration 
time was set at 4 s. Spectra recordings were made in triplicate. Nitrogen gas was 
supplied throughout the experiment at 5 L/min. 
Protein samples were buffer exchanged into CD buffer: potassium phosphate 
buffer pH 7.7 10 mM, KF 40 mM, to a final protein concentration of 0.6 mg/mL. 
Samples were centrifuged at 10,000 x g for 10 min to remove any protein 
aggregate prior to measurement.  
A baseline was set by measuring a buffer only spectrum. All results were 
corrected using the baseline reading.  
Following data collection, the relative quantity of secondary structure elements 
was estimated using three separate algorithms: Jasco-CD Multivariate SSE, 
Raussens (Raussens et al., 2003) and BeStSel (Misconai et al., 2018). 
2.8.6.1 Monitoring thermal stability with CD spectroscopy 
Thermal stability of proteins was monitored by measuring CD spectra at 5°C 
increments from 25°C to 85°C using the “Temperature Interval Measurement” 
scan function of the Jasco software. The experimental parameters were the same 
as above. Three full spectrum scans were made at each specified temperature for a 












This chapter describes the production of libraries of hybrid genes generated 
from fragments of whole E. coli genes.  The methodologies used were developed in 
part during this study, and as such, required optimisation. As discussed in 
Chapter 1.4.1, the main method used for generating hybrid genes was ITCHY. 
This method joins two randomly truncated genes together to form a single 
chimeric gene from two random parental genes. 
3.2 ITCHY methodology 
Chapter 1.4.1 highlighted the key steps of all of the ITCHY variants: gene 
combination, truncation, and recombination. For use in this study, the limiting 
factor of the previous iterations of ITCHY was in the gene combination step. 
Previous ITCHY studies aimed to combine fragments from two known genes of 
interest, while this study required the combination of fragments of all E. coli 
ORFs. This meant that individually cloning genes of interest into a single 
construct was not plausible. Instead a two-plasmid ITCHY method was used to 
randomly combine any combination of ORFs using overlap extension PCR 
(Figure 3.1). 
Two-plasmid ITCHY uses the plasmids pSALect-FseI and pSALect-NotI, which 
have almost identical backbones, while each has a unique restriction site (FseI, or 
NotI respectively) for linearizing the plasmids. An ORF (or ORF library) is cloned 
into each plasmid. The FseI restriction is site at the 5¢ end of the ORF insertion 
site, whereas the NotI cut site is at the 3¢ end of the ORF insertion site. The 
differing position of the restriction sites means that once linearised the two 
plasmid backbones act as mega-primers and allow for overlap extension PCR to 
be used to splice the two ORFs into a single construct. Once combined using 
overlap extension PCR, universal primers that recognise site P1 and P2 are used to 
amplify across the entire linear plasmid, now including two parental genes and the 
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plasmid backbone (Figure 3.1). Amplification is followed by partial digestion of 
the linear DNA using Exonuclease III – which digests in a 3ʹ–5ʹ direction from 
each end of the DNA – leaving single stranded overhangs. The single stranded 
DNA is then removed using mung bean nuclease, and the ends of the DNA are 
polished with the Klenow fragment of DNA polymerase I, which is a process 
filling any single nucleotide overhangs. The DNA is recircularised to result in a 
complete plasmid, containing a hybrid gene made of fragments from two parental 
genes.  
This two-plasmid ITCHY protocol had been described previously for the 
simplest case in which there was a single parent in each plasmid (Gerth & Lutz, 
2007). In this study, each step required optimisation for use in the vastly more 
complicated scenario in which each plasmid contained a pool of every E. coli ORF. 
The most problematic step was the overlap extension PCR. The method was first 
optimised using two randomly-selected parental genes, before moving forward 



















Figure 3.1 Two plasmid ITCHY. Overview of the ITCHY protocol using overlap extension 
to combine any two ORFs. Truncation of the combined ORFs and ligation results in a 
hybrid ORF built from fragments of any two parental genes. 
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3.3 Two parent ITCHY 
3.3.1 Overlap extension PCR  
It was important to optimise the overlap extension PCR step of the ITCHY 
protocol. The primary goal of this step was to produce as much of the desired 
DNA product as possible, with as few off target products as possible. However, 
because the ITCHY protocol requires >3500 ng of DNA, off target products were 
acceptable if the conditions produced a large amount of the target DNA. While 
the overall goal was to combine every E. coli ORF with every other E. coli ORF, the 
first step was to optimise to process with only two parental genes. 
3.3.1.1 Optimisation attempts 
In initial optimisation trials two clones were randomly chosen from the ASKA 
collection: pCA24N-lit and pCA24N-dusA. The ORFs were excised from pCA24N 
and subcloned into the two plasmids used for ITCHY, pSALect-FseI and pSALect-
NotI (Figure 3.2). The result was pSALect-FseI:lit and pSALect-NotI:dusA. The 
two plasmids were linearised with the restriction enzymes FseI and NotI. Whole-
plasmid overlap extension PCR was attempted with the primers P1 and P2 (Table 
2.3). Attempts to combine the lit and dusA genes onto a single plasmid backbone 
using PCR were unsuccessful. A ~5500 base pair (bp) product was expected from 
a successful PCR. Only non-specific, low molecular weight DNA was observed in 
initial experiments. 
Many modifications were made to the protocol in attempts to overcome the 
failure of the overlap extension PCR including: varying the annealing temperature 
between 50°C and 70°C; altering the DNA template amount from 5 ng–20 ng of 
each plasmid per reaction; adding DMSO to final concentrations of 2%–6% (v/v); 
using Phusion and KAPA Taq polymerases; and testing a variety of buffer 
conditions. 
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A PCR product of the expected size was not produced under any of the 
conditions tested. The failure of the PCRs indicated a potential issue with the 
design and/or construction of the pSALect plasmids that were used for overlap 
extension. Careful re-analysis of the plasmid sequences revealed a sequence 
mismatch between the two plasmids (Figure 3.2). In order for the overlap 
extension PCR to work, the 5’ end of the linearised pSALect-FseI:lit must anneal 
with the plasmid backbone of the linearised pSALect-NotI:dusA, and vice versa. 
While ~3200 kb of each backbone matched the other perfectly, 6 mismatched 
bases at the 3ʹ end of pSALect-FseI meant that this could not act as a mega-primer 
for amplifying pSALect-NotI. The mismatch was a result of the overhang left after 
the digestion of pSALect-FseI with FseI restriction enzyme. This overhang was not 
considered by past lab members in the original design and construction of the 
plasmids. The error remained undetected as the system had not been tested until 
the time of this research. 
3.3.1.2 Altering pSALect-NotI 
In order for the overlap extension PCR to work the plasmid backbone of 
pSALect-NotI needed to be altered. A 9 base pair insertion was made in pSALect-
NotI (Figure 3.2b) using QuikChange mutagenesis. The insert created an 
annealing site for the 3’ end of pSALect-FseI, once linearised with FseI, that had 







3.3.1.3 Results with modified pSALect-NotI 
The E. coli gene yeeL, was randomly selected and sub-cloned into the modified 
pSALect-NotI plasmid. Overlap extension PCR was attempted with pSALect-
FseI:lit and pSALect-NotI:yeeL, using the P1 and P2 primers to amplify across the 
entire construct after the two genes were combined (as shown in Figure 3.2). The 
Figure 3.2 Overview of mismatched sequence in pSALect plasmids, and cloning strategy 
to correct the mismatch. A) schematic highlighting the reason why overlap extension 
failed, as well as an alignment of the two pSALect plasmids, indicating mismatched 
nucleotides. Because the mismatch occurred at the 3’ end of the linear pSALect-FseI, the 
plasmid could not act as a mega-primer for amplification of the recombined construct. B) 
Summary of the QuikChange mutagenesis strategy employed to alter pSALect-NotI. 
Overlapping primers with the insert to be added were used to amplify the entire plasmid. 
Cells were transformed with the amplified construct and then screened for the insert by 
sequencing. C) An alignment of pSALect-FseI and pSALect-NotI after the insert had been 
added, showing how pSALect-FseI could now act as a primer for amplification of the 
altered pSALect-NotI. 
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PCR successfully combined lit and yeeL onto a single construct and amplified the 
assembled DNA (Figure 3.3). 
Initial experiments yielded the desired PCR product, but also a number of off-
target products (Figure 3.3). Following sequence analysis of the pSALect plasmids 
and the primers designed to amplify across the whole construct, it was believed 
that one of the sources of off-target products was the misspriming of the P1 and 
P2 primers. P1 was designed to anneal to pSALect-FseI in the forward direction, 
and P2 was designed to anneal to pSALect-NotI in the reverse direction. However, 
because of the modifications that had been made to pSALect-NotI, as well as 
similarities in the primer binding sites of each plasmid (particularly the presence 
of SfiI restriction sites) P1 and P2 would likely be able to bind to both plasmid 
backbones. In an attempt to minimise the off-target products P1 and P2 were 
redesigned. The P1 annealing site was shifted in the 5ʹ direction by 6 bp, resulting 
in P1ver2. P2 was reduced to 19 bp and its annealing site shifted 8 bp in the 5ʹ 
direction, resulting in P2ver2.  P1ver2 and P2ver2 were used in all subsequent 
experiments. The new primers did not greatly reduce off-target products; 
however, they did increase the yield from the overlap extension PCR (Figure 3.3). 
This result suggested the off-target products were likely a result of incomplete 
amplification of the whole construct, potentially due to Taq polymerase being less 
processive than other polymerases. Phusion polymerase was also trialled however 
the yield of target product was found to be lower. 
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3.3.2 Truncation, end polishing, and ligation 
 After the lit and yeeL genes were recombined onto a single construct, they were 
randomly truncated and prepared such that the two fragments could be ligated 
together. Each of these steps were more straightforward than the overlap 
extension PCR, however each was still optimised to yield the maximum sized 
library.  
3.3.2.1 Truncation 
 Exonuclease III (exoIII) was used to make random truncations from each end 
of the amplified construct. ExoIII removes nucleotides in a 3’–5’ direction leaving 
Figure 3.3 Overlap extension PCR of pSALect-FseI:lit and pSALect-NotI:yeeL. Agarose 
gel electrophoresis of DNA from attempts to combine lit and yeeL by overlap 
extension PCR. L: KAPA DNA ladder; 1+2: PCRs using P1 and P2 primers with 
annealing temperatures of 53°C and 56°C respectively; 3: PCR with optimised 
conditions as per Chapter 2.4.1. 
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single stranded 5’ overhangs. The single stranded overhangs were removed using 
mung bean nuclease. The exoIII reaction was controlled in a time dependent 
manner to determine the lengths of the final truncated genes. For the purpose of 
the experiment it was important to generate a library of hybrids with a variety of 
lengths, therefore after a 5 min incubation aliquots of the exoIII reaction were 
removed and inactivated every 30 s, up until 20 min (as described in Methods 
section 2.4.2), for subsequent analysis on an agarose gel. The efficacy of the time-
dependent truncation step was shown using a single DNA construct where the 
DNA was treated with exoIII and inactivated at 2 min intervals (a longer time 
interval than in ITCHY experiments to better show truncation occurring), and 
then treated with mung bean nuclease to remove single stranded overhangs 
(Figure 3.4). 
3.3.2.2 End polishing and ligation 
In order for the construct to be recircularized, any single-nucleotide overhangs 
left from the truncation steps needed to be “polished”. The Klenow fragment of 
E. coli DNA polymerase I was used. The Klenow fragment removes 3’ overhangs, 
Figure 3.4 Time dependent truncation test. Agarose gel electrophoresis showing the 
time dependent truncation of a linear DNA construct with ExoIII and mung bean 
nuclease. Samples were taken at two min intervals from the ExoIII reaction mixture and 
the ExoIII inactivated. The times indicate the relative time each sample was digested 
with ExoIII nuclease. 
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and fills in 5’ overhangs, leaving blunt ends. This was a necessary step as 
experiments undertaken without end polishing resulted in little to no product able 
to transform bacterial cells. 
Blunt end ligation was achieved using a method of cycling ligation temperatures 
between 10°C–30°C (Lund et al., 1996) for 16 h. This method yielded the greatest 
number of colony forming units (CFU) following transformation of E. coli cells. 
3.3.3 Results of optimised two-parent ITCHY 
Following optimisation of each step of the ITCHY protocol, the ligated pool of 
truncated hybrids was used to transform the E. coli strain Ecloni 10G. Colonies 
which grew on selective media were screened by PCR for the presence of the   
pSALect plasmid, containing an insert (Figure 3.5A). Approximately one third of 
the colonies were able to be amplified, suggesting some of the clones were 
truncated past one, or both, of the primer sites. Further optimisation of the 
truncation step was unnecessary as the "All versus All" ITCHY experiment 
included different genes of differing lengths. Sequence analysis of the amplified 
inserts revealed that the ITCHY experiment had been successful. Colonies 
contained hybrids built from randomly truncated pieces of yeeL and lit (e.g. 
Figure 3.5B). Sequencing of 8 clones revealed an average hybrid gene of ~700 bp, 
with ~410 bp of yeeL and ~290 bp lit. The yeeL fragments ranged from 123 bp to 
819 bp while the lit fragments ranged from 102 bp to 790 bp. 
The successful combination of different sized fragments of yeeL and lit 
confirmed that the two plasmid ITCHY protocol worked with two known 
parental genes. The next step was to recombine all of the E. coli ORFs. 
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.  
Figure 3.5 Screening of two-parent ITCHY clones. Results of experiments to 
combine fragments of lit and yeeL using the ITCHY protocol. A) Agarose gel 
electrophoresis showing colony PCR amplification of the inserts from the pSALect 
plasmid in colonies transformed by ITCHY clones. Lanes 1, 3 and 10 indicate 
products able to be successfully amplified. The other lanes indicate a number of 
off target products, this unsuccessful amplification is likely due to over-truncation 
of the pSALect construct. B) A schematic showing the gene structure of the 
lit/yeeL ITCHY hybrid from lane 1 as shown by DNA sequencing results.  
 67 
3.4 "All versus All" ITCHY 
The overarching goals of this thesis were to generate a large library of shuffled 
subdomains, and to identify novel folded and/or functional hybrid proteins within 
it. By utilising the two plasmid ITCHY protocol, it was theoretically possible to 
start with a pool of all E. coli ORFs cloned into both pSALect-FseI and pSALect-
NotI, and to finish with a library which contained any possible 5’ fragment of one 
ORF fused to any possible 3’ fragment of another. The pool of E. coli ORFs first 
needed to be cloned into the pSALect plasmids. 
3.4.1 Subcloning the ASKA collection 
As discussed in 1.4.1, the ASKA collection was used as a source of E. coli ORFs. 
Each ORF from the ASKA collection could be subcloned into the pSALect 
plasmids using the SfiI restriction enzyme. SfiI has a number of unusual 
properties which make it useful in molecular biology. It has a 13 bp recognition 
site where the middle 5 bp are free to vary (Figure 3.6a). The enzyme only cuts 
efficiently when two cut sites are present, cutting both sites simultaneously. This 
means that cut sites can be engineered such that sections of DNA can be sub-
cloned with directionality using a single restriction enzyme (Figure 3.6b).  
Figure 3.6 The SfiI restriction 
enzyme. A) The recognition site 
of SfiI restriction enzyme. The 
five base pairs in the middle of 
the site can be unique to the 
designed site B) When two 
unique SfiI sites are used 
together it allows for 
maintenance of directionality 
during cloning. The insert will 
only be able to ligate into the 
plasmid if the two sites are 
oriented correctly.  
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Each ORF in the ASKA collection is flanked by two SfiI sites with unique 
recognition sites, which match those in the pSALect plasmids. The entire 
collection of ~4,200 ASKA clones had previously been pooled (Patrick et al. 2007). 
The pool was cultured and plasmid DNA was isolated from it. This DNA was 
digested using SfiI, and the DNA purified from an agarose gel. Because the genes 
are of varying lengths, a smear of DNA is observed on an agarose gel. All of the 
DNA within the desired size range was purified. The purified DNA, which 
contained every ORF from the ASKA collection, was ligated into both pSALect-
FseI and pSALect-NotI. E. coli cells were transformed with the ligated 
pSALect:ASKA libraries. Colonies were screened by PCR to investigate the sizes of 
the subcloned ORFs (Figure 3.7). From the 24 colonies screened the ORF sizes 
ranged from ~400 bp to ~3000 bp. To maximise the likelihood of covering the 
entire ASKA collection, ~100,000 colonies were recovered for both the pSALect-
FseI:ASKA pool, and the pSALect-NotI:ASKA pool.  
Figure 3.7 PCR screen of subcloned ASKA collection in pSALect-FseI and pSALect-NotI. 
Agarose gel electrophoresis of DNA from colony PCR amplification using pSALect.for and 
pSALect.rev2 of colonies from ASKA collection subcloning experiments. Each band is 
indicative of the size of the ORF in the respective pSALect plasmid.  
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3.4.2 "All versus All" ITCHY issues 
Predictably, implementing the two-plasmid ITCHY protocol (Figure 3.1) with 
~4200 different parental genes in each plasmid was non-trivial. A number of steps 
required careful re-optimisation. 
3.4.2.1 Overlap extension PCR 
With so many parental genes, there was the potential for off-target products to 
be formed any time that an ORF sequence misannealed to the pSALect backbone. 
This was found to be the case both in early experiments, and subsequent rounds of 
optimisation (Figure 3.8). However, these off-target PCR products were unlikely 
to affect the results of the experiment overall, as they would lack the functional 
elements (such as the origin of replication and/or the antibiotic resistance marker) 
required for maintenance in E. coli. Therefore, PCR optimisation focussed on 
increasing the yield of target product, with reduction of off-target products a 
secondary concern. Alterations to annealing temperatures throughout different 
phases of the PCR, parental DNA concentration, and choice of DNA polymerase 
lead to optimum conditions for the "All vs All" overlap extension PCR 
(Figure 3.8). The final PCR conditions can be found in section 2.4. 
Figure 3.8 "All versus All" overlap extension PCR 
optimisation. Agarose gel electrophoresis showing 
the products of the overlap extension PCRs to 
randomly combine ORFs from the ASKA collection. 
Despite attempts to optimise the protocol off-
target products were still produced. Instead, the 
optimised protocol produced more DNA, which 
was key to the rest of the experiment. Note: the 
target products appear as a smear of DNA 
extending above 4000 bp. This is due to the 
combination of ORFs of varying sizes. The final 
condition of the PCR can be found in section 2.4.1 
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3.4.2.2 Truncation of hybrids 
Because the ORFs ranged in size from a few hundred to a few thousand base 
pairs, truncating the pool of hybrids to lengths in the range of subdomains 
(~150 bp – 350 bp) was problematic. Early experiments resulted in over 
truncation, where one or both of the parental genes was completely digested by 
exoIII. The truncation conditions were altered to reduce truncation time; aliquots 
were taken every 15 s with the initial incubation time reduced to 2 min and a total 
reaction time of 15 min. Equally, hybrids with little to no digestion of ORFs were 
also observed.   
Because of the potential variation in size of the parental genes it was impossible 
to completely control the size of the fragments generated. Therefore, despite 
attempts to optimise the truncation steps of the of the "All versus All" ITCHY 
many of the issues discussed were not completely eliminated. 
3.4.2.3 Parental DNA contamination 
 In initial experiments, it was discovered that parental plasmid DNA used in the 
overlap extension PCR was contaminating the later stages of the experiment. This 
lead to complete single gene constructs being identified in screens of transformed 
colonies. To overcome this, a DpnI digest step was introduced following PCR 
amplification of the hybrid constructs. In bacteria, the sequence GATC is 
methylated by the enzyme DNA adenine methyltransferase. GATC is also the 
recognition sequence for the restriction enzyme DpnI. DpnI cleaves only when its 
recognition site is methylated, meaning it will digest parental plasmid, which is 
produced in the bacteria, but not PCR products as they are not methylated. The 
pSALect plasmids have 20 DpnI recognition sites, meaning it is extremely unlikely 
any of the parental plasmid DNA would ligate together to form a functional 
plasmid. 
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3.4.3 Results of "All vs All" ITCHY 
Ultimately, the optimised protocol yielded libraries of hybrid genes. The 
hybrids comprised combinations of randomly sized fragments of random E. coli 
genes. Screening by colony PCR revealed that hybrids were of varying sizes 
(Figure 3.9). As mentioned above, many colonies still contained plasmids with one 
or both of the parental genes over-truncated, resulting in no distinct PCR product. 
It was estimated from 60 PCR reactions that ~50% of the clones were over-
truncated hybrids.  
Sequencing results highlighted examples of the hybrids identified. A 
combination of the two yciG and ydjO was sequenced (Figure 3.10). In this 
example, a 74 bp 5ʹ fragment of the 180 bp yciG gene is fused to a 91 bp fragment 
from the 3’ end of ydjO (271 bp). The hybrids in the library are further analysed in 
Chapter 4. 
Figure 3.9 Colony PCR screen of cells transformed with "All versus All" ITCHY Library. 
Agarose gel electrophoresis DNA from colony PCR screen. Following the generation of the 
"All versus All" ITCHY library, E. coli cells were transformed with the library. Cells were 
screened to determine the insert size using colony PCR. The lanes without bright bands likely 
represent clones that have been over-truncated by ExoIII and lack the required primer sites.   
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The largest library generated was ~10,000,000 clones, which resulted from 36 
separate transformations. As up to 50% of the library may include over-truncated 
gene fragments, the functional size of this library is likely ~5,000,000. This ITCHY 
library was used for all future experiments unless otherwise stated.  
3.5 Restriction digest fragment libraries 
Most of the work of this thesis focussed around the generation and screening of 
ITCHY libraries, however, alternate methods for creating libraries of hybrid genes 
were also investigated. The most promising alternate method was one which 
utilised blunt cutting restriction enzymes to fragment E. coli ORFs into pieces, 
which were then ligated back together as shuffled hybrids. The rationale behind 
the method, and the results obtained, are described briefly below for the benefit of 
future researchers in the field. 
Figure 3.10 Gene structure of the hybrid yciG/ydjO. Sequencing of DNA from the 
colony PCR screen in Figure 3.9 revealed a nuber of truncated hybrids. One of the 
hybrids was a combination of fragments of the genes yciG and ydjO. The presence of 
these truncated hybrids highlighted the success of the "All versus All" ITCHY 
experiment.  
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3.5.1 Experimental design 
This method utilised two restriction enzymes, AluI and BstUI. Both of these 
enzymes are blunt cutters, with 4 bp recognition sites, meaning they cut the E. coli 
genome frequently. AluI has ~13,340 recognition sites in the E. coli genome; 
approximately 1 every 350 bp. BstUI has ~28,220 recognition sites in the E. coli 
genome; approximately 1 in every 165 bp. In conjunction, the two enzymes would 
give fragments with an average size of ~110 base pairs. Used together or 
individually, AluI and BstUI would produce DNA fragments in the range 
predicted to encode subdomain-sized polypeptides. 
Instead of using genomic DNA, plasmid DNA from the pooled clones of the 
ASKA collection was isolated. The plasmids were digested with SfiI, excising the 
ORFs. The ORFs were purified from an agarose gel before being further digested 
using AluI, BstUI, or both. The resulting blunt-ended fragments were ligated back 
together to form hybrids, with the potential to be built from fragments of any 
E. coli genes. The convenient part of this method was that some of the fragments 
still had a digested SfiI site on one end, with a single-stranded overhang. The 
overhangs would not be able to ligate to the blunt fragments, or to other SfiI 
overhangs (because of the non-palindromic nature of SfiI sites). These 
overhanging ends would act to "cap" each end of the growing hybrid. If a hybrid 
was "capped" by 5’ and 3’ SfiI overhangs in the correct orientation, then this 
hybrid could be ligated directly into a vector with complementary SfiI sites 
(Figure 3.11). 
3.5.2 Library construction results 
Restriction digest fragment libraries were constructed with varying levels of 
success. There were a number of problems which meant that this method was not 
used widely throughout this research project. 
Initial trials proved that the concept could work; hybrid genes were built from 
fragments of other genes (Figure 3.12). However, further investigation found that 
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within the small-scale libraries, many ORFs were not digested at all by the 
restriction enzymes (found by sequencing), despite the presence of the correct 
restriction sites. The partial digestion was thought to be a result of having too 
much DNA in the initial digest, however repeated experiments were unable to 
completely eliminate this issue.  
Figure 3.11 Restriction digest fragment library experimental design. Begin with a pool 
of ORFs flanked by the desired SfiI sites; in the case of this experiments, the ORFs from 
the ASKA collection. Digest with a restriction enzyme to generate a pool of fragments. 
Ligate these fragments back together, to generate hybrid genes. A subset of these 
hybrid genes will be flanked by the correct SfiI sites to enable further ligation into a 
vector.  
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The method was also problematic with regards to small ORFs. There are 787 
E.coli ORFs smaller than 350 bp (average size of AluI fragment) and 109 ORFs 
smaller than 165 bp (average size of BstUI fragment). These intact ORFs would 
cause issues with screening as one of the main types of screening that was 
undertaken was for soluble protein hybrids (discussed in detail in Chapter 4). 
Small, intact ORFs would flood the selection for soluble hybrids. Of the clones 
sequenced, ~60% were intact ORFs.  This bias towards intact ORFs in trial 
selection experiments, meant restriction fragment hybrid libraries were not used 
for further selection experiments in this study. 
3.6 Discussion 
The goal of the work in this chapter was to generate a library of hybrids made 
from subdomain sized fragments of E. coli ORFs. The quality of this library will be 
highlighted in Chapter 4, however, the efficacy of the library preparation methods 
used is discussed below.  
3.6.1 Expanding the bounds ITCHY 
This work pushed the limits of the ITCHY protocol. As discussed, previous 
ITCHY experiments have aimed to combine two closely related genes (Gerth & 
Lutz 2007), while this work attempted to combine fragments of any two E. coli 
Figure 3.12 Example hybrid generated via assembly of restriction digest fragments. The 
map shows the combination of fragments from four genes to generate a single hybrid 
gene. The arrows indicate the directionality of each fragment. This example was proof 
of principle for the methodology. The hybrid also highlights one of the major issues 
with the method, as half of the fragments are in the wrong direction to be correctly 
expressed. 
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ORFs. The overall size of the library is similar to libraries described previously, 
however the potential diversity of the library generated in this work in much 
greater. For example, in Gerth & Lutz (2007), the potential size of the library was 
~4.9 x 105 (648 bp of one gene x 750 bp of the second gene). This assumes that the 
cross point could occur at every single base pair of either gene. For the work 
presented here the potential library size is ~1.6 x 1013. This is based on the average 
length of the ORFs being 1000 bp, and there being 4000 ORF. Hence every 
possible combination is equal to: 
  1000 bp x 4000 ORFs (Parent one) x 1000 bp x 4000 ORFs (Parent two)  
This work has therefore expanded the scope of ITCHY to be able to 
simultaneously combine fragments of multiple parental genes. Many of the issues 
described above are as a result of the attempt to combine and fragment genes of 
differing length. This makes optimisation of some facets of the protocol almost 
impossible. However, the library was never intended to be perfect, as the selection 
tools utilised in Chapter 4 were designed such over-truncation of genes would 
result in a clone unable to survive selection. As such, full length genes were more 
problematic, which was why more emphasis was placed on removing these during 
library preparation.  
3.6.2 Comparison of library preparation techniques 
One of the disadvantages of ITCHY is that it is only able to combine two 
fragments; one containing the N-terminus of "protein A", and the other 
containing the C-terminus of "protein B". Being constrained to these fragments by 
ITCHY was one reason the restriction digest fragment libraries were attempted. 
These fragment libraries could combine any part of any protein, and also combine 
more than two fragments. Aside from the fact that the fragment libraries had 
issues with whole length ORFs, ITCHY is useful as it preserves the directionality 
of the two fragments. Because all fragments in the ITCHY hybrids will be in the 
right direction it means that the ITCHY library will need to be half the size (when 
 77 
two fragments are combined) of libraries produced by techniques that do not 
preserve directionality, in order to have the same effective size. Furthermore, for 
the purpose of determining if subdomains play a role in the evolution of proteins, 
randomly generated sequences, which have been used in the past to generate 
proteins (Prijambada et al., 1996; Keefe & Szostak, 2001) will be unhelpful. 
ITCHY (and the restriction digest fragment libraries) preserve the sequence of the 
parental ORFs, potentially preserving subdomains within the hybrid sequences. 
3.6.3 Overall assessment of the ITCHY library 
As discussed throughout this chapter, the limited sequence analysis of the 
10,000,000 clone ITCHY library suggests that there are a number of artefacts in 
the library which will reduce its effective size. It was predicted that ~50% of the 
clones contained either over-truncated, or full length ORFs. Previous studies have 
not mentioned similar issues; however, this work is the most complicated 
application of ITCHY to date, and thus much more difficult to optimise. Like all 
ITCHY libraries, ~66% of the clones will be out of frame, due to randomly 
recombining DNA sequences. This means the effective library size is ~1,650,000.  
To find proteins of interests in this library powerful selection tools were 
employed to select for solubility and function (Chapter 4). Both of the tools were 
able to avoid selecting for over-truncated and out of frame ORFs. Overall, this 
library had the greatest potential diversity of any ITCHY library generated to date, 











4.1 Foreword  
The overarching goal of this thesis was to find folded and/or functional hybrid 
proteins from the ~107-member ITCHY library. The study utilised the pSALect 
plasmid, which uses β-lactam resistance to select for soluble proteins (Lutz et al., 
2002). To find functional proteins, conditionally auxotrophic strains of E. coli 
with single gene knockouts were transformed with the ITCHY library, to 
determine whether any hybrid could complement each knockout.  
4.2 Solubility selection 
4.2.1 pSALect 
As described in Chapter 3, the construction of the ITCHY libraries was 
undertaken in the plasmid pSALect. This plasmid was originally designed to select 
for reading frame and solubility of proteins (Lutz et al., 2002), then adapted for 
use in ITCHY library construction (Lutz & Ostermeier, 2003). In the pSALect 
plasmid a gene of interest is flanked by an upstream Twin-arginine translocation 
(Tat) signal peptide, which targets the protein for export via the Tat system, and a 
downstream β-lactamase gene, which once in the periplasm confers resistance to 
β-lactam antibiotics (Figure 4.1). The effectiveness of the pSALect folding 
selection relies on the ability of the Tat system to selectively export folded 
proteins. 
4.2.1.1 Tat pathway 
In bacteria, proteins are targeted for export to the periplasm by specific, 
cleavable, N-terminal signal peptides. Most proteins are exported by the general 
secretory (Sec) pathway (Pugsley, 1993), which exports proteins in an unfolded  
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state, typically bound to chaperones to prevent folding during export (Berks et 
al., 2000). The Tat pathway, however, selectively exports folded proteins, meaning 
that it can be used as the basis of a selection for whether a protein is folded or not. 
The Tat signal peptide is on average 24 amino acids long and contains: a 
positively charged N-terminal sequence (n-region), an ⍺-helical region (h-region) 
which is hydrophobic, and a cleavage site at the c-domain. A conserved feature at 
the n-region/h-region boundary is the two consecutive arginine residues that give 
the system its name (Figure 4.2a).  The signal peptide used in this study was from 
the E. coli gene torA (Figure 4.2a). 
	
Figure 4.1 Folding selection via pSALect plasmid. A graphical representation of the selection 
of folded ORFs using the pSALect system. A fusion protein consisting of a Tat signal-peptide, 
and ORF of interest, and β-lactamase is expressed from the pSALect plasmid. If the ORF is 
able to fold the fusion protein will be exported to the periplasm (the Tat signal-peptide is 
cleaved during transport). If the ORF is unfolded export will not occur, as the Tat translocon 
selectively exports folded proteins. Once in the periplasm, the β-lactamase fusion is able to 
confer resistance to the bacterium against β-lactam antibiotics, allowing selection for folded 
clones on media containing a β-lactam antibiotic.  
pSALect 
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The Tat pathway consists of five components, TatA – TatE. TatC is the only 
protein in the pathway with multiple transmembrane domains, and is therefore 
predicted to directly facilitate the movement of target proteins through the 
membrane (Behrendt et al., 2006). TatA, TatB, and TatE are also transmembrane 
Figure 4.2 The Tat translocation system. A) The different regions of the Tat signal peptide are 
indicated by different colours. Consensus sequences for a given region are shown within each 
block. The n-region contains the recognition site with the consensus motif: SRRXFLK. The c-
region contains the cleavage site with the recognition motif: AXA. The c-region also contains 
positively charged amino acids which prevent targeting via the Sec pathway (Blaudeck et al., 
2003). The TorA signal peptide is shown, with each region highlighted and consensus motifs 
in bold. B) A summary of Tat mediated protein export. 1) Signal peptide recognition and 
binding via TatC leads targeting of the protein to the Tat translocon at the cell membrane. 
The binding to the signal peptide leads to oligomerisation of TatA or TatE and association 
with the TatBC complex via TatB. 2) If the target protein is folded it will be selectively 
exported via the newly formed TatA/E oligomer. The protein will be moved through the 
complex into the periplasm. 3) During transport a signal peptidase is recruited that cleaves 
the signal peptide. Both the signal peptide and the folded protein are released into the 
periplasm.	
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proteins, with TatB being necessary for the function of the system. TatA and TatE 
are paralogs, and loss of Tat export is only observed with a ∆tatA∆tatE double 
knockout, suggesting at least partial functional complementation between TatA 
and TatE (Sargent et al., 1998). TatC is thought to recognise the signal peptide, 
while TatA (or TatE) polymerize to form a membrane channel. During transport 
the signal peptide is cleaved to release to protein into the periplasm (Figure 4.2b) 
(Palmer & Berks, 2012).  
DeLisa et al. (2003) reported that the Tat translocation pathway does not export 
unfolded proteins, in an experiment which controlled folding via a bacterial 
strains ability to form disulfide bonds. This selectivity makes the Tat translocon 
ideal as a quality control mechanism in protein engineering.   
4.2.1.2 Antibiotic selection 
The pSALect system utilises a β-lactamase fusion to the C-terminus of the 
protein, allowing for selection using β-lactam antibiotics. Because β-lactam 
antibiotics act by inhibiting peptidoglycan synthesis from within the periplasm, 
β-lactamase hydrolyses the antibiotic once exported to the periplasm of Gram-
negative cells (Fisher et al., 2005). Therefore, the chimeric protein needs to be 
exported to the periplasm to confer resistance. Because the Tat signal peptide 
targets the chimera to the Tat translocon, the chimera is only exported if it is 
folded. The pSALect system has been investigated extensively for its ability to 
select for folded proteins. The system was shown to be effective in the genetic 
selection for protein solubility with regards to the Alzheimer's Aβ42 peptide 
(Fisher et al., 2006) as well as antibody selection (Fisher & DeLisa, 2009). 
Furthermore, because of its bias towards folded proteins, pSALect has even been 
modified for other studies to generate an unbiased reading frame selection tool 
(Gerth et al., 2004). Therefore, folded hybrids should have been be selectable from 
the ITCHY library by transforming E. coli cells with the library (in pSAlect) and 
simply plating on media containing a β-lactam antibiotic.   
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4.2.2 Identification of truncated hybrids with pSALect 
4.2.2.1 Initial pSALect experiments 
The first goal was to estimate what fraction of the library was pSALect positive 
(able to grow on a β-lactam antibiotic). This would give some indication of the 
number of in frame clones which were successfully being exported. 
Approximately 33% of the was expected to be in frame, however only a fraction of 
these in frame clones were expected to be folded. The percentage of pSALect 
positive hybrids was determined by comparing the colony forming units (CFU) of 
E. coli transformed with the pSALect ITCHY library on chloramphenicol 
(selection for cells containing the pSALect plasmid) versus carbenicillin (only 
pSALect positive clones). Within the library ~1.2% of clones were pSALect 
positive. This is a pool of ~120,000 clones which may produce folded truncated 
hybrids proteins.  
Randomly-chosen positive clones were picked from selective growth media. 
The pSALect-encoded library ORFs were amplified using colony PCR and 
compared to clones picked from non-folding selective media. The sizes of the 
ORFs from the total ITCHY library were compared to that of the folded pool. 
Compared to the whole ITCHY library, the pSALect positive pool was biased 
towards smaller ORFs (Figure 4.3). This bias towards small ORFs could suggest 
that either smaller ORFs are more likely to be folded, or that unfolded small ORFs 
are able to pass through the Tat translocon when fused with the folded 
β-lactamase. 
Sequencing of 23 pSALect positive clones revealed nine truncated hybrids 
(clones with significant fragments from two parental genes). However, there was 
also a large number of “junk” sequences, which either contained artefacts from the 
ITCHY protocol, or simply were not hybrid genes with fragments from two 
parental genes. It was shown that pSALect was successfully selecting for in-frame 
clones with an intact β-lactamase gene. Nine of the sequenced clones contained 
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truncated hybrids (Table 4.1). This result highlighted that the library did contain 
clones of interest, able to survive the folding selection, but also that every pSALect 
positive clone would need to go through secondary screening via sequencing to 
determine which ones were truncated hybrids. This drastically decreased the 
throughput for downstream experiments to identify soluble hybrids. The other 
pSALect positive clones were made up of single gene inserts, full length genes with 
and without a fusion partner, or insignificant ORFs (<75 bp) (Table 4.1). 
Figure 4.3 ITCHY clone size comparison pre- and post- selection. The average 
size of ITCHY clones from selection on chloramphenicol or carbenicillin was 
compared by colony PCR. The clones from colonies picked from media 
containing chloramphenicol represented the entire ITCHY library, with no folding 
selection. The clones from colonies picked from media containing carbenicillin 
represented clones which survived folding selection via pSALect. The post-
selection clones are significantly smaller than those pre-selection, suggesting the 




Table 4.1 Results of initial sequencing of pSALect positive clones. From 23 
sequenced pSALect positive clones it was found that 9 contained ORFs with two 
truncated parental genes. However, the remaining 14 sequences were of ORFs 
which were not desired in down-stream analysis. These 14 ORFs contained either 
full length genes, single gene ORFs, insignificant ORFs, or no insert.	
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The early selection experiments did highlight the key function of pSALect in 
this context; the ability to select for in-frame ORFs with full length β-lactamase 
genes. The primers used to amplify ITCHY clones anneal within the Tat signal 
peptide and the β-lactamase gene. If the inserted gene is over-truncated at the 3' 
(β-lactamase) end of the ORF then the binding site for the reverse primer will be 
lost, as well as part of the β-lactamase gene. It was observed that PCR screening of 
ITCHY library clones had a higher failure rate with colonies screened prior to 
pSALect selection, than pSALect positive clones (Figure 4.4a/b). The pSALect 
positive clones had a failure rate equal to the baseline rate for colony PCR 
indicating all of the clones had an intact primer binding site (and therefore an 
Figure 4.4 Comparison of PCR 
amplification of ITCHY clones 
pre- and post- folding selection. 
Shown are examples of agarose 
gels each with DNA samples 
from 12 colony PCR reactions 
utilising pSALect.for and 
pSALect.rev primers. A) shows 
failure of 2/3 of the reactions 
due to over truncation of the 
ORFs. B) only has one failed PCR 
reaction due to the requirement 




intact β-lactamase gene). The pre-selection pool of ITCHY clones had a colony 
PCR failure rate of ~66%, suggesting about 2/3 of clones had a truncation of the β-
lactamase gene or the Tat signal peptide. The requirement for an intact β-
lactamase gene appears to have almost completely removed sequences with 
truncated primer sites, suggesting this over-truncation occurred more frequently 
at the 3ʹ	(β-lactamase) end or on both the 5ʹ	and	3ʹ	ends of the hybrid 
simultaneously. 
4.2.2.2 Solubility trials with pSALect positive clones 
Despite the issues with the pSALect positive pool highlighted in early selection 
experiments, in-frame, truncated hybrids had still been identified (Table 4.1). 48 
more colonies were screened by sequencing to identify clones for solubility trials. 
Six clones were selected and subcloned into the expression vector pCA24N, and 
solubility trials were undertaken. One of the clones was a single gene insert, used 
as a control. Following induction, the cells were harvested and lysed. The soluble 
and insoluble fractions were collected and samples were run on SDS-PAGE gels to 
compare the soluble and insoluble fractions, pre- and post- induction (Figure 4.5). 
The control clone was soluble under the expression conditions. Clones T2 and T4 
were too small to be easily observed and were therefore excluded from 
consideration. None of the hybrids T1, T3, or T5 appeared to be soluble under the 
conditions tested. No overexpression of proteins of the expected sizes (indicated 
in Figure 4.5) was observed in the soluble fractions. There did appear to be 
expression of the T1, T3, and T5 in the insoluble fraction, indicating that 
expression of the proteins had been successful.  
At this stage, the aim of the project was to identify a large number of soluble 
hybrids in order to make conclusions about subdomain assembly, rather than to 
invest time and effort in any particular hybrid(s). Therefore, no further expression 
trials or buffer screens were attempted with these six clones. 
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4.2.2.3 Large scale screening of pSALect positive clones 
 The small-scale tests in the previous section showed that all pSALect-positive 
hybrids identified to date were, in fact, false positives. The next aim was to 
streamline and scale up the search for true positives; that is, soluble hybrids 
containing fragments from two parents. 
One particularly common source of these false positives was that ~50% of 
hybrids contained a full-length gene fused to a second gene or gene fragment. To 
Figure 4.5 Small scale 
expression trials of pSALect 
positive hybrids. SDS PAGE 
gel showing protein samples 
from expression trials of five 
truncated hybrids (T1–T5), 
and one single gene ORF 
(T6) as a positive control. 
Shown is soluble and 
insoluble samples before and 
after induction. The orange 
boxes indicate the expected 
sizes of the product. T2 and 
T4 were too small to be 
easily observed by SDS 
PAGE (4.1 and 5.0 kDa 
respectively). T1, T3, and T5 
were not observed to be 
expressed in either the 
soluble or insoluble samples. 
T6 was observed in both the 
soluble and insoluble 
samples following induction, 
indicating the experimental 
procedure had worked. 	
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remove such clones prior to sequencing, a new PCR screen was designed. If the 
gene at the 3' end of the hybrid was not truncated, then the P1v2 primer site (used 
to amplify across the entire construct during the ITCHY protocol (Figure 3.2) 
would be present in the hybrid ORF (Figure 4.6a). Therefore, pSALect positive 
clones were screened using primer P1v2, and excluded from downstream analysis 
if a PCR product was generated (Figure 4.6b).  
 
Figure 4.6 pSALect positive clone screen using P1v2 primer site. A) a schematic showing the 
concept behind screening clones for full length genes using the P1v2 primer. Following 
truncation during the ITCHY protocol, any 3ʹ ORFs that have not been truncated will contain 
the P1v2 primer site. Once ligated this site ends up in the middle of the hybrid ORF. By 
attempting to PCR amplify the entire hybrid with pSALect.for and pSALect.rev2, as well as 
P1v2 and pSALect.rev2, it was possible to determine which clones included the P1v2 site, 
and hence a full-length gene. B) shows example gels from the screen. Clones 57–68 were 
PCR amplified using the two primer sets. All of the clones were able to be amplified using 
pSALect.for and pSALect.rev2, while 4 of the clones could not be amplified using as P1v2 
and pSALect.rev2. These four clone were then sequenced. Overall, 394 clones were screened 
using this method, and 185 were sequenced	
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Figure 4.7 Summary of the nature of the ITCHY library ORFs. Overall ~1.2% of the clones 
in the ITCHY library are pSALect positive. However, PCR screening and sequencing 
showed that of this ~120,000 clones only ~25% are truncated hybrids. 79 clones were 
confirmed by sequencing to be truncated hybrids. These 79 clones are mapped above to 
the E. coli K12 genome, where the two parents of each clone are linked by a line which 
indicates the overall size of the hybrid.	
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The new PCR screen was used to test 394 pSALect positive clones. Of these, 185 
gave amplicons with the outside primers, but not when P1v2 was used as the 
forward primer. Sequencing revealed that 79 of the 185 were correctly truncated 
hybrids, with fragments of two parental genes contributing to the ORF 
(Appendix, Supplementary Table S1).  
 The 79 pSALect positive clones were assessed to determine the diversity of the 
selected pool of ORFs. It was found that there was a high level of diversity across 
the 79 clones in terms of the parental genes represented. Only three genes were 
observed to be present in more than one ORF: yaaF was found in three ORFs, 
while ygaG and aroB were each observed in two ORFs. The diversity of the 79 
pSALect positive hybrids is shown graphically in Figure 4.7. The circle represents 
the E. coli genome and each line links the two parental genes in each hybrid ORF. 
Figure 4.8 Expression trials of 43 pSALect positive truncated hybrids. SDS PAGE gels with 
the soluble protein fraction after induction of 43 truncated hybrids being expressed in 
pCA24N. Due to the need for high throughput screening, the 43 strains were grown as 1 mL 
cultures in deep well 96-well plates. No overexpression was observed in any of the lanes, 
indicating that none of the 43 hybrids are being expressed in the soluble fraction. 	
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To determine how many of the 79 hybrids were truly soluble they were 
subcloned into pCA24N for expression and purification trials. 43 of the 79 hybrids 
were successfully cloned into pCA24N in the first round of cloning. Cultures were 
grown and expression was induced for these 43 hybrids, and the soluble lysate was 
compared to the insoluble fraction, pre- and post- induction. Across the 43 
hybrids, none appeared to be over-expressed in the soluble fraction under the 
conditions tested (Figure 4.8).  
Figure 4.9 Trial purification of 43 pSALect positive truncated hybrids. SDS PAGE gels 
showing the protein from the elution fraction of purifications of 43 pSALect positive 
clones using HisPur plates. The hybrids were expressed and purified in a 96-well plate 
based format allowing for high throughput screening for soluble hybrids. None of the 
43 hybrids appeared to be purified in the elution fraction, as shown by the wells all 
having the same banding pattern.	
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Trial purifications were undertaken using HisPur plates. These are 96-well 
plates containing cobalt resin, for high-throughput purification by metal affinity 
chromatography. A protocol had previously been established by a previous 
laboratory member (Maddock et al., 2017). Cultures are grown in deep-well 96-
well plates, and the soluble lysate from each well is loaded onto the HisPur plate. 
The purification proceeds similarly to a typical gravity flow experiment, except 
that the plate is centrifuged to mediate flow of buffers, and fractions are collected 
in a 96-well collection plate. This high throughput method allowed for small scale 
purification tests on a large number of samples. None of 43 purifications indicated 
that any of the hybrids was being expressed in the soluble fraction, as the banding 
patterns of each of the elution fractions across all of the hybrids was identical 
(Figure 4.9).  
The lack of soluble protein across these 43 pSALect positive hybrids indicated 
that the false positive rate of pSALect was too high to allow hybrids of interest to 
be found at a rate which could provide evidence towards subdomain assembly. It 
was therefore necessary to determine a new way to screen the ITCHY library for 
hybrids of interest. 
4.3 Functional selection 
The key points of interests in protein biochemistry tend to be structure and 
function. It was hypothesised at the beginning of this study that soluble proteins 
would be relatively simple to select for, and would give insights into the evolution 
of protein structure. Finding soluble proteins turned out to be very challenging, 
mainly due to the lack of stringency of pSALect. Therefore, the logical next step 
was to look for functional hybrids within the ITCHY library.  
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4.3.1 Auxotroph rescue methodology 
Previously, 107 strains of E. coli with single gene knockouts had been identified 
as conditionally auxotrophic (Patrick et al., 2007). While these strains were viable 
on rich media such as LB, they were unable to grow on M9 minimal media + 0.4% 
(w/v) glucose. Each of these strains was from the Keio collection, which is a 
complete collection of individual gene knockouts of all non-essential E. coli genes 
(Baba et al., 2006). The genes were replaced with kanamycin resistance cassettes 
for ORF removal. Of the 107 strains tested, 62 are deficient in amino acid 
metabolism, 20 in cofactor biosynthesis, and 17 in nucleotide biosynthesis 
(Patrick et al., 2007). 
In this study the 107 conditional auxotrophs were each made electrocompetent, 
transformed with the ITCHY library and the transformants were plated on M9 
agar + glucose (Figure 4.10). On non-selective media, the CFU plated was 
~500,000, so the whole library was not represented in the experiment. This also 
meant that cells were plated at a very high density, which was overcome by 
re-streaking clones of interest to obtain single colonies. The plates were incubated 
at 37°C for up to 28 days. As a control each strain was also transformed with 
pSALect:metC, and treated the same as the library plates. If colonies were observed 
on plates correlating to strains in which no growth was observed for the control 
plate, the colonies were picked and used to re-streak a fresh M9 agar + glucose 
plate. Both the new plate and original were incubated at 37°C. A single colony was 
picked from the fresh streak plates and used to inoculate LB media from which 
plasmid was isolated and the hybrid ORF sequenced. Isolated plasmids found to 
contain truncated hybrids were used to re-transform the knockout strain to 
confirm the ability for the individual clone to rescue the auxotrophic phenotype.  
It should be noted that the rescue experiment was undertaken with clones in the 
pSALect plasmid, this meant that they were fused to a Tat signal-peptide and 
β-lactamase. The rescue is therefore in the context of this fusion and the 
constitutive expression of this plasmid.  
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4.3.2 Auxotroph rescue results 
After transforming the 107 conditionally auxotrophic strains with the ITCHY 
library 56 colonies were picked from 24 different plates (Appendix, 
Supplementary Table S2). Of the 56 colonies, six were confirmed by sequencing to 
contain plasmids encoding truncated hybrids. The six hybrids of interest rescued 
five different conditionally auxotrophic strains (Table 4.2). All six hybrids were 
Figure 4.10 Functional selection of ITCHY hybrids. 
107 different conditionally auxotrophic strains of E. 
coli, each with a different single gene knockout, 
were transformed with the ITCHY library. The 
transformed cells were plated on selective media. 
Any colonies which grew indicated the hybrid 
being expressed was able to rescue the 
auxotrophic phenotype. Plasmid DNA was isolated 
from growing colonies and the hybrid ORF 
identified by sequencing. 	
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confirmed to rescue the knockout strains by retransformation tests. In general, the 
six rescuing clones grew slower than normal E. coli cells; from the original 
transformations, colonies appeared after 3–10 days (Table 4.2). Interestingly, 
colonies grew more quickly (2–3 days) after re-streaking, potentially due to cells 
already having produced and stored the metabolites required to overcome the 
auxotrophic conditions. 
Five of the six hybrids of interest contained at least one fragment in the 
approximate size range of subdomains (~25–100 amino acids). This means these 
five hybrids have the potential to contribute to the understanding of subdomain 
driven evolution. The other hybrid YdjO257/GuaB283, was included as a control 
as it represented a self-rescue of the E. coli ∆guaB.  
Of the remaining rescuing clones, five were found to still include an un-
truncated gene. This meant that they also included an SfiI restriction site between 
the two fused genes. This meant that they were unable to be cloned into an 
expression vector for further study. Furthermore, three of these five clones had a 
complete or almost complete copy of the knocked-out gene they were rescuing as 
one of the parental genes. These self-rescues were interesting in that they second 
fragment did not appear to prevent the function of the self-rescuing parent. The 
Table 4.2 List of truncated hybrids able to rescue conditionally auxotrophic E. coli strains. Six 
truncated hybrids were able to rescue five different conditionally auxotrophic strains of E. coli. The 
hybrids were named based on the two parental proteins which contributed to the hybrid, and the 
number of amino acids contributed by each. The N-terminal fragment is listed first, then the 
C-terminal fragment.	
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remaining 45 clones were single parental gene fragments, whole parental genes 
with or without a fusion partner, clones without inserts, or failed PCRs.  
4.3.2.1 Rescue of E. coli ΔcysN  
E. coli ΔcysN was rescued by the hybrid SgbE147/MioC82, which was a 
combination of 147 amino acids of SgbE and 82 amino acids of MioC. Full length 
SgbE is 231 amino acids long, while full length MioC is 148 amino acids long. 
CysN is subunit 1 of the ATP sulfurylase complex, which is involved in the 
assimilation of sulfur. Sulfur assimilation is a key step in cysteine biosynthesis and 
CysN has GTPase activity (Leyh & Suo, 1992). CysN interacts directly with 
another protein, CysD, to form the complete ATP sulfurylase complex, and the 
complex is activated upon GTP hydrolysis. SgbE is an L-ribulose-5-phosphate 4-
epimerase involved in the degradation of L-lyxose and L-ascorbate by the 
conversion of L-ribulose 5-phosphate to D-xylulose 5-phosphate (Yew & Gerlt, 
2002). MioC is a flavoprotein important for biotin biosynthesis and regulation of 
cell division (Hu et al., 2006; Lies et al., 2015). Interestingly, SgbE147/MioC82 did 
not result from a typical ITCHY gene fusion; instead the gene fragment of sgbE 
was fused to a full length mioC gene. However, the mioC gene had a point 
mutation which resulted in a stop codon. It is the stop codon that causes the 
truncation of the MioC protein (Discussed further in Chapter 5). This means that 
the fusion is between two N-terminal fragments. The introduction of this stop 
codon also means that SgbE147/MioC82 would not have been found using 
pSALect selection, as the protein is not fused with β-lactamase. The compostion of 
SgbE147/MioC82 as well as characteristics of CysN, SgbE, and MioC are discussed 
further in Chapter 5 and Chapter 6.  
4.3.2.2 Rescue of E. coli ΔaroB  
E. coli ΔaroB was rescued by the hybrid PheS47/GarR35 which is a fusion of 47 
amino acids of PheS and 35 amino acids of GarR. The full length PheS protein is 
327 amino acids in length, while GarR is 294 amino acids long. AroB is a 3-
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dehydroquinate synthase that converts 3-deoxy-D-arabino-heptulosonate 7-
phosphate to dehydroquinate in the biosynthesis of 3-dehydroquinate (Frost et al., 
1984). PheS is the phenylalanine-tRNA ligase ⍺-subunit. PheS has a phenylalanine 
binding site (Kaast & Hennecke, 1991) and binds to the 3ʹ	adenosine of tRNAPhe 
(Hountondji et al., 1987). GarR is a tartronate semialdehyde reductase which is 
involved in D-galactarate degradation and D-glucarate degradation. It catalyses 
the conversion of tartronate semialdehyde to (R)-glycerate (Hubbard et al., 1998).  
It was interesting that the fusion of two fragments each less than 50 amino acids 
long resulted in a hybrid capable of rescuing an auxotrophic phenotype. The 
ability to rescue the knockout strain may be a result of the fusion to β-lactamase. 
PheS47/GarR35 may somehow modulate the activity of the fusion partner, 
conferring a new function to the overall fusion protein.  
4.3.2.3 Rescue of E. coli ΔilvC 
E. coli ΔilvC was rescued by the hybrid YmdE67/TdcE216. YmdE is a 107 amino 
acid long protein, while TdcE is a 764 amino acid long protein . IlvC is important 
in the synthesis of valine and isoleucine from the degradation of threonine by 
catalysing the two analogous reactions: converting 2-acetolactate to 2,3-
dihydroxy-3-methylbutanoate (Ramakrishnan & Adelberg, 1964), and converting 
2-aceto-2hydroxy-butanoate to 2,3-dihydroxy-3-methylpentanoate (Chunduru et 
al., 1989). TdcE catalyses a reaction in the threonine degradation pathway, which 
may help to explain how E. coli ΔilvC is rescued by TdcE216/YmdE67. TdcE, 
catalyses the formation of propanoyl-CoA from 2-oxobutanoate and coenzyme A 
(Hagewood et al., 1994). Because IlvC uses threonine degradation to generate 
isoleucine, an increased flux through the threonine degradation pathway may 
overcome the loss of IlvC. TdcE is also involved in mixed acid fermentation, 
where it produces formate and acetyl-CoA from pyruvate and coenzyme A 
(Sawers, 2001). YmdE is a protein of unknown function.   
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4.3.2.4 Rescue of E. coli ΔguaB 
The rescue of E. coli ΔguaB represents a partial self-rescue; it was rescued by the 
hybrid YdjO257/GuaB283, a combination of 257 amino acids of YdjO and 283 
amino acids of GuaB. The full length GuaB is 488 amino acids, meaning that 
~60% of GuaB, fused to an almost full length YdjO (267 amino acids), seemingly 
performed the function of GuaB. GuaB is an inosine 5ʹ-monophosphate 
dehydrogenase which catalyses the transition between inosine 5ʹ-monophosphate 
and xanthosine 5ʹ-phosphate. GuaB is key to the de novo biosynthesis of 
guanosine ribonucleotides (Gilbert et al., 1979). YdjO is a protein of unknown 
function. YdjO257/GuaB283 is not necessarily the most interesting of the rescuing 
hybrids; it is an apparent self-rescue, and the fragment of GuaB is fused to an 
almost full length YdjO. However, the finding is still potentially important to the 
study. The presence of a self-rescuing hybrid acts, to a degree, as a control for the 
selection method. Proteins were expected to self-rescue the associated knockouts, 
so the selection of self-rescuing clones indicates the selection is working as 
expected.  
4.3.2.5 Rescue E. coli DthrA 
ThrA is a bifunctional enzyme that acts as both an aspartate kinase I and a 
homoserine dehydrogenase. It can catalyse the conversion of L-aspartate to 
L-aspartyl-4phosphate (Starnes et al., 1972) and the conversion of L-aspartate 
4-semialdehyde to L-homoserine (Clarke & Ogilvie, 1972). ThrA is 820 amino 
acids, and utilises different cofactors (ATP or NAD(P)H) in its different reactions. 
Interestingly, two unrelated hybrids both rescued the auxotrophy of E. coli ΔthrA 
on M9-glucose medium. The first, YtfI168/YncH42, was a combination of 168 
amino acids from the N-terminus of YtfI and 42 amino acids from the C-terminus 
of YncH. The native YtfI is 312 amino acids long, while YncH is a short protein of 
only 70 amino acids. Neither protein has been characterised, structurally or 
functionally. 
 101 
The second hybrid to rescue E. coli ΔthrA was made from fragments of two 
proteins unrelated to those from YtfI168/YncH42. This hybrid, 
YcaA147/YafO132, comprised of 157 amino acids from the N-terminus of the 220 
amino acid long YcaA, and 68 amino acids from the 132 amino acid long YafO. 
YcaA is a leucyl/phenylalanyl-tRNA–protein transferase; it attaches leucine and 
alanine to amino terminal arginine and lysine (Kuno et al., 2003). This is a 
necessary step in the N-end rule degredation pathway, in which ClpAP dependent 
proteases degrade proteins with amino-terminal arginine, lysine, leucine, 
phenylalanine, tyrosine, or tryptophan (Tobias et al., 1991). YafO is a ribosome-
dependent mRNA interferase toxin. YafO works as part of the YafO/YafN toxin-
antitoxin system, and cleaves mRNA downstream of the translation initiation site 
to inhibit protein synthesis (Zhang et al., 2009).   
4.4 Solubility trials with functional hybrids 
4.4.1 Subcloning 
As discussed above the rescue experiment was undertaken with the clones in 
pSALect. The clones were therefore subcloned into the expression vector pCA24N 
in order to attempt expression trials and purification experiments. Subcloning was 
completed using SfiI restriction digests, agarose gel purification, and ligation into 
the new pCA24N vector. The clones were confirmed by DNA sequencing across 
the insert site. With the addition of the His6-Tag to each protein (from the 
pCA24N vector) the molecular weights for each of the hybrids was as follows:  
SgbE147/MioC82 ~27 kDa, PheS47/GarR35 ~12.5 kDa, TdcE216/YmdE67 ~33.5 
kDa, YdjO257/GuaB283 ~66 kDa, YtfI168/YncH42 ~25 kDa, and 
YcaA157/YafO68 ~28 kDa.  
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4.4.2 Solubility trials 
The six hybrid proteins were expressed in small-scale (50 mL) cultures, grown 
in both TB and AIM media. Following induction (using IPTG for TB media) for 
16 hours, soluble lysate and insoluble pellet samples from pre- and post- 
induction time points were analysed using SDS-PAGE (Figure 4.11). Gels were 
analysed for over-expressed bands correlating to the expected size of each hybrid 
protein. Four of the six of the hybrids (SgbE147/MioC82, TdcE216/YmdE67, 
YdjO257/GuaB283, and YcaA157/YafO68) were able to be overexpressed, with 
differing levels of soluble protein produced. PheS47/GarR35 and YtfI168/YncH42 
did not appear to be expressed to detectable amounts. In the lanes associated with 
PheS47/GarR35 a protein did appear to be expressed following induction, 
however, the expressed protein was ~27 kDa not 12.5 kDa as was expected.  
Figure 4.11 Expression trials of the six 
rescuing hybrids. SDS PAGE gels 
showing whole protein samples pre- and 
post- induction, and soluble protein 
samples post induction for each of the 
six rescuing hybrids expressed in both 
AIM and TB. The coloured boxes 
indicate the approximate expected size 
of the hybrid. Orange boxes indicate 
potential over-expression of the hybrid 
under the given condition. Red boxes 
indicate no over-expression of the hybrid 
was observed under the given condition.	
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The presence of soluble protein was the first detected from the ITCHY library, 
meaning that not only were the hybrids able to rescue conditionally auxotrophic 
bacteria, they were able to be over-expressed for further study. 
4.4.3 Trial purifications of functional hybrids 
Following the solubility trials it was important to determine whether any of the 
six hybrids could be purified. Despite the over-expression of two of the clones 
failing, purifications were attempted using all 6 clones. Trial purifications were 
attempted by affinity purification using Talon resin in gravity flow columns. The 
fractions were analysed using SDS-PAGE (Figure 4.12). Of the six hybrids, only 
SgbE147/MioC82 was observed in the soluble fraction following purification, as 
highlighted in Figure 4.14.  
For this trial, only a single lysis buffer was used across all six of the functional 
hybrids. This means that other hybrids may have been able to be purified under 
different conditions. However, the discovery of a functional hybrid that was able 
to be purified meant that biophysical characterisation could begin using 
SgbE147/MioC82.  
For the other three hybrids that could be expressed but not purified under these 
conditions, it seems that bands can be observed at the expected size in the 
"Whole", "Clarified lysate", and "Unbound" fractions. This suggests that expression 
took place, but that the protein did not bind to the column. This may indicate that 
the His6-Tag is buried in each of these constructs, meaning it does not have access 










Figure 4.12 Trial purifications of the six rescuing truncated hybrids. SDS PAGE gels 
showing protein samples of whole protein, clarified lysate, unbound protein, Wash 1 
(buffer), Wash 2 (7 mM imidazole), and three elution fractions (150 mM imidazole) for 
each of the six rescuing hybrids. The coloured boxes indicate the approximate 
expected size of the hybrid. Orange boxes indicate hybrids which appear to be purified 
in the elution fractions. Red boxes indicate hybrids which do not appear to have 
purified under these conditions. SgbE147/MioC82 is the only hybrid which appears to 




The results presented in this chapter highlight the difficulties of finding proteins 
of interest in a large and diverse library. The ITCHY library which was screened 
was ~10,000,000 clones in size, however, as shown here contained a large number 
of artefacts, junk sequences, and single gene ORFs. These parts of the library 
represented a challenge when trying to make sweeping conclusions about the 
library. Instead selection tools became a method to find individual proteins, and 
in the end, a single protein of interest. 
4.5.1 ITCHY as a source of soluble truncated hybrids 
While this chapter focussed on the screening of the ITCHY library, rather than 
its preparation, the results presented further highlighted some of the issues with 
ITCHY discussed in Chapter 3. Many of the issues observed were a result of 
under, or over truncation of one, or both, of the fragments in a hybrid pair. This 
issue was caused by the fact that ORFs of a significant size range were paired 
together, then truncated simultaneously. This meant there was very little control 
over the final size of each fragment. Previous work with ITCHY has combined 
only two ORFs of known sizes (Gerth & Lutz, 2007; Qian et al., 2009). These 
simpler experiments allowed for greater control to the final fragment sizes. 
However, the combination of all E. coli ORFs was a more complex situation.  
One possible solution would be to separate the ORF pool based on size into 
smaller subsets, and recombine ORFs within these subsets. This would mean ORF 
pairs would be closer in size, allowing for ORF size appropriate truncation times. 
However, this would reduce the potential diversity of the hybrids, as the potential 
crossovers would be limited to ORFs of a similar size.  
Another solution would be to reverse the order of the ITCHY protocol. The 
ORF pool (in pSALect-FseI and pSALect-NotI) could be separated in to subsets 
based on size, linearised and then truncated. The truncated pool could then be 
selected for appropriate sized inserts (the size of subdomains 75–300 bp) by 
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agarose gel electrophoresis and gel purification. The truncated ORFs could then 
be combined by overlap extension PCR as per ITCHY. This would allow for the 
potential combination of all ORFs while controlling for the size of the fragments 
combined.  
As used in this study, ITCHY was successful at generating a diverse library of 
truncated hybrid ORFs, however, the lack of control over the size of the fragments 
made screening, particularly for soluble truncated hybrids, extremely problematic. 
4.5.2 pSALect as a selection tool 
The Tat translocon and the pSALect plasmid have been shown in previous work 
to be selective for folded proteins (DeLisa et al., 2003; Fisher et al., 2006; Fisher & 
DeLisa, 2009). In the work presented here, however, pSALect was found to have 
an impractically high false positive rate. What differentiates this study from 
previous work is the diversity of the library. In the cited work, the proteins 
screened were somewhat predetermined; Fisher et al. (2006) selected for solubility 
of the Aβ42 peptide, Fisher & DeLisa (2009) selected for soluble antibodies, and 
DeLisa et al. (2003) controlled the folding of antibodies to test the system. 
However, this study generated a diverse library, with proteins of different sizes 
and fold structures, and many junk sequences of varying types.  
Overall, ~50 pSALect positive clones underwent solubility trials, none of which 
were found to be soluble. These solubility trials only tested a single buffer 
condition so were by no means comprehensive. However, what made selection for 
solubility impractical was that the ~50 clones tested had already been through 
multiple rounds of selection; firstly, using pSALect, then a PCR screen to 
determine if the clone had an insert, a second PCR screen to determine if the 
clone included a complete ORF, followed by sequence analysis to determine if the 
clone had two truncated ORFs. This process was not practical, particularly given 
the goal at the outset of the project was to find a large number of soluble clones to 
characterise, and make conclusions about subdomain assembly. 
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One of the potential issues with pSALect is that selection is undertaken with the 
protein of interest fused β-lactamase. The β-lactamase fusion could be a problem 
for two reasons. Firstly, fusion partners are known to increase solubility in many 
proteins (Esposito & Chatterjee, 2009). Therefore, the proteins of interest may be 
folded and soluble in the context of β-lactamase, but insoluble when expressed 
alone. This could be tested by expressing the hybrid ORFs fused to β-lactamase, or 
another fusion partner. Wholescale cloning of hybrid ORF to fusion partners was 
outside of the scope of this study given the desire for a high throughput approach. 
Furthermore, the ORFs being fused to β-lactamase may have led to a bias 
towards small ORFs in the pSALect positive clones (Figure 4.3). This result may 
indicate that the Tat translocon was unable to detect small, unfolded polypeptides 
fused to a folded β-lactamase, allowing the entire fusion protein to be exported to 
the periplasm. It is possible that small hybrids were more likely to be folded (fewer 
amino acids might mean less complexity), however, given the results of solubility 
trials this does not appear to be the case.  
Overall, pSALect failed to identify soluble hybrids for further study. What this 
work shows is that pSALect is not suited for use in libraries with as many 
unknown factors as the "All versus All" ITCHY library generated in this study. 
4.5.3 Auxotroph rescue 
The ability to allow a cell to survive is a key reason for proteins to exist, 
therefore, many studies of both natural proteins, and engineered proteins have 
been previously undertaken. A library of de novo designed 4-helix bundles has 
members which rescue E. coli ∆serB (Digianantonio & Hecht 2016), E. coli ∆gltA 
(Digianantonio et al., 2017), E. coli ∆ilvA, and E. coli ∆fes (Fisher et al., 2011), and 
also enable E. coli cells to grow in the presence of typically lethal concentrations of 
copper (Hoegler & Hecht, 2016). However, the work presented differs greatly in 
that there was no rational approach when generating the ITCHY library. Previous 
work has used libraries designed to form specific fold types. 
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The auxotroph rescue method used in this work were based around work by 
Patrick et al., (2007), in which the same 107 conditionally auxotrophic strains of E. 
coli were transformed by every member of the ASKA collection (Kitagawa et al., 
2005). The Patrick study identified a number of E. coli proteins with apparent 
promiscuous activity. The work presented here uses the same methodology to 
determine if randomly combined fragments of every member of the ASKA 
collection can rescue any of the 107 conditionally auxotrophic strains.  
Patrick et al. (2007) found 21 conditionally auxotrophic strains that could be 
rescued by over-expression of different members of the ASKA collection. None of 
these 21 strains were rescued by the hybrids identified in this work. This 
potentially suggests that none of the hybrid proteins found in this study rescue via 
a mechanism which a single parental fragment could initiate. Interestingly, in this 
study ∆ilvC was rescued by the hybrid YmdE67/TdcE216. ∆ilvA has been shown 
to be rescued by TdcB (Patrick et al., 2007). IlvA and TdcB have significant levels 
of homology, and in fact perform the same reaction, converting L-threonine to 
(2Z)-2-aminobut-2-enoate (Umbarger & Brown, 1957). IlvC and TdcE do not 
perform the same function, however, IlvC is involved in the biosynthesis of 
isoleucine from threonine (Ramakrishnan & Adelberg 1964), while TdcE is 
involved in threonine degradation (Bell & Turner, 1977). Therefore, if 
YmdE67/TdcE216 is able to perform the function of TdcE, then it may increase 
metabolic flux through the threonine degradation pathway. This might allow for 
cells to overcome the loss of IlvC through another protein able to perform the 
same reaction as IlvC at a level typically not sufficient for cell survival.  
Further analysis of the rescue of E. coli ∆cysN by SgbE147/MioC82 is 
undertaken in Chapter 6, however, no biophysical characterisation was possible 
for the other rescuing hybrids. Therefore, speculation about the mechanism of 
rescue by these other hybrids was unjustified. Hence further work needs to be 
undertaken with all of the hybrids (including SgbE147/MioC82) to determine the 
mechanisms of rescue.  
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4.5.3.1 The role of Tat signal peptide & β-lactamase	in	rescue 
One factor to consider in the rescue experiments is that the hybrids were in the 
context of pSALect. This meant that each hybrid was fused between a Tat signal 
peptide and β-lactamase. While SgbE147/MioC82 had a stop codon which meant 
it was expressed without β-lactamase (Figure 5.1), the other five rescuing clones 
were all fused to β-lactamase. It is not clear at this point whether the hybrids 
would rescue the knockout strains without this fusion. The experiment included a 
negative control (pSALect:metC), which showed that none of the relevant strains 
were rescued by β-lactamase fused to MetC, although this does not mean that the 
fusion of β-lactamase to the hybrids did not play a role in rescue. Furthermore, 
because the Tat signal peptide targeted the proteins to the periplasm, the cellular 
location of the hybrids may be playing a role in rescue. 
To determine whether the fusion partners are involved in the rescue of each 
strain, the rescue experiment needs to be repeated, with each hybrid cloned into 
the vector pCA24N (or another expression vector without a large fusion partner). 
If the hybrids alone could rescue the knockout strains it would confirm that the 
mechanism of rescue is solely related to the properties of the hybrids. 
4.5.4 Selection versus screening 
One of the obvious results from this chapter was that screening very complex 
and diverse libraries can be very difficult without the right tools. Typically, protein 
engineering projects have a goal; often it is to make a protein that does "x" 
function better, or has a new function. When the desired function of a protein is 
known, screens can be designed to look for the function. These types of screens 
have typically been used when screening ITCHY libraries. For example, Gerth & 
Lutz (2007) screened for proteins with increased levels of deoxyribonucleoside 
kinase activity. However, in the work presented here there was no goal for the 
proteins that were created, instead broad characteristics were searched for, like 
folding and function.  
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In hindsight, the use of pSALect as a folding selection tool was always going to 
be problematic, partly due to the fact that it is a binary tool, life or death selection. 
Protein folding exists on a spectrum; from highly disordered to highly ordered. 
This work was interested in the entire spectrum of protein folding. However, 
clones of interest were selected based on whether enough β-lactamase was 
exported to the periplasm. Cells exporting the fusion would survive even if the 
mechanism by which the export occurred was atypical, which could lead to a high 
false positive rate, as seen in this study. The alternative would be to fuse the ORFs 
between a Tat signal peptide and green fluorescent protein (GFP) and then screen 
for GFP export (Thomas et al., 2001). Cells could be sorted using fluorescent-
activated cell sorting to increase the throughput of the screening process. This 
would also allow for the cells to be sorted based on the amount of GFP export 
giving an indication of how folded the ORF is. The use of a screen instead of a 
selection would remove the pressure on the bacteria to export the protein in order 
to survive, potentially leading to fewer false positive results.  
4.5.5 Summary 
The selection of hybrids of interest from the 10,000,000 clone ITCHY library 
proved to be very challenging. Folding selection using pSALect failed to identify 
and soluble hybrid proteins, and instead highlighted the limitations in the 
pSALect system. The false positive rate of pSALect clones was found to be too high 
for use with a library as diverse as the one generated in this study. Instead hybrids 
of interest were identified by rescuing strains of conditionally auxotrophic E. coli. 
Six hybrids were identified that could rescue five different strains, of which only 
one, Sgbe147/MioC82, could be purified.  
SgbE147/MioC82 was characterised further in Chapter 5, while more work 
remains to be completed with the other five hybrids. The specifics of the future 
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As discussed in Chapter 4, screening of ITCHY libraries revealed a single 
truncated hybrid able to be expressed and purified. SgbE147/MioC82, a 
combination of fragments of the proteins MioC and SgbE, was found to rescue the 
conditional auxotroph E. coli ∆cysN. Biophysical characterisation of 
SgbE147/MioC82 was undertaken, where SEC-MALS, circular dichroism, and 
thermal shift assays were utilised. The goal was to determine the structural 
characteristics of SgbE147/MioC82, how the protein behaved in comparison to 
the two parental proteins MioC and SgbE, and to provide insights into a potential 
mechanism for the rescue of E. coli ∆cysN.  
5.2 Composition of SgbE147/MioC82 
5.2.1 Sequence composition 
Despite the best attempts to optimise the ITCHY protocol, the libraries 
generated still included a large number of sequences with unexpected and varied 
artefacts; indeed, even the sequence of SgbE147/MioC82 included such an 
artefact. The ITCHY protocol was designed to fuse a fragment from the 5’ end of 
one gene to a fragment from the 3’ end of another gene. In the case of 
SgbE147/MioC82 a fragment from the 5’ end of sgbE was fused to the full length 
mioC gene (Figure 5.1). During the PCR stage of the ITCHY protocol a single 
nucleotide in mioC was changed from C to T at position 226, resulting in a 
mutation of a glutamine to a stop codon. The addition of this stop codon meant 
that SgbE147/MioC82 was expressed in pSALect as a hybrid of two N-terminal 
fragments without a b-lactamase fusion (Figure 5.1). This means 
SgbE147/MioC82 would never have survived the beta-lactamase based folding 
selection that was implemented in Chapter 4. The fortuitous addition of the stop 
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codon into MioC meant that the goal of combining fragments from two parental 
proteins was satisfied in SgbE147/MioC82, albeit by an unintended mechanism. 
The resulting protein comprised 147 amino acids from the N-terminal of SgbE, 
fused in frame to 82 amino acids, 81 from the N-terminal of MioC, and one amino 
acid produced at the crossover point. In the selection experiments 
SgbE147/MioC82 was expressed with an N-terminal Tat signal peptide, however 
this was not part of the pCA24N expression construct. Therefore, the biophysical 
characterisation did not include the Tat signal peptide.  
5.2.2 Structural analysis 
The Phyre2 server (Kelley et al., 2015) was used to make structural predictions 
of SgbE147/MioC82, with the goal of comparing the potential structure of 
SgbE147/MioC82 to the existing NMR structure of MioC (Hu et al., 2006) and the 
solved crystal structure of SgbE (Luo et al., 2001). The structure of 
SgbE147/MioC82 (Figure 5.2a) is predicted to be an epimerase like fold, the same 
Figure 5.1 Structure of sgbE/mioC 
hybrid ORF. A) selection experiments 
were undertaken in pSALect, which 
has the ORF fused between a Tat 
signal peptide and a β-lactamase 
gene. However, the sgbE gene 
fragment was fused to the full-length 
mioC gene with the introduction of a 
stop codon. This meant the construct 
was expressed as the hybrid of two 
gene fragments, without the β-
lactamase fusion. B) a schematic 
showing the ORF of 
SgbE147/MioC82, with comparisons 
to the parental gene sizes and 
indications of the truncation points	
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fold as SgbE (Figure 5.2b), probably as a result SgbE contributing almost two 
thirds of the sequence of SgbE147/MioC82. The solved structure of SgbE is a 
homo-tetramer, where each monomer is comprised of a single domain with a 
typical ⍺/β fold. The fragment of SgbE in SgbE147/MioC82 potentially preserves 
five out of eight ⍺-helices, and seven out of nine β-sheets. In SgbE the interface 
between adjacent monomers is formed by key residues in two loops (Pro43–
Asp47 and Pro73–Thr77) and a linker (Gly139–Glu142), all of which were 
retained in SgbE147/MioC82, however, the predicted structure suggests the 
Gly139–Glu142 linker is now part of an ⍺-helix. The other monomer at the 
interface contributes ⍺-helices a4 and a8, of which only a4 is preserved in 
SgbE147/MioC82. The interface also acts as the active site of the SgbE enzyme, 
providing a Zn2+ binding site via three conserved histidine residues, His95, His97, 
and His171 (Luo et al., 2001). His95 and His97 are preserved in the 
SgbE147/MioC82 sequence.  The implications of the potentially preserved 
interface and other SgbE structural and catalytic elements will be discussed later in 
this chapter. 	
MioC is monomeric, and exhibits a high level of structural symmetry, with two 
Rossmann-like folds combining to form the protein (Figure 5.2c) (Hu et al., 2006). 
The fragment of MioC present in SgbE147/MioC82 interrupts one of the 
Rossmann folds, essentially splitting the MioC protein structure in half and 
exposing a b-strand which is typically buried. The potential implications of the 
MioC structural symmetry and its contribution to SgbE147/MioC82 will be 
discussed further in 5.7.1 The SgbE break point in SgbE147/MioC82 occurs at the 
end of a b-strand, which in SgbE forms a b-sheet. This exposed b-strand may 
make interactions with the b-strand at the N-terminus of MioC, now linked to the 
SgbE fragment. This would potentially minimise unfavourable interactions which 
could result from the exposure of the residues in the b-strands from SgbE and 
MioC. Furthermore, previous work has shown that unprotected edge strands in 
b-sheets form interactions leading to amyloid-like aggregation products 
(Richardson et al., 1992; Richardson & Richardson, 2002; Wang & Hecht, 2002). 
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SgbE147/MioC82 does not form observable amyloid-like fibrils (data to follow), 
indicating that the protein may be making intra- or inter- molecular interactions 
that protect the exposed b-strands.  
Figure 5.2 Structures of SgbE, MioC, and SgbE147/MioC82. A) Shown is the structure 
of SgbE as a monomer. The crystal structure was solved as a homo-tetramer (Luo et al., 
2001). The blue part of the structure shows the part of SgbE present in the hybrid. The 
truncation would likely expose a β-strand which typically forms part of the central β-
sheet of SgbE. B) The structure of MioC, solved by NMR (Hu et al., 2006). The structure 
shown in red indicates the portion of MioC present in the hybrid protein. The 
truncation of MioC, like SgbE, seemingly exposes a β-strand from the core β-sheet of 
the protein. C) The structure of SgbE147/MioC82, as predicted by the Phyre2 server. 
The blue structure indicates sequence contributed by SgbE and the red structure 
sequence contributed by MioC. The overall structure bears similarity to that of SgbE. 
Interestingly, the core β-sheet is predicted to be made from strands contributed by 
both SgbE and MioC.  	
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5.3 Protein Purification 
5.3.1 Purification of SgbE147/MioC82 
As discussed in Chapter 4, SgbE147/MioC82 was able to be purified using the 
N-terminal His6-tag and Talon resin. For biophysical characterisation, the protein 
was purified further using size exclusion chromatography (SEC). 
Metal affinity purification resulted in elution fractions with a large number of 
contaminants (Figure 5.3A), with a large band at ~22 kDa just below the target 
band at ~27 kDa. Following SEC a pure sample was able to be obtained (Figure 
5.3b), however the elution of SgbE147/MioC82 and the ~22 kDa contaminant 
overlapped, as shown in the chromatogram, meaning the loss of a significant 
amount of SgbE147/MioC82 protein. Overall, the typical yield from 1 L of 
expression culture was ~10 mg of pure SgbE147/MioC82 protein.  
Purification experiments were undertaken at room temperature, so the ability 
to purify SgbE147/MioC82 in these experiments indicated that the protein was not 
particularly temperature sensitive. It was observed that purified SgbE147/MioC82 
precipitated upon freeze/thaw, so it was stored at 4°C and further experiments 
were undertaken within 3 days of SEC. 
5.3.2 Purification of MioC and SgbE 
MioC and SgbE were purified so that the characteristics of SgbE147/MioC82 
could be compared to those of its two parental proteins. Both could be expressed 
from pCA24N vectors that were part of the ASKA collection (Kitagawa et al., 
2005). The ASKA plasmid collection encodes E. coli ORFs fused to GFP, which 
needed to be removed via cloning so the proteins of interest could be expressed. 







Figure 5.3 Purification of 
SgbE147/MioC82. The hybrid protein 
SgbE147/MioC82 was purified by a 
two-stage purification. Firstly, A) metal 
affinity chromatography was used. The 
orange box indicates the approximate 
size of the desired product. In Elution 
1 a major contaminant is seen 
intersected by the bottom of the 
orange box. This was followed by B) 
size exclusion chromatography, to give 
a pure product. The peak at 90 mL 
volume is likely the 22 kDa 
contaminant being eluted. 
.	
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5.3.2.1 Removal of GFP fusion 
Molecular cloning was undertaken to remove the GFP fusion. The 
pCA24N-mioC and pCA24N-sgbE plasmids were purified and digested with NotI 
restriction enzymes. The construct was recircularised by ligation and used to 
transform the E. coli strain Ecloni 10G. PCR screening (Figure 5.4) and 
sequencing revealed that GFP had been successfully removed from both 
constructs.  
5.3.2.2    Purification 
Both MioC, and SgbE have been purified in previous studies, MioC for and 
NMR structure (Hu et al., 2006) and SgbE for an x-ray crystal structure (Luo et al., 
2001) MioC and SgbE were purified using the same protocols as SgbE147/MioC82 
and purified at room temperature and were eluted from SEC as pure protein. 
MioC purifications yielded ~7 mg of pure protein per litre of expression culture 
while SgbE yielded ~15 mg of pure protein per litre of expression culture 
(Supplementary S4). 
Figure 5.4 Removal of GFP from the SgbE and 
MioC expression constructs. The GFP gene was 
removed from the pCA24N expression 
constructs of SgbE and MioC by restriction 
digest cloning. Following digestion with NotI the 
constructs were recircularised and used to 
transform E. coli cells. The cells were screened 
by PCR using the primers pCA24N.for and 
pCA24N.rev2. The products indicated that GFP 
had been removed from both constructs. The 
blue boxes indicate the size of the products 
expected from mioC+GFP and sgbE+GFP.  	
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5.4   SEC-MALS  
Size exclusion chromatography (SEC) combined with multi-angle light 
scattering (MALS) is a technique used to accurately measure the observed molar 
mass of a protein sample. SEC-MALS can, therefore, also be used to determine 
oligomeric state. For SgbE147/MioC82 it was important to determine whether the 
protein behaved like a typical globular protein. An absolute molar mass similar to 
its expected size of ~27 kDa would have indicated that SgbE147/MioC82 is 
globular, while a significantly larger value may have suggested a less structured 
protein, such as a molten globule, or an intrinsically disordered protein. Because 
SgbE147/MioC82 arose from the combination of fragments from two random 
proteins, there was an expectation that it may be relatively disordered. It has been 
shown that de novo proteins may be less structured than their more ancient 
counterparts, and then evolve to a more stable, structured form over time. One 
example of this is in the construction of novel (β⍺)8-barrels. Fusion of two half 
barrels resulted in a de novo protein which was mutated to increase its stability 
(Höcker et al., 2004; Seitz et al., 2007). Non-homologous recombination of 
existing genes is one mechanism for de novo protein emergence, so 
SgbE147/MioC82 could represent this type of newly emerged protein.  
The SEC-MALS results showed the observed molar mass of SgbE147/MioC82 
to be ~56 kDa (Figure 5.5). This value suggested that SgbE147/MioC82 was 
present in the sample as a dimer, which indicated that SgbE147/MioC82 had 
stable tertiary and quaternary structure, potentially ruling out SgbE147/MioC82 as 
a disordered protein. It is possible that a disordered monomeric state is stabilised 
by dimerisation, an idea discussed in length in section 5.7.1. This result showed 
that SgbE147/MioC82 is likely somewhat ordered, globular protein, forming a 
homodimer.  
The fragments from both MioC and SgbE have the potential to contribute 
dimer interfaces. As discussed in 5.2.2 SgbE is a homo-tetramer, and the 
monomer to monomer interface is partially preserved in the sequence of 
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SgbE147/MioC82. MioC has a high degree of structural symmetry, with the 
fragment preserved in SgbE147/MioC82 splitting the protein down the axis of 
symmetry. It is possible that the now exposed β-strand of one MioC fragment 
would form an interface with another, allowing dimerisation. These ideas are 
discussed further in 5.7.1.  
5.5 Thermal shift assays 
Thermal shift assays were used to determine the denaturation temperature of 
SgbE147/MioC82, MioC, and SgbE. The fluorophore SYPRO Orange was used in 
these experiments. SYPRO Orange binds non-specifically to hydrophobic protein 
residues resulting in increased fluorescence upon binding. As proteins unfold, 
more of the hydrophobic core is exposed resulting in more bound SYPRO 
Orange, leading to an increase in fluorescence signal.  
 
Figure 5.5 Molar mass determination for SgbE147/MioC82. SEC-MALS was 
used to determine the molar mass of SgbE147/MioC82. The mass was 
calculated to be 57.6 kDa. This value was indicative of a homodimer.	
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Figure 5.6 Thermal shift assays. Results from thermal shift assays using 
SYPRO Orange to measure the melting temperatures of A) SgbE, B) MioC, 
and C) SgbE147/MioC82. In A) and B) the first derivative is used to indicate 
the melting temperatures for the proteins. In C) the protein has an abnormal 
melt curve meaning the melting temperature could not be determined.	
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The denaturation temperature of SgbE was estimated to be ~61°C (Figure 5.6a). 
The graph shows a typical profile of a thermal shift assay, where increasing 
temperature results in a rapid increase in fluorescence as the structured protein 
denatures. Once the protein begins to aggregate, the dye dissociates and 
fluorescence drops.  
The melting temperature for MioC was less clear. The melting temperature was 
estimated at ~45°C (Figure 5.6b), however the profile of the graph suggests that 
MioC was able to bind a high proportion of the dye at room temperature. The 
high initial fluorescence shows a large amount of SYPRO Orange is bound at the 
beginning of the experiment, indicating that MioC has exposed hydrophobic 
groups, perhaps due to unfolding or aggregation. Increasing the temperature did 
result in increased fluorescence intensity, suggesting further unfolding. This result 
indicates that MioC was initially at least partially unfolded in the conditions 
tested.  
The melting temperature for SgbE147/MioC82 was unable to be determined 
using thermal shift assays. Fluorescence intensity was maximal at room 
temperature (Figure 5.6c). As temperature was increased the fluorescence 
intensity decreased, suggesting that the hydrophobic residues of SgbE147/MioC82 
were mostly solvent-exposed, even at room temperature. The decrease in 
fluorescence with increasing temperature could be attributed to protein 
aggregation, resulting in SYPRO Orange dissociating from SgbE147/MioC82.  
The results of the thermal shift assays suggest that under the conditions tested 
SgbE147/MioC82 does not behave like either parental protein. SgbE behaved like a 
typical globular protein, with a melting temperature at ~61°C, while MioC 
appeared to be somewhat disordered with a high proportion of exposed 
hydrophobic residues at room temperature. SgbE147/MioC82 appeared to be 
almost completely denatured at room temperature in the test conditions. This 
could suggest that the buffer used or SYPRO Orange lead to unfolding of the 
protein, or that SgbE147/MioC82 has a large number of exposed hydrophobic 
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residues in its soluble state. It has been previously reported that fluorescence 
intensity can sometimes decrease following protein unfolding, depending on the 
hydrophobicity of the protein surface (Neira et al., 2017). While this results 
suggests that SgbE147/MioC82 has a high proportion of exposed hydrophobic 
residues in these assay conditions, it does not necessarily point to a disordered 
protein. The MioC thermal shift assay results also had unusually high fluorescence 
at room temperature, and MioC has a solved structure, highlighting its structured 
nature. The SEC-MALS data also suggests SgbE147/MioC82 is present as a dimer 
with the protein eluting as a relatively clean peak, which indicates an ordered 
protein. Circular dichroism was therefore completed to confirm the secondary 
structural elements present in SgbE147/MioC82. 
5.6 Circular dichroism spectroscopy 
5.6.1 Far UV CD spectroscopy 
Circular dichroism (CD) spectroscopy measures the difference in the 
absorption of left handed circularly polarised light and right handed circularly 
polarised light. The difference in these two absorbance values occurs in the 
presence of chiral molecules. Amino acids are chiral molecules, meaning they 




(185 nm–260 nm) was used to determine the secondary structure composition of 
SgbE147/MioC82, MioC, and SgbE. All CD experiments used freshly purified 
protein. 
Figure 5.7 shows the CD spectra for SgbE147/MioC82, MioC, and SgbE. ⍺-
helical proteins have minima at 222 nm and 208 nm, and a peak at 193nm. 
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Antiparallel β-sheets result in minima at 218 nm and a peak at 195 nm. 
Disordered proteins result in negative bands near 195 nm and low ellipticity above 
210 nm (Greenfield, 2006). The spectra for both SgbE and MioC are indicative of 
proteins with mixture of distinct secondary structure elements. The 
SgbE147/MioC82 spectrum is somewhat atypical. It displays some evidence for 
both antiparallel β-sheets and ⍺-helices, however, as shown, it is quite different to 
the more typical spectra of MioC and SgbE. The SgbE147/MioC82 spectra lacks a 
distinct dip at ~222 nm, typical of ⍺-helices, however does show a dip at 208 nm, 
suggestive of ⍺-helices. Without this dip at 208 nm, the spectra would be more 
typical of a spectrum for antiparallel β-sheets. The low ellipticity above 210 nm for 
the SgbE147/MioC82 spectra may indicate some disorder in the protein. However, 
the peak at 195 nm rather than a minima at 195 nm indicates the protein does 
have distinct secondary structure elements.  
Figure 5.7 CD spectra of SgbE147/MioC82, SgbE, and MioC. Secondary structure elements 
of SgbE147/mioC82, SgbE, and MioC were detected by CD spectroscopy between 260nm 
and 185 nm. Mean residue ellipticity (MRE) is shown on the y-axis. The spectra indicate that 
all three proteins have differing levels of secondary structure elements. 
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Table 5.1 shows the predicted proportions of ⍺-helices and β-sheets for 
SgbE147/MioC82 and the two parent proteins as calculated from the CD data 
using the average results from three algorithms. Table 5.1 also indicates the actual 
proportion of the ⍺-helices and β-sheets for SgbE and MioC as determined from 
the solved structures of these two proteins. While the predicted values are not 
expected to be exact, the predictions for SgbE and MioC are somewhat validated 
by the actual values for these two proteins. While the predicted value for ⍺-helices 
in SgbE was low (30% predicted, 41% actual), the other values were all within 4% 
of the actual. What the result potentially reflects is that SgbE147/MioC82 has 
proportionally less β-sheet than SgbE, but a similar proportion of ⍺-helices.  
The far UV CD spectra supported and clarified results from SEC-MALS and 
thermal shift assays; SgbE147/MioC82 has structural elements which do not 
reflect exactly either of the two parental proteins. SgbE147/MioC82 is not 
completely devoid of structure, which confirms the SEC-MALS data. Like the 
thermal shift assays for SgbE147/MioC82, its CD spectrum is also somewhat 
atypical for a globular protein.  
Table 5.1 Predicted secondary structure elements from CD spectroscopy. Three algorithms 
were used to predict the proportion of ⍺-helices and β-strands/sheets making up the secondary 
structure of SgbE, MioC, and SgbE147/MioC82. The averages were compared to the actual 
proportions for SgbE and MioC from their respective solved structures. The three algorithms 
used were: the Jasco- CD multivariate SSE software, the Raussens algorithm (Raussens et al., 
2003), and the BeStSel algorithm (Micsonai et al., 2018). 
*Actual fraction of secondary structure elements was taken from the PDB entries of SgbE (1JDI) 
and MioC (2HNA) 
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5.6.2 Protein melting monitored by CD spectroscopy	
To determine how the secondary structure elements changed as the proteins 
denatured, far UV CD spectra were recorded at 5°C increments from 25°C to 
85°C. The most dramatic changes were observed by comparing the 25°C spectra 
against the 85°C spectra (Figure 5.8). The most drastic change was observed in 
MioC (Figure 5.8a), where almost all secondary structure elements were lost, 
resulting in a complete change in the shape of the spectrum. The change in SgbE 
was not as drastic as MioC, but still significant. A large reduction in CD signals 
associated with ⍺-helices	left	a	spectrum	more	synonymous	with	β-sheets 
(Figure 5.8b). In sharp contrast, the SgbE147/MioC82 spectra changed very little 
between 25°C and 85°C (Figure 5.8c. There was a small reduction in the CD signal 
at ~195 nm. The lack of significant changes in SgbE147/MioC82 as the sample was 
heated suggest that the secondary structure of SgbE147/MioC82 is stable up to at 
least 85°C. Heat stability can be associated with intrinsically disordered proteins as 
they do not possess a hydrophobic core typical of globular proteins (Tompa 2002), 













Figure 5.8 Protein melting observed by CD spectroscopy. CD spectra were 
recorded at 5°C increments from 25°C – 85°C. Shown are the 25°C spectra and 
85°C spectra for A) MioC, B) SgbE, and C) SgbE147/MioC82. The differing levels 
of heat stability can be observed between the three proteins.	
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5.7 Discussion 
5.7.1 The structure and properties of SgbE147/MioC82  
Overall the results suggest that SgbE147/MioC82 is a protein with distinct 
secondary structure elements (CD data), likely with stable tertiary and quaternary 
structure (SEC-MALS data). However, the results from thermal shift assays and 
the atypical CD-spectra suggest that the protein also has areas of disorder and 
exposed hydrophobic residues. This picture of a semi-ordered protein with areas 
of disorder is not surprising; SgbE147/MioC82 was constructed from the random 
combination of two unrelated protein fragments. The fact that this de novo hybrid 
protein, looks and acts like a protein at all is interesting in itself. What is not 
known at this point, is whether the structural elements are contributed by one or 
both of the parental protein fragments, and whether the two fragments interact to 
form a single protein, or whether they behave as two linked protein fragments.  
5.7.1.1 Oligomerisation 
Potentially the most interesting and surprising result is the fact that 
SgbE147/MioC82 appears to form a stable dimer in solution. SEC-MALS is able to 
determine the dimerisation state of proteins even if that protein is highly 
disordered (Nourse & Mittag, 2014). In the case of SgbE147/MioC82 the peak in 
the SEC-MALS experiment is also relatively sharp, indicating the protein is mostly 
present in a single oligomeric state (Figure 5.5). The two most likely mechanisms 
for dimerisation are: via dimer interfaces retained from SgbE, or dimerisation is 
induced because of new interactions resulting from the truncations of SgbE and 
MioC. 
As discussed in section 5.2.2, the crystal structure of SgbE was solved as homo-
tetramer. In SgbE, two ⍺-helices from one molecule form interactions with two 
loops and a linker in a neighbouring molecule. The sequence of one of the 
⍺-helices and the two loops is retained in SgbE147/MioC82. Furthermore, the 
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predicted structure of SgbE147/MioC82 suggests that these three elements are also 
retained in the structure. In the SgbE147/MioC82 structure the second ⍺-helix 
important for SgbE oligomerisation appears to be replaced by helix from MioC 
(Figure 5.9). Whether any of these elements are retained in the actual structure of 
SgbE147/MioC82 is unknown, however, the retention of these elements is a 
plausible solution to how dimerisation is occurring.  
Figure 5.9 SgbE oligomerisation interface. A) The structure of SgbE highlight the two ⍺-
helices (Red) and the two loops and a linker (blue) that form the interface between 
adjacent SgbE monomers (Luo et al., 2001). B) the predicted structure of 
SgbE147/MioC82 retains both of the ⍺-helices (Red and Pink) and the two loops (Blue) 
that form the interface. The helix shown in pink is contributed from the MioC fragment of 
the hybrid protein while the other key interface features are retained in the sequence of 
the SgbE fragment.	
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A second option for the mechanism of dimerisation is that the truncation of 
SgbE and MioC led to exposure of residues which are making new interactions; 
essentially generating a new dimer interface. The truncation of MioC split the 
protein between two β-strands that form part of a core β-sheet. As discussed, 
exposed β-strands can lead to oligomerisation (Richardson & Richardson, 2002), 
therefore, the exposure of this β-strand could potentially allow dimerisation. The 
predicted structure of SgbE147/MioC82 suggests that this region forms an 
exposed ⍺-helix, however, this may not be the case in reality. Alternatively, 
dimerisation could be induced by the interaction between hydrophobic residues 
that are exposed in the hybrid protein. It is likely that SgbE147/MioC82 has 
regions of disorder, which could result in hydrophobic residues being exposed to 
solvent. It is possible that dimerisation is sufficient to bury these residues, rather 
than requiring complete aggregation.  
5.7.1.2 A potentially disordered protein 
If the SgbE147/MioC82 does have significant regions of disorder, 
oligomerisation could be inducing stability in these regions. Intrinsically 
disordered proteins (IDPs) have been regularly observed to couple folding with 
binding to other proteins or ligands (Dyson & Wright, 2002; Wright & Dyson, 
2009). These IDPs are important is eukaryotic signal transduction where 
unstructured domains have been observed to fold into globular proteins upon 
formation of protein complexes (Kim et al., 2000). A similar mechanism is also 
observed in transcriptional regulation, where transcription factors to DNA results 
in the folding of accessory domains (Bowers et al., 1999). SgbE147/MioC82 may 
represent a protein with similar conformational flexibility to some IDPs. 
It has been proposed (Tokuriki & Tawfik, 2009) that proteins with high 
conformational flexibility are highly evolvable. This flexibility facilitates 
divergence of existing folds to produce new functions. Local flexibility, such as in 
an active site, can lead to promiscuity. For example, the active site of cytochrome 
P450 can adopt a range of conformations that bind to a variety of substrates 
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(Lange et al., 2008). Some proteins are even able to switch between two 
conformations at a whole protein level, making global structural rearrangements 
and transitions between different folds (Andreeva & Murzin, 2006). The protein 
Mad2 can adopt two globally different structures (Tuinstra et al., 2008). In terms 
of evolution, in vitro studies have shown ribozymes able to switch between two 
different functions and different folds with only a few point mutations (Curtis & 
Bartel). If SgbE147/MioC82 is somewhat disordered, as the data suggests, it 
indicates a level of conformational flexibility whilst remaining soluble. This would 
indicate that non-homologous recombination could be a source of proteins with 
high levels of conformational flexibility and evolvability. 
5.7.1.3 Future work 
To determine what parts of SgbE147/MioC82 contribute to the structural 
elements observed, and the oligomerisation, the SgbE147 and MioC82 fragments 
need to be expressed separately. If neither is soluble then it would indicate that 
SgbE147/MioC82 is behaving as a single protein, with stabilising interactions 
occurring between the two fragments. If both fragments are soluble individually 
then the oligomerisation state of each could indicate what parts of the overall 
protein are important for oligomerisation to occur. As an extension to these 
experiments, mutagenesis studies could be used to mutate or remove parts of 
SgbE147/MioC82, to determine if this alters oligomerisation. If only one of the 
fragments is soluble then this would suggest the other contributes to the 
unstructured nature observed for SgbE147/MioC82.  
One key experiment would be nuclear magnetic resonance (NMR) 
spectroscopy. Heteronuclear single quantum coherence (HSQC) spectroscopy 
could give a definitive answer as to whether the two parental fragments are 
associating with one another in SgbE147/MioC82. Collaborators (Mackay Group, 
School of Life and Environmental Sciences, The University of Sydney) have 
completed a preliminary 1D-NMR spectrum for SgbE147/MioC82 (Appendix, 
Supplementary Figure S3). The 1D-NMR confirmed what was inferred from 
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CD spectroscopy and SEC-MALS data; SgbE147/MioC82 has areas of distinct 
structure which appear to form some sort of ordered fold. However, the data 
cannot determine if the structure is all contributed by a single parental fragment, 
or how the two parental fragments interact, if at all. A 2D-HSQC spectra could 
answer this question. Collaborators are working towards this at present.  
5.7.2 Summary 
SgbE147/MioC82 has been observed to not only have distinct secondary 
structure elements, but to also form a dimer in solution, indicating higher order 
structure. Two hypotheses currently exist to explain the observed structural data. 
Firstly, SgbE147/MoC82 is a relatively stable protein with at least a partially folded 
SgbE-derived fold. This preserved SgbE structure has resulted in the ability for the 
hybrid protein to dimerise via the preserved oligomerisation interface. This 
hypothesis is supported to a degree by the CD data, which confirms that the 
SgbE147/MioC82 has both ⍺-helices and β-sheets,	suggesting	a	level	of	
structure	in	the	protein.	This	hypothesis	is	further	supported	by	the	fact	that	
a	large	proportion	of	the	two	oligomerisation	interfaces	of	SgbE	have	been	
preserved	(at	least	in	amino	acid	sequence)	in	SgbE147/MioC82. However, the 
heat stability observed in the CD data of SgbE147/MioC82 would be atypical for a 
globular protein.  
The second hypothesis is that SgbE147/MioC82 has large areas of disorder and 
that dimerisation is induced by association of hydrophobic residues. The heat 
stability observed supports this hypothesis as if hydrophobic interactions are the 
key stabilising interactions then the protein is less likely to be effected by heat. 











6.1 SgbE147/MioC82 as evidence for 
subdomain assembly 
The overall goal of this project was to determine whether the recombination of 
subdomain encoding genes was a viable mechanism for the evolution of protein 
domains, and to determine whether this mechanism is still giving rise to new folds 
in modern biology. The work presented offers evidence that non-homologous 
recombination of modern genes can, in fact, yield new proteins with new 
structures and functions. The discovery of hybrid protein SgbE147/MioC82 
indicates that recombination of genetic material with subdomain encoding genes 
could be an important evolutionary mechanism.  
The generation of SgbE147/MioC82 nicely replicates the evolution of new 
proteins via non-homologous end joining – two fragments of full sized, modern 
genes were recombined. In order to compare this to subdomain assembly, a few 
suppositions need to be made: firstly, that one or both of the fragments of 
SgbE147/MioC82 represent a subdomain; secondly, that these fragments could 
represent ancient peptides. These ideas are discussed below. 
6.1.1 MioC 
MioC contributes less to the SgbE147/MioC82 sequence than SgbE (82 residues 
versus 147 residues), however, it may play a critical role in the global structure of 
SgbE147/MioC82. The fragment of MioC present in SgbE147/MioC82 forms a 
β-⍺-β motif (in the context of MioC) (Figure 6.1). This motif was the first 
subdomain identified (Buehner et al., 1973), so the presence of this motif in 
SgbE147/MioC82 is compelling. Importantly for this work, its presence in the only 
hybrid able to be characterised in vitro suggests that this subdomain is more likely 
to form a stable, selectable structure than a random peptide. More structural 
information will be required from SgbE147/MioC82 to confirm that the MioC-
derived sequence adopts its native β-⍺-β motif. At this point the motif is inferred 
to be part of the SgbE147/MioC82 structure from the sequence of 
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SgbE147/MioC82 and the solved structure of MioC. Previous studies support 
subdomain structures being maintained within the context of new protein 
architectures (Fischer, Reichmann & Winter, 2004; de Bono et al., 2005; 
Reichmann & Winter, 2006). In these studies, subdomains were used as “bait” in 
fusions with random peptide sequences to form new proteins (Chapter 1.3.1.2). 
The studies show that subdomain structures are often maintained even when the 
global structure of the parental protein is completely different to the global 
structure of the new fusion protein.  
	
MioC shows structural symmetry, via repetition of a β-⍺-β	motif	(discussed in 
Chapter 5) (Hu et al., 2006), which is a feature that could indicate the role of 
subdomains in its evolution. Repetition of subdomains is an important 
evolutionary mechanism. Subdomains have been shown to repeat within a protein 
domain or fold. Over time the repeated units diversify leading to new functions 
and at times less structural symmetry (Smock et al., 2016). The flavodoxin fold is 
thought to be one of the most ancient, potentially dating to LUCA (Farias-Rico et 
al., 2014), adding another link to MioC and the ancient protein world.  
Figure 6.1 MioC fragment structure. 
The fragment of MioC present in 
SgbE147/MioC82 contains the β-⍺-β 
motif (shown in yellow), which is 
believed to be one of the most ancient 
protein structural motifs.  
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6.1.2 SgbE and overall protein architecture 
Sequence from SgbE makes up almost two thirds of SgbE147/MioC82, however, 
as discussed above it may be the fragment from MioC which nucleates the 
structure of SgbE147/MioC82. At 148 amino acids, the SgbE fragment is larger 
than a typical subdomain, and does not appear to reflect subdomains described in 
literature (Alva, Söding & Lupas, 2015). The formation of SgbE147/MioC82 
therefore does not represent the tidy/precise recombination of two or more 
subdomains. The formation of SgbE147/MioC82 is instead similar to previous 
studies which have shown evolution of new proteins via accretion with a 
subdomain as the scaffold for building a free folding protein (Fischer, Reichmann 
& Winter, 2004; de Bono et al., 2005; Reichmann & Winter, 2006). However, 
while it seems that the formation of this hybrid protein is not between two 
subdomains, this does not rule out SgbE147/MioC82 as a representation of 
subdomain driven evolution. The MioC fragment does resemble a subdomain. 
Therefore, subdomains may also facilitate the evolution of new proteins by 
conferring structure or function for the rest of the protein to build around.  
The key to understanding the roles of the MioC and SgbE fragments in 
SgbE147/MioC82 will be to gain a better understanding of the tertiary structure of 
the protein. The evidence presented in Chapter 5 suggests that SgbE147/MioC82 
has secondary structure (CD data), as well as tertiary and quaternary structure 
(SEC-MALS data). What is not known is how the two fragments of the protein 
interact. It is possible that part (or all) of only one of the fragments is structured, 
with this being sufficient to ensure the entire protein is soluble. In the pilot study 
that led to this work, a hybrid protein was soluble despite being almost completely 
disordered according to NMR data (Saraswat, 2014). 
However, the SEC-MALS data for SgbE147/MioC82 indicates a protein which 
forms a stable dimer and elutes with a single sharp peak, suggesting a large 
proportion of the protein is ordered. It is therefore likely that if only one fragment 
is contributing to structure then it would be the larger SgbE fragment. It is also 
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possible that both fragments are folding independently, joined by a flexible linker. 
In this case the two parts again would likely adopt structures that resemble the 
native ones in the parental proteins. The most captivating option would be that 
parts of the two fragments are forming a stable tertiary structure with interaction 
between both fragments. If the two fragments are folding to form a cooperative 
protein structure, this would almost certainly be a structure unique from the two 
parents. These options are to this point speculative, as to date no structure for 
SgbE147/MioC82 has been solved. The Phyre2 model for SgbE147/MioC82 
(Figure 5.2c) indicates that the two fragments are integrated into a single 
structure, with the MioC fragment contributing to an architecture dominated by 
the original SgbE structure.  
Outside of biophysical data there is one piece of evidence that suggests 
SgbE147/MioC82 folds into a single cooperative structure; SgbE147/MioC82 has a 
function not shared by either parent (Patrick et al., 2007). The new function of 
SgbE147/MioC82 means that the protein is behaving differently to either parent, 
suggesting there is potentially a new structure forming also. Once the structure is 
solved, a key observation will be whether the β-⍺-β	motif from MioC remains 
within the new protein architecture. The presence of the	β-⍺-β	motif in the 
context of a new protein would indicate that the motif was key in the formation of 
the overall protein, highlighting the importance of subdomains as scaffolds for 
protein domain evolution. 
There is precedent for subdomains imparting function to a protein outside of 
the context of an evolved active site. The phosphate binding loop (P-loop) is an 
essential motif in modern NTPases, but the enzyme is only active in the context of 
specific active site residues contributed by other parts of the protein (Walker et al., 
1982; Frasch, 2000).  In recent work, it was shown that with minimal modification 
a P-loop within a simple protein architecture retains activity, despite the protein 
lacking a binding pocket or other active site residues typically associated with 
NTPase activity (Romero et al., 2018). The activity of the P-loop in this context 
suggest that subdomains may still retain the functionality of ancient subdomains, 
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despite the more complex structural context within which they exist in modern 
proteins.  
6.2 Function of SgbE147/MioC82 
As discussed in Chapter 4, expression of the hybrid SgbE147/MioC82 was able 
to rescue the conditional auxotroph E. coli ∆cysN. The nature of the mechanism of 
rescue remains unanswered. With knowledge of the functions of CysN, MioC and 
SgbE, two plausible (and testable) hypotheses can be formulated. 
SgbE147/MioC82 was either able to directly complement the function of CysN, or 
upregulate some alternative pathway leading to the rescue of the ∆cysN 
phenotype.  
6.2.1 CysN 
The assimilation of sulfate into bioavailable molecules is key in bacterial 
metabolism. CysN, or sulfate adenylyltransferase subunit 1, is a 62 kDa protein 
that makes up the ATP sulfurylase complex along with CysD. ATP sulfurylase 
catalyses the formation of adenosine 5’-phosphosulfate (AP) from sulfate and 
ATP (Leyh et al., 1988). This assimilation of sulfate is a key step in the production 
of L-cysteine, which also requires the proteins CysC, CysH, CysJ, and CysI (Figure 
6.2). ATP sulfurylase activity is mediated by hydrolysis of GTP, with CysN having 
a GTP binding consensus sequence and consequent GTPase activity (Leyh & Suo, 
1992). Hydrolysis of GTP is thought to activate the ATP sulfurylase complex, 
leading to the formation of AP. AP formation is extremely thermodynamically 
unfavourable. GTP hydrolysis is coupled to the transfer of an adenylyl group from 
pyrophosphate to sulfate, which results in the high energy phosphoric—sulfuric 
acid anhydride bond, facilitating the transfer of the sulfuryl group to cellular 
recipients (Wei & Leyh, 1999). GTPase activity is controlled in part by an 
isomerisation event in ATP sulfurylase, which is mediated by a complex 
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interaction between the active sites of CysN and CysD as well as the presence of 
GTP, ATP, and sulfate (Wei et al., 2000).   
With the interactions and roles of CysN and CysD in mind, the goal was to 
formulate hypotheses on how SgbE147/MioC82 may rescue ∆cysN.  
6.2.2 Direct complementation of ∆cysN 
Conceptually, the simplest mode of rescue that SgbE147/MioC82 could perform 
would be direct complementation of the missing function of CysN. However, this 
would mean that SgbE147/MioC82 is able to bind to and hydrolyse GTP, as well 
as form an allosteric interaction with CysD. Neither of the parental proteins MioC 
or SgbE are known to contain a GTP binding motif or possess GTPase activity. 
Furthermore, as discussed above the activation of ATP sulfurylase involves 
complex interactions between CysN and CysD. In some organisms, such as 
Bacillus subtilis, CysN and CysD are fused, indicating the importance and 
specificity of this particular interaction (Mansilla & de Mendoza, 1997). 
Therefore, it is unlikely that SgbE147/MioC82 directly complements ∆cysN, as it is 
extremely unlikely that the random combination of two protein fragments would 
lead to the formation of a protein with a new activity distinct from either parent, 
Figure 6.2 Sulfate assimilation pathway. The reaction pathway required for the assimilation 
of sulfate in E. coli. The enzymes involved are shown in blue, while the reaction catalysed by 
CysN/CysD is highlighted in red. 
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and the ability to bind to another protein which requires the newly acquired 
function. 
Direct complementation is a testable hypothesis. In order to rule this out, a 
number of further experiments could be completed. The rescue experiments 
should be attempted with in a ∆cysN∆cysD double knockout strain. If the rescue 
was successful it would indicate that SgbE147/MioC82 was not directly 
complementing CysN, but instead it was bypassing the need for an ATP 
sulfurylase complex completely. Furthermore, if SgbE147/MioC82 rescued a triple 
knockout of cysN, cysD, and a protein from further down the L-cysteine 
biosynthesis pathway, it would indicate that SgbE147/MioC82 is bypassing the 
pathway completely. 
SgbE147/MioC82 could also be assayed for GTP binding and GTPase activity, 
as well as the ability to interact with CysD. However these experiments would be 
unnecessary if knockout experiments indicated that SgbE147/MioC82 was not an 
iso-functional replacement for CysN.  
6.2.3 Indirect rescue of ∆cysN 
The most plausible hypothesis is that SgbE147/MioC82 rescues ∆cysN 
indirectly, by upregulating an alternative metabolic pathway and allowing the cells 
to bypass the non-functional ATP sulfurylase. Assimilated sulfate is still required 
by the bacterium for L-cysteine biosynthesis, an indirect rescue mechanism would 
likely rely on the scavenging and catabolism of bioactive sulfur containing 
compounds. Previous studies which found de novo generated 4-helix bundles that 
could rescue conditionally auxotrophic E. coli strains indicate that indirect rescue 
is highly likely. The de novo protein SynSerB3 rescued ∆serB by upregulating 
transcription of hisB, which encodes histidinol phosphate phosphatase, a 
promiscuous enzyme that is able to compensate for the loss of SerB when over-
expressed (Digianantonio & Hecht, 2016). Similarly, ∆gltA is rescued by the 
expression of the de novo protein SynGltA. Expression of SynGltA results in the 
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over-expression of prpC, which encodes methylcitrate synthase. The over-
expression of the promiscuous methylcitrate synthase is able to overcome the 
deletion of the gltA gene (Digianantonio et al., 2017). 
These examples highlight that it is likely SgbE147/MioC82 is leading to the 
upregulation of another gene or genes, which is allowing ∆cysN to overcome the 
loss of CysN activity. 
6.3 Significance of the research 
This work is significant on two fronts: it is the first experiment to date which 
recombines random fragments of all E. coli open reading frames; and is the first 
generation of de novo proteins from fragments of extant proteins which has 
resulted in proteins able to rescue auxotrophic strains of E. coli. 
This work has pushed the limits of the method ITCHY, resulting in the first 
ITCHY library generated from a pool of all E. coli ORFs. The pool of ORFs 
allowed for the generation of hybrids with the potential for ~1013 unique clones; 
essentially the combination of any sized fragment of any two E. coli proteins. A 
number of past experiments have created de novo proteins using more guided 
approaches. As discussed in Chapter 1, a number of experiments have generated 
de novo proteins utilising subdomains (Höcker et al., 2001; Main et al., 2003; 
Fischer, Reichmann & Winter, 2004; de Bono et al., 2005; Reichmann & Winter, 
2006;	Arnold et al., 2007; Bharat et al., 2008; Yadid & Tawfik, 2010; Smock et al., 
2016; Zhu et al., 2016). Furthermore, de novo proteins have been generated from 
random amino acid sequences using phage display libraries (Chiarabelli et al., 
2008), the random combination of rationally designed peptide libraries aimed at 
generating four-helix bundles (Hecht et al., 2004), and other random 
combinatorial methods. However, this is the first library to be generated from 
every ORF in a genome, without constraining potential combinations or targeting 
a specific outcome.  
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As previously discussed, efforts to recapitulate the evolution of a lectin propeller 
through the repetition of a lectin motif resulted in a functional protein (Smock et 
al., 2016). However, this was the targeted generation of a protein via a 
hypothesised evolutionary pathway, not the random generation of a functional 
protein. Similarly, the combination of fragments designed to generate four-helix 
bundles resulted in four-helix bundles with a number of functions including 
conferring copper resistance to E. coli when expressed in the cells (Hoegler et al., 
2016), and rescuing a ∆serB E. coli strain (Digianantonio et al., 2016). Like the 
previous example the de novo generation of these four-helix bundles was  designed 
using binary patterning, meaning that the proteins generated were restrained to a 
specific conformation, limiting the sequence space accessible, and increasing the 
likelihood of a functional proteins.  SgbE147/MioC82 was generated from a 
methodology with far fewer constraints, meaning the generation of folded or 
functional protein was less probable.  
6.3.1 Extant proteins as a source of subdomains 
To support the concept of primordial subdomain assembly, this project aimed 
to recombine subdomains from extant proteins to form new proteins. The 
assumption was that subdomains remain as modular components of modern 
proteins, able to be reassembled into new architectures. The work discussed above 
(section 6.2) highlighted examples in which well-known subdomains were used to 
build new proteins. However, the approach taken in this study was completely 
random and not guided by any preconceived assumptions about the fragments 
that were most likely to contribute structure or function to a new protein.  
The most comprehensive search for evidence of subdomains across extant 
proteins was the work of Alva et al. (2015). The researchers analysed a set of 1,194 
folds but only found evidence for 40 subdomains, in 130 of the folds. One possible 
explanation is that subdomains have played a limited role in protein evolution. 
However, Alva et al. note that 14 of the 25 most common folds (and 7 of the top 
10) do contain fragments from their set of 40. They also argue that their 
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bioinformatics cut-offs for finding subdomains were stringent, and that the total 
number of ancestral subdomains may be closer to 100. Nevertheless, it appears 
that most extant proteins have diverged so much from their ancient counterparts 
that it is no longer possible to detect their subdomain building blocks.  
The analysis of Alva et al. (2015) suggests that fragments of extant proteins may 
not be the best source of subdomains for an experiment like the one undertaken in 
this study. Ancestral proteins would be expected to have more autonomous (and 
therefore easier to detect) subdomains. The field of ancestral protein 
reconstruction is growing rapidly (Harms & Thornton, 2013; Risso et al., 2018). In 
the future, it may be possible to repeat the work presented in this thesis using a 
library of ancestral ORFs as the source of subdomains.  
6.3.2 Expanding the protein repertoire 
One of the goals of this research was to sample parts of the protein universe that 
may have never been sampled by nature, and in doing so discover new proteins, 
with potential new folds. SgbE147/MioC82 and the other rescuing hybrids do 
represent proteins not found in nature, and may represent proteins never before 
sampled by nature. However, because of the absence of structural data, it is 
impossible to determine whether any of these proteins represent a new fold. This 
work also aimed to determine the rate of evolution of new proteins via the 
recombination of modern sub-domains. This rate was impossible to determine, 
because of the issues around selection of folded proteins. Because of these issues, 
even an estimate of the actual proportion of the library that is folded is not 
possible. Despite this, the six potentially functional hybrids generated in this study 
do appear to represent novel proteins, built from fragment of existing proteins. 
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6.4 Future directions 
6.4.1 ITCHY modifications 
At the outset of this project the aim was to be able to express, purify and 
characterise a number of hybrid proteins. Data from multiple hybrids would have 
allowed for overarching conclusions about subdomain assembly, and whether 
extant proteins still contain stable and autonomous subdomains. Beyond 
biophysical characterisation, a pool of truly soluble hybrids from pSALect 
selection would have allowed for the potential identification of subdomains within 
the sequences of the soluble pool. Sequences could be compared to previous 
studies detecting subdomains (such as Lupas et al., 2015) to determine whether 
the pool in this study was enriched for subdomains. As it stands, 
SgbE147/MioC82 is the only functional or soluble hybrid found in the library 
which was able to be purified. Because only one protein could be purified it was 
not possible to make overarching conclusions about subdomain driven evolution 
in the context of recombination. Specific details about how the library 
construction and screening could have been changed to address these issues were 
discussed in Chapter 4.5. 
6.4.2 Characterisation of SgbE147/MioC82 
The hybrid protein SgbE147/MioC82 needs to be further characterised 
biophysically and functionally. In order to determine the interactions between the 
two parental fragments of SgbE147/MioC82 it is likely that a 3D structure will 
need to be solved. At the time of writing, NMR and crystallography experiments 
were being initiated by collaborators (Mackay Group, School of Life and 
Environmental Sciences, The University of Sydney) (preliminary data shown 
Supplementary Figure S3). Aside from solving a structure, there are a number of 
simpler experiments which could assist in determining the nature of 
SgbE147/MioC82’s tertiary and quaternary structure. Expressing the two 
fragments individually could be identify whether each fragment is stable when 
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removed from the context of the other fragment (Discussed in detail in Chapter 
5.7.1.3).  
Individual expression of each fragment could also be used to inform the nature 
of the ∆cysN rescue. If either of the parental fragments alone were able to rescue 
the knockout strain it would indicate that SgbE147/MioC82’s function is not a 
result of interactions between the two fragments. The potential mechanisms of 
∆cysN rescue, and the experiments required to test these mechanisms, is discussed 
in depth is in 6.3. In addition to this metabolomics could be used to determine 
which other pathways are upregulated and give indications of how 
SgbE147/MioC82 may be functioning.  
6.4.3 Further work with other functional clones 
Other than SgbE147/MioC82, there were five functional hybrids identified 
which were able to rescue different knockout strains of E. coli (Table 4.2). None of 
these five clones was able to be purified for further characterisation. Exhaustive 
induction trials and buffer screens need to be completed to determine whether 
any of the five hybrids can be produced solubly. If conditions are found in which 
any of the proteins can be purified, then further characterisation of the proteins 
could be undertaken.  
Furthermore, an in-depth sequence analysis and structural prediction of the five 
functional hybrids needs to be undertaken. It may be possible to detect areas 
within the hybrids which resemble subdomains. If subdomains are detected in any 
of the hybrids it would support the idea that new proteins are more likely to form 
around the scaffold of a subdomain fragment. The presence of a subdomain like 
fragment in SgbE147/MioC82 alone would not be as significant as if multiple 
hybrids appeared to contain subdomains. 
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6.4.4 Subdomain array experiments 
This project aimed to replicate subdomain assembly using modern proteins as a 
potential source of subdomains. However, the ITCHY method offered an indirect 
way to achieve this as the source material was not an enriched pool of subdomains 
(but instead random fragments of the ASKA ORF library). With the publication of 
a repertoire of subdomains (Lupas et al., 2015) it may be possible to generate an 
array of these subdomains in such a way that they could be shuffled to directly 
replicate subdomain assembly.  
6.4.5 Extending the use of ITCHY for the generation of 
random libraries 
This work pushed the limits of the ITCHY protocol and opened the possibility 
for new applications of the method. Subdomain driven protein evolution by 
accretion and recombination could be studied using a modified ITCHY library. 
The ITCHY protocol could be modified such that a random subdomain could be 
fused to a truncated ORF, meaning at least one of the fused peptides would be a 
subdomain. Much of the power of the ITCHY method used in this work is the 
ability to recombine any two clones within the plasmid pool. This non-










Figure 6.3 Generating hybrids by joining subdomains to fragments of ORFs. 
Modification of the ITCHY protocol, could allow the study of combinations of different 
known subdomains with fragments of ORFs. 1) clone a pool of known subdomains into a 
plasmid containing a primer site and unique cut site at the 3ʹ- end of the insert site. 
Clone the ASKA ORFs from the ASKA collection into a second plasmid with a unique 
cut site and primer site at the 5ʹ- end of the insert site. Linearise the plasmids using the 
unique restriction sites. 2) Perform overlap extension PCR as per the typical ITCHY 
protocol, however the Primer 1* includes a modified dNTP (star) at its 3ʹ- end, which 
prevents digestion past it by ExoIII. 3) Truncation with ExoIII and mung bean nuclease 
as per ITCHY, except the subdomain insert ORF is not digested due to the 
incorporation of a modified dNTP. Ligation results in a plasmid containing a full-length 
subdomain linked to a truncated ASKA ORF.	
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6.5 Concluding remarks 
This work represents the first attempt to recapitulate subdomain assembly from 
a complete pool of E. coli open reading frames. The method of Incremental 
Truncation for the Creation of Hybrid enzYmes was used to randomly combine 
fragments from over 4000 different ORFs, which massively extended the method 
past its previous limit of two-parent recombination. Selection from the resulting 
libraries revealed six hybrids that were able to rescue conditionally auxotrophic 
strains of E. coli. Of these six clones, one (SgbE147/MioC82) was able to be 
purified and characterised. 
The mechanism for SgbE147/MioC82’s rescue of E. coli ∆cysN remains 
unknown; however, one of the fragments which makes up SgbE147/MioC82 does 
resemble a known subdomain. The presence of a subdomain like fragment in 
SgbE147/MioC82 provides evidence for a subdomain assembly model for the 
formation of new proteins from small peptides. Further work is required to 
elucidate the structure and functional mechanism of SgbE147/MioC82, however 
SgbE147/MioC82 is one of the first examples of a de novo protein generated by a 
non-rational approach from fragments of extant proteins, which has resulted in a 
functional soluble protein. Without solving the structure of SgbE147/MioC82, it is 
impossible to determine whether it represents a new fold architecture. 
The generation of SgbE147/MioC82 indicates that non-homologous end joining 
is still a relevant evolutionary mechanism, even within the context of modern day 
proteins. Furthermore, the MioC fragment in SgbE147/MioC82 resembles a 
known subdomain suggesting that recapitulation of subdomain driven evolution 
may be possible using fragments of extant genes. Modifications to the 
methodology used could allow for further investigation of subdomain assembly, to 
ascertain whether the subset of subdomains observed in nature could give rise to 









Alva, V., & Lupas, A. N. (2018). From ancestral peptides to designed proteins. Current 
opinion in structural biology, 48, 103-109. 
Alva, V., Söding, J., & Lupas, A. N. (2015). A vocabulary of ancient peptides at the origin 
of folded proteins. Elife, 4, e09410. 
Anderson, R. P., & Roth, J. R. (1977). Tandem genetic duplications in phage and bacteria. 
Annual Review of Microbiology, 31, 473-505.  
Andreeva, A., & Murzin, A. G. (2006). Evolution of protein fold in the presence of 
functional constraints. Current opinion in structural biology, 16, 399-408. 
Arnold, T., Poynor, M., Nussberger, S., Lupas, A. N., & Linke, D. (2007). Gene 
duplication of the eight-stranded β-barrel OmpX produces a functional pore: a 
scenario for the evolution of transmembrane β-barrels. Journal of Molecular 
Biology, 366, 1174-1184. 
Begun, D. J., Lindfors, H. A., Thompson, M. E., & Holloway, A. K. (2006). Recently 
evolved genes identified from Drosophila yakuba and D. erecta accessory gland 
expressed sequence tags. Genetics, 172, 1675-1681. 
Behrendt, J., Standar, K., Lindenstrauß, U., & Brüser, T. (2006). Topological studies on 
the twin-arginine translocase component TatC. FEMS Microbiology Letters, 234, 
303-308. 
Bell, S. C., & Turner, J. M. (1977). Bacterial catabolism of threonine. Threonine 
degradation initiated by l-threonine hydrolyase (deaminating) in a species of 
Corynebacterium. Biochemical Journal, 164, 579-587. 
Belogurov, G. A., Vassylyeva, M. N., Svetlov, V., Klyuyev, S., Grishin, N. V., Vassylyev, D. 
G., & Artsimovitch, I. (2007). Structural basis for converting a general transcription 
factor into an operon-specific virulence regulator. Molecular Cell, 26, 117-129.  
Berks, B. C., Sargent, F., & Palmer, T. (2000). The Tat protein export pathway. Molecular 
Microbiology, 35, 260-274. 
Bharat, T. A., Eisenbeis, S., Zeth, K., & Höcker, B. (2008). A βα-barrel built by the 
combination of fragments from different folds. Proceedings of the National Academy of 
Sciences, 105, 9942-9947. 
 156 
Blaudeck, N., Kreutzenbeck, P., Freudl, R., & Sprenger, G. A. (2003). Genetic analysis of 
pathway specificity during posttranslational protein translocation across the 
Escherichia coli plasma membrane. Journal of Bacteriology, 185, 2811-2819. 
Bogarad, L. D., & Deem, M. W. (1999). A hierarchical approach to protein molecular 
evolution. Proceedings of the National Academy of Sciences, 96, 2591-2595.  
Bowers, P. M., Schaufler, L. E., & Klevit, R. E. (1999). A folding transition and novel zinc 
finger accessory domain in the transcription factor ADR1. Nature Structural & 
Molecular Biology, 6, 478-485. 
Brennan, R. G., & Matthews, B. W. (1989). The helix-turn-helix DNA binding 
motif. Journal of Biological Chemistry, 264, 1903-1906. 
Buehner, M., Ford, G. C., Moras, D., Olsen, K. W., & Rossmann, M. G. (1973). 
D-glyceraldehyde-3-phosphate dehydrogenase: three-dimensional structure and 
evolutionary significance. Proceedings of the National Academy of Sciences, 70, 
3052-3054. 
Caetano-Anollés, G., Kim, H. S., & Mittenthal, J. E. (2007). The origin of modern 
metabolic networks inferred from phylogenomic analysis of protein architecture. 
Proceedings of the National Academy of Sciences, 104, 9358-9363. 
Cai, J., Zhao, R., Jiang, H., & Wang, W. (2008). De novo origination of a new protein-
coding gene in Saccharomyces cerevisiae. Genetics, 179, 487-496.  
Chiarabelli, C., Vrijbloed, J. W., De Lucrezia, D., Thomas, R. M., Stano, P., Polticelli, F., 
Ottone, T., Papa, E., & Luisi, P. L. (2006). Investigation of de novo totally random 
biosequences, Part II: On the folding frequency in a totally random library of de novo 
proteins obtained by phage display. Chemistry & Biodiversity, 3, 840-859. 
Clark, R. B., & Ogilvie, J. W. (1972). Aspartokinase I-homoserine dehydrogenase I of 
Escherichia coli K12 λ. Subunit molecular weight and nicotinamide-adenine 
dinucleotide phosphate binding. Biochemistry, 11, 1278-1282. 
Cui, Y., Wong, W. H., Bornberg-Bauer, E., & Chan, H. S. (2002). Recombinatoric 
exploration of novel folded structures: a heteropolymer-based model of protein 
evolutionary landscapes. Proceedings of the National Academy of Sciences, 99, 809-814.  
Curtis, E. A., & Bartel, D. P. (2005). New catalytic structures from an existing ribozyme. 
Nature Structural & Molecular Biology, 12, 994-1000. 
 157 
Daniel, R., Greger, J. G., Katz, R. A., Taganov, K. D., Wu, X., Kappes, J. C., & Skalka, A. 
M. (2004). Evidence that stable retroviral transduction and cell survival following DNA 
integration depend on components of the nonhomologous end joining repair pathway. 
Journal of Virology, 78, 8573-8581. 
Das, A. K., Cohen, P. T., & Barford, D. (1998). The structure of the tetratricopeptide 
repeats of protein phosphatase 5: implications for TPR‐mediated protein–protein 
interactions. The EMBO Journal, 17, 1192-1199. 
de Bono, S., Riechmann, L., Girard, E., Williams, R. L., & Winter, G. (2005). A segment of 
cold shock protein directs the folding of a combinatorial protein. Proceedings of the 
National Academy of Sciences, 102, 1396-1401. 
de Koning, A. P., Brinkman, F. S., Jones, S. J., & Keeling, P. J. (2000). Lateral gene transfer 
and metabolic adaptation in the human parasite Trichomonas vaginalis. Molecular 
Biology & Evolution, 17, 1769-1773.  
de la Cruz, F., & Davies, J. (2000). Horizontal gene transfer and the origin of species: 
lessons from bacteria. Trends in Microbioly, 8, 128-133.  
DeLisa, M. P., Tullman, D., & Georgiou, G. (2003). Folding quality control in the export 
of proteins by the bacterial twin-arginine translocation pathway. Proceedings of the 
National Academy of Sciences, 100, 6115-6120. 
Della, M., Palmbos, P. L., Tseng, H. M., Tonkin, L. M., Daley, J. M., Topper, L. M., 
Pitcher, R. S., Tomkinson, A. E., Wilson, T. E., & Doherty, A. J. (2004). Mycobacterial 
Ku and ligase proteins constitute a two-component NHEJ repair machine. Science, 306, 
683-685. 
Digianantonio, K. M., & Hecht, M. H. (2016). A protein constructed de novo enables cell 
growth by altering gene regulation. Proceedings of the National Academy of Sciences, 
113, 2400-2405.  
Digianantonio, K. M., Korolev, M., & Hecht, M. H. (2017). A non-natural protein rescues 
cells deleted for a key enzyme in central metabolism. ACS Synthetic Biology, 6, 694-700. 
Dill, K. A. (1999). Polymer principles and protein folding. Protein Science, 8, 1166-1180. 
Ding, Y., Zhou, Q., & Wang, W. (2012). Origins of new genes and evolution of their novel 
function. Annual Review of Ecology, Evolution, and Systematics, 43, 345-363. 
 158 
Dyson, H. J., & Wright, P. E. (2002). Coupling of folding and binding for unstructured 
proteins. Current Opinion in Structural Biology, 12, 54-60. 
Eck, R. V., & Dayhoff, M. O. (1966). Evolution of the structure of ferredoxin based on 
living relics of primitive amino acid sequences. Science, 152, 363-366. 
Esposito, D., & Chatterjee, D. K. (2006). Enhancement of soluble protein expression 
through the use of fusion tags. Current Opinion in Biotechnology, 17, 353-358. 
Farías-Rico, J. A., Schmidt, S., & Höcker, B. (2014). Evolutionary relationship of two 
ancient protein superfolds. Nature chemical biology, 10, 710-715. 
Finn, R. D., Coggill, P., Eberhardt, R. Y., Eddy, S. R., Mistry, J., Mitchell, A. L., Potter, S. 
C., Punta, M., Qureshi, M., Sangrador-Vegas, A. & Salazar, G. A. (2015). The Pfam 
protein families database: towards a more sustainable future. Nucleic Acids 
Research, 44, 279-285. 
Fischer, N., Riechmann, L., & Winter, G. (2004). A native‐like artificial protein from 
antisense DNA. Protein Engineering Design and Selection, 17, 13-20. 
Fisher, A. C., & DeLisa, M. P. (2009). Efficient isolation of soluble intracellular single-
chain antibodies using the twin-arginine translocation machinery. Journal of Molecular 
Biology, 385, 299-311. 
Fisher, A. C., Kim, W., & Delisa, M. P. (2006). Genetic selection for protein solubility 
enabled by the folding quality control feature of the twin‐arginine translocation 
pathway. Protein Science, 15, 449-458. 
Fisher, J. F., Meroueh, S. O., & Mobashery, S. (2005). Bacterial resistance to β-lactam 
antibiotics: compelling opportunism, compelling opportunity. Chemical Reviews, 105, 
395-424. 
Fisher, M. A., McKinley, K. L., Bradley, L. H., Viola, S. R., & Hecht, M. H. (2011). De novo 
designed proteins from a library of artificial sequences function in Escherichia coli and 
enable cell growth. PloS One, 6, e15364. 
Force, A., Lynch, M., Pickett, F. B., Amores, A., Yan, Y. L., & Postlethwait, J. (1999). 
Preservation of duplicate genes by complementary, degenerative mutations. Genetics, 
151, 1531-1545.  
 159 
Fox, N. K., Brenner, S. E., & Chandonia, J. M. (2013). SCOPe: Structural Classification of 
Proteins—extended, integrating SCOP and ASTRAL data and classification of new 
structures. Nucleic Acids Research, 42, 304-309. 
Frasch, W. D. (2000). The participation of metals in the mechanism of the F1-
ATPase. Biochimica et Biophysica Acta - Bioenergetics, 1458, 310-325. 
Friesen, J. D. (1988). Escherichia coli and Salmonella typhimurium: Cellular and 
Molecular Biology. Science, 240, 1678-1681. 
Frost, J. W., Bender, J. L., Kadonaga, J. T., & Knowles, J. R. (1984). Dehydroquinate 
synthetase from Escherichia coli: purification, cloning, and construction of 
overproducers of the enzyme. Biochemistry, 23, 4470-4475. 
Gerth, M. L., & Lutz, S. (2007). Non-homologous recombination of deoxyribonucleoside 
kinases from human and Drosophila melanogaster yields human-like enzymes with 
novel activities. Journal of Molecular Biology, 370, 742-751. 
Gerth, M. L., Patrick, W. M., & Lutz, S. (2004). A second-generation system for unbiased 
reading frame selection. Protein Engineering Design and Selection, 17, 595-602. 
Gilbert, H. J., Lowe, C. R., & Drabble, W. T. (1979). Inosine 5ʹ-monophosphate 
dehydrogenase of Escherichia coli. Purification by affinity chromatography, subunit 
structure and inhibition by guanosine 5ʹ-monophosphate. Biochemical Journal, 183, 
481-494. 
Gilbert, W. (1986). Origin of life: The RNA world. Nature, 319, 618. 
Greenfield, N. J. (2006). Using circular dichroism spectra to estimate protein secondary 
structure. Nature Protocols, 1, 2876-2890 
Grishin, N. V. (2001). KH domain: one motif, two folds. Nucleic Acids Research, 29, 
638-643. 
Hagewood, B. T., Ganduri, Y. L., & Datta, P. (1994). Functional analysis of the tdcABC 
promoter of Escherichia coli: roles of TdcA and TdcR. Journal of Bacteriology, 176, 
6214-6220. 
Harms, M. J., & Thornton, J. W. (2013). Evolutionary biochemistry: revealing the 
historical and physical causes of protein properties. Nature Reviews Genetics, 14, 
559-571. 
 160 
Hecht, M. H., Das, A., Go, A., Bradley, L. H., & Wei, Y. (2004). De novo proteins from 
designed combinatorial libraries. Protein Science, 13, 1711-1723. 
Höcker, B., Beismann-Driemeyer, S., Hettwer, S., Lustig, A., & Sterner, R. (2001). 
Dissection of a (βα) 8-barrel enzyme into two folded halves. Nature Structural & 
Molecular Biology, 8, 32-36. 
Höcker, B., Claren, J., & Sterner, R. (2004). Mimicking enzyme evolution by generating 
new (βα) 8-barrels from (βα) 4-half-barrels. Proceedings of the National Academy of 
Sciences, 101, 16448-16453. 
Hoegler, K. J., & Hecht, M. H. (2016). A de novo protein confers copper resistance in 
Escherichia Coli. Protein Science, 25, 1249-1259 
Horn, F., Vriend, G., & Cohen, F. E. (2001). Collecting and harvesting biological data: the 
GPCRDB and NucleaRDB information systems. Nucleic Acids Research, 29, 346-349.  
Hountondji, C., Schmitter, J. M., Beauvallet, C., & Blanquet, S. (1987). Affinity labeling of 
Escherichia coli phenylalanyl-tRNA synthetase at the binding site for tRNAPhe. 
Biochemistry, 26, 5433-5439. 
Hu, Y., Li, Y., Zhang, X., Guo, X., Xia, B., & Jin, C. (2006). Solution structures and 
backbone dynamics of a Flavodoxin MioC from Escherichia coli in both apo-and holo-
forms implications for cofactor binding and electron transfer. Journal of Biological 
Chemistry, 281, 35454-35466. 
Hubbard, B. K., Koch, M., Palmer, D. R., Babbitt, P. C., & Gerlt, J. A. (1998). Evolution of 
enzymatic activities in the enolase superfamily: characterization of the 
(D)-glucarate/galactarate catabolic pathway in Escherichia coli. Biochemistry, 37, 
14369-14375. 
Kast, P., & Hennecke, H. (1991). Amino acid substrate specificity of Escherichia coli 
phenylalanyl-tRNA synthetase altered by distinct mutations. Journal of Molecular 
Biology, 222, 99-124. 
Keefe, A. D., & Szostak, J. W. (2001). Functional proteins from a random-sequence 
library. Nature, 410, 715-718. 
Kegel, A., Martinez, P., Carter, S. D., & Astrom, S. U. (2006). Genome wide distribution 
of illegitimate recombination events in Kluyveromyces lactis. Nucleic Acids Research, 
34, 1633-1645.  
 161 
Kelley, L. A., Mezulis, S., Yates, C. M., Wass, M. N., & Sternberg, M. J. (2015). The Phyre2 
web portal for protein modeling, prediction and analysis. Nature Protocols, 10, 
845-858. 
Kim, A. S., Kakalis, L. T., Abdul-Manan, N., Liu, G. A., & Rosen, M. K. (2000). 
Autoinhibition and activation mechanisms of the Wiskott–Aldrich syndrome protein. 
Nature, 404, 151-158. 
Kitagawa, M., Ara, T., Arifuzzaman, M., Ioka-Nakamichi, T., Inamoto, E., Toyonaga, H., 
& Mori, H. (2005). Complete set of ORF clones of Escherichia coli ASKA library (A 
Complete Set of E. coli K-12 ORF Archive): Unique Resources for Biological Research. 
DNA Research, 12, 291-299. 
Kolodny, R., Pereyaslavets, L., Samson, A. O., & Levitt, M. (2013). On the universe of 
protein folds. Annual Review of Biophysics, 42, 559-582 
Kuno, A., Taki, M., Kaneko, S., Taira, K., & Hasegawa, T. (2003). Leucyl/phenylalanyl 
(L/F)-tRNA-protein transferase-mediated N-terminal specific labelling of a protein in 
vitro. In Nucleic acids symposium series, 3, 259-260. Oxford University Press., Oxford. 
Lange, O. F., Lakomek, N. A., Farès, C., Schröder, G. F., Walter, K. F., Becker, S., Meiler, 
J., Grubmüller, H., Griesinger, C., & De Groot, B. L. (2008). Recognition dynamics up 
to microseconds revealed from an RDC-derived ubiquitin ensemble in solution. 
Science, 320, 1471-1475. 
Laurino, P., Tóth-Petróczy, Á., Meana-Pañeda, R., Lin, W., Truhlar, D. G., & Tawfik, D. S. 
(2016). An ancient fingerprint indicates the common ancestry of Rossmann-fold 
enzymes utilizing different ribose-based cofactors. PLoS Biology, 14, e1002396. 
Lawrence, J. G. (1997). Selfish operons and speciation by gene transfer. Trends in 
Microbioly, 5, 355-359.  
Levine, M. T., Jones, C. D., Kern, A. D., Lindfors, H. A., & Begun, D. J. (2006). Novel 
genes derived from noncoding DNA in Drosophila melanogaster are frequently X-
linked and exhibit testis-biased expression. Proceedings of the National Academy of 
Sciences, 103, 9935-9939.  
Leyh, T. S., & Suo, Y. (1992). GTPase-mediated activation of ATP sulfurylase. Journal of 
Biological Chemistry, 267, 542-545. 
 162 
Leyh, T. S., Taylor, J. C., & Markham, G. D. (1988). The sulfate activation locus of 
Escherichia coli K12: cloning, genetic, and enzymatic characterization. Journal of 
Biological Chemistry, 263, 2409-2416. 
Li, W. H. (1997). Molecular Evolution. Sinauer Associates Incorporated, Sunderland, 
Massachusetts.  
Lies, M., Visser, B. J., Joshi, M. C., Magnan, D., & Bates, D. (2015). MioC and GidA 
proteins promote cell division in E. coli. Frontiers in Microbiology, 6, e516. 
Lo, M. C., Aulabaugh, A., Jin, G., Cowling, R., Bard, J., Malamas, M., & Ellestad, G. 
(2004). Evaluation of fluorescence-based thermal shift assays for hit identification in 
drug discovery. Analytical Biochemistry, 332, 153-159. 
Long, M. (2001). Evolution of novel genes. Current Opinion in Genets & Development, 11, 
673-680.  
Long, M., Betran, E., Thornton, K., & Wang, W. (2003). The origin of new genes: 
glimpses from the young and old. Nature Reviews Genetics, 4, 865-875.  
Long, M., Deutsch, M., Wang, W., Betran, E., Brunet, F. G., & Zhang, J. (2003). Origin of 
new genes: evidence from experimental and computational analyses. Genetica, 118, 
171-182.  
Lund, A. H., Duch, M., & Skou Pedersen, F. (1996). Increased cloning efficiency by 
temperature-cycle ligation. Nucleic Acids Research, 24, 800-801. 
Luo, Y., Samuel, J., Mosimann, S. C., Lee, J. E., Tanner, M. E., & Strynadka, N. C. (2001). 
The structure of L-ribulose-5-phosphate 4-epimerase: an aldolase-like platform for 
epimerization. Biochemistry, 40, 14763-14771. 
Lupas, A. N., Ponting, C. P., & Russell, R. B. (2001). On the evolution of protein folds: are 
similar motifs in different protein folds the result of convergence, insertion, or relics of 
an ancient peptide world? Journal of Structural Biology, 134, 191-203.  
Lutz, S., & Ostermeier, M. (2003). Preparation of SCRATCHY hybrid protein libraries. In 
Directed Evolution Library Creation (143-151). Humana Press. 
Lutz, S., Fast, W., & Benkovic, S. J. (2002). A universal, vector-based system for nucleic 
acid reading-frame selection. Protein Engineering, 15, 1025-1030. 
 163 
Lutz, S., Ostermeier, M., Moore, G. L., Maranas, C. D., & Benkovic, S. J. (2001). Creating 
multiple-crossover DNA libraries independent of sequence identity. Proceedings of the 
National Academy of Sciences, 98, 11248-11253. 
Lynch, M., & Conery, J. S. (2000). The evolutionary fate and consequences of duplicate 
genes. Science, 290, 1151-1155.  
Lynch, M., & Force, A. (2000). The probability of duplicate gene preservation by 
subfunctionalization. Genetics, 154, 459-473.  
Maddock, D. J., Gerth, M. L., & Patrick, W. M. (2017). An engineered glycerol 
dehydratase with improved activity for the conversion of meso‐2, 3‐butanediol to 
butanone. Biotechnology Journal, 12, e1700480. 
Main, E. R., Xiong, Y., Cocco, M. J., D'Andrea, L., & Regan, L. (2003). Design of stable 
α-helical arrays from an idealized TPR motif. Structure, 11, 497-508. 
Mansilla, M. C., & de Mendoza, D. I. (1997). L-cysteine biosynthesis in Bacillus subtilis: 
identification, sequencing, and functional characterization of the gene coding for 
phosphoadenylylsulfate sulfotransferase. Journal of Bacteriology, 179, 976-981. 
Mapelli, M., Massimiliano, L., Santaguida, S., & Musacchio, A. (2007). The Mad2 
conformational dimer: structure and implications for the spindle assembly checkpoint. 
Cell, 131, 730-743.  
McClintock, B. (1950). The origin and behavior of mutable loci in maize. Proceedings of 
the National Academy of Sciences, 36, 344-355.  
Michel, B., & Leach, D. (2012) Homologous recombination-enzymes and pathways. 
EcoSal Plus, 5, e7. 
Micsonai, A., Wien, F., Bulyáki, É., Kun, J., Moussong, E., Lee, Y. H., Goto, Y., Réfrégiers, 
M., & Kardos, J. (2018). BeStSel: a web server for accurate protein secondary structure 
prediction and fold recognition from the circular dichroism spectra. Nucleic Acids 
Research, 46, 315-322. 
Murzin, A. G. (2008). Metamorphic proteins. Science, 320, 1725-1726. 
Nagano, N., Orengo, C. A., & Thornton, J. M. (2002). One fold with many functions: the 
evolutionary relationships between TIM barrel families based on their sequences, 
structures and functions. Journal of Molecular Biology, 321, 741-765. 
 164 
Neira, J. L., Bintz, J., Arruebo, M., Rizzuti, B., Bonacci, T., Vega, S., Lanas, A., Velázquez-
Campoy, A., Iovanna, J. L., & Abián, O. (2017). Identification of a drug targeting an 
intrinsically disordered protein involved in pancreatic adenocarcinoma. Scientific 
Reports, 7, e39732. 
Nekrutenko, A., & Li, W. H. S. (2001). Transposable elements are found in a large 
number of human protein-coding genes. Trends in Genetics, 17, 619-621.  
Nourse, A., & Mittag, T. (2014). The cytoplasmic domain of the T-cell receptor zeta 
subunit does not form disordered dimers. Journal of Molecular Biology, 426, 62-70. 
Ochman, H., Lawrence, J. G., & Groisman, E. A. (2000). Lateral gene transfer and the 
nature of bacterial innovation. Nature, 405, 299-304.  
Ohno, S. (1970). Duplication for the Sake of Producing More of the Same. In Evolution by 
Gene Duplication, Springer, Berlin, Heidelberg.  
Ostermeier, M., & Benkovic, S. J. (2001). Construction of hybrid gene libraries involving 
the circular permutation of DNA. Biotechnology Letters, 23, 303-310. 
Ostermeier, M., Shim, J. H., & Benkovic, S. J. (1999). A combinatorial approach to hybrid 
enzymes independent of DNA homology. Nature Biotechnology, 17, 1205-1209. 
Palmer, T., & Berks, B. C. (2012). The twin-arginine translocation (Tat) protein export 
pathway. Nature Reviews Microbiology, 10, 483-496. 
Patel, P. H., & Loeb, L. A. (2000). Multiple amino acid substitutions allow DNA 
polymerases to synthesize RNA. Journal of Biological Chemistry, 275, 40266-40272 
Patrick W. M., & Gerth M. L. (2014) ITCHY: Incremental Truncation for the Creation of 
Hybrid Enzymes. In Directed Evolution Library Creation. Methods in Molecular 
Biology. Springer, New York, NY 
Patrick, W. M., Quandt, E. M., Swartzlander, D. B., & Matsumura, I. (2007). Multicopy 
suppression underpins metabolic evolvability. Molecular Biology and Evolution, 24, 
2716-2722. 
Prijambada, I. D., Yomo, T., Tanaka, F., Kawama, T., Yamamoto, K., Hasegawa, A., 
Shima, Y., Negoro, S., & Urabe, I. (1996). Solubility of artificial proteins with random 
sequences. FEBS Letters, 382, 21-25. 
 165 
Pruitt, K. D., Tatusova, T., & Maglott, D. R. (2006). NCBI reference sequences (RefSeq): a 
curated non-redundant sequence database of genomes, transcripts and proteins. 
Nucleic Acids Research, 35, 61-65. 
Pugsley, A.P. (1993) The complete general secretory pathway in Gram‐negative bacteria. 
Microbiological Reviews, 57, 50–108 
Qian, Z., Horton, J. R., Cheng, X., & Lutz, S. (2009). Structural redesign of lipase B from 
Candida antarctica by circular permutation and incremental truncation. Journal of 
Molecular Biology, 393, 191-201. 
Ramakrishnan, T., & Adelberg, E. A. (1964). Regulatory mechanisms in the biosynthesis 
of isoleucine and valine I: genetic derepression of enzyme formation. Journal of 
Bacteriology, 87, 566-573. 
Raussens, V., Ruysschaert, J. M., & Goormaghtigh, E. (2003). Protein concentration is not 
an absolute prerequisite for the determination of secondary structure from circular 
dichroism spectra: a new scaling method. Analytical Biochemistry, 319, 114-121. 
Richardson, J. S., & Richardson, D. C. (2002). Natural β-sheet proteins use negative 
design to avoid edge-to-edge aggregation. Proceedings of the National Academy of 
Sciences, 99, 2754-2759. 
Richardson, J. S., Richardson, D. C., Tweedy, N. B., Gernert, K. M., Quinn, T. P., Hecht, 
M. H., Erickson, B. W., Yan, Y., McClain, R. D., & Donlan, M. E. (1992). Looking at 
proteins: representations, folding, packing, and design. Biophysical Journal, 63, 1185. 
Richter, M., Bosnali, M., Carstensen, L., Seitz, T., Durchschlag, H., Blanquart, S., Merkl, 
R., & Sterner, R. (2010). Computational and experimental evidence for the evolution of 
a (βα) 8-barrel protein from an ancestral quarter-barrel stabilised by disulfide bonds. 
Journal of Molecular Biology, 398, 763-773. 
Riechmann, L., & Winter, G. (2006). Early protein evolution: building domains from 
ligand-binding polypeptide segments. Journal of Molecular Biology, 363, 460-468. 
Risso, V. A., Sanchez-Ruiz, J. M., & Ozkan, S. B. (2018). Biotechnological and protein-
engineering implications of ancestral protein resurrection. Current Opinion in 
Structural Biology, 51, 106-115. 
Rogers, R. L., & Hartl, D. L. (2012). Chimeric genes as a source of rapid evolution in 
Drosophila melanogaster. Molecular Biology & Evolution, 29, 517-529.  
 166 
Romero, M. L. R., Yang, F., Lin, Y. R., Toth-Petroczy, A., Berezovsky, I. N., Goncearenco, 
A., Yang, W., Wellner, A., Kumar-Deshmukh, F., Sharon, M. & Baker, D. (2018). 
Simple yet functional phosphate-loop proteins. Proceedings of the National Academy of 
Sciences, 115, 11943-11950. 
Rossmann, M. G., Moras, D., & Olsen, K. W. (1974). Chemical and biological evolution of 
a nucleotide-binding protein. Nature, 250, 194-199. 
Rost, B. (1999). Twilight zone of protein sequence alignments. Protein Engineering, 12, 
85-94. 
Sabath, N., Wagner, A., & Karlin, D. (2012). Evolution of viral proteins originated de novo 
by overprinting. Molecular Biology & Evolution, 29, 3767-3780. 
Sambrook J., & Russell D. W. (2001). Molecular Cloning: A Laboratory Manual. Cold 
Spring Harbor Laboratory Press, Cold Spring Harbor, New York, USA. 
Sambrook, J. E. F. Fritsch, and T. Maniatis, (1989). Molecular cloning: a laboratory 
manual, Cold Spring Harbour laboratory, Cold Spring Harbour, N.Y. 
Saraswat, M. (2014) In search of novel folds : protein evolution via non-homologous 
recombination (Doctoral dissertation). Dunedin, New Zealand: University of Otago. 
Sargent, F., Bogsch, E. G., Stanley, N. R., Wexler, M., Robinson, C., Berks, B. C., & 
Palmer, T. (1998). Overlapping functions of components of a bacterial Sec‐
independent protein export pathway. The EMBO Journal, 17, 3640-3650. 
Sawers, G. (2001). A novel mechanism controls anaerobic and catabolite regulation of the 
Escherichia coli tdc operon. Molecular Microbiology, 39, 1285-1298. 
Seitz, T., Bocola, M., Claren, J., & Sterner, R. (2007). Stabilisation of a (βα) 8-barrel 
protein designed from identical half barrels. Journal of Molecular Biology, 372, 114-129. 
Semisotnov, G. V., Rodionova, N., Razgulyaev, O. I., Uversky, V. N., Gripas', A. F., & 
Gilmanshin, R. I. (1991). Study of the “molten globule” intermediate state in protein 
folding by a hydrophobic fluorescent probe. Biopolymers: Original Research on 
Biomolecules, 31, 119-128. 
Setiyaputra, S., Mackay, J. P., & Patrick, W. M. (2011). The structure of a truncated 
phosphoribosylanthranilate isomerase suggests a unified model for evolution of the 
(βα) 8 barrel fold. Journal of Molecular Biology, 408, 291-303. 
 167 
Sidow, A. (1996). Gen(om)e duplications in the evolution of early vertebrates. Current 
Opinion in Genetics & Development, 6, 715-722.  
Sieber, V., Martinez, C. A., & Arnold, F. H. (2001). Libraries of hybrid proteins from 
distantly related sequences. Nature Biotechnology, 19, 456-460. 
Smith. (1976). Evolution of repeated DNA sequences by unequal crossover. Science, 191, 
528-535.  
Smock, R. G., Yadid, I., Dym, O., Clarke, J., & Tawfik, D. S. (2016). De Novo evolutionary 
emergence of a symmetrical protein is shaped by folding constraints. Cell, 164, 
476-486. 
So ̈ding, J., & Lupas, A. N. (2003). More than the sum of their parts: on the evolution of 
proteins from peptides. Bioessays, 25, 837-846. 
Starnes, W. L., Munk, P., Maul, S. B., Cunningham, G. N., Cox, D. J., & Shive, W. (1972). 
Threonine-sensitive aspartokinase-homoserine dehydrogenase complex amino acid 
compositions, molecular weight, and subunit composition of the complex. 
Biochemistry, 11, 677-687. 
Sterner, R., & Höcker, B. (2005). Catalytic versatility, stability, and evolution of the (βα) 8-
barrel enzyme fold. Chemical Reviews, 105, 4038-4055. 
Tautz, D., & Domazet-Loso, T. (2011). The evolutionary origin of orphan genes. Nature 
Reviews Genetics, 12, 692-702. 
Thomas, J. D., Daniel, R. A., Errington, J., & Robinson, C. (2001). Export of active green 
fluorescent protein to the periplasm by the twin‐arginine translocase (Tat) pathway in 
Escherichia coli. Molecular Microbiology, 39, 47-53. 
Tobias, J. W., Shrader, T. E., Rocap, G., & Varshavsky, A. (1991). The N-end rule in 
bacteria. Science, 254, 1374-1377. 
Tokuriki, N., & Tawfik, D. S. (2009). Protein dynamism and evolvability. Science, 324, 
203-207. 
Tompa, P. (2002). Intrinsically unstructured proteins. Trends in Biochemical Sciences, 27, 
527-533. 
 168 
Tuinstra, R. L., Peterson, F. C., Kutlesa, S., Elgin, E. S., Kron, M. A., & Volkman, B. F. 
(2008). Interconversion between two unrelated protein folds in the lymphotactin native 
state. Proceedings of the National Academy of Sciences, 105, 5057-5062. 
Umbarger, H. E., & Brown, B. (1957). Threonine deamination in Escherichia coli ii.: 
Evidence for two l-threonine deaminases. Journal of Bacteriology, 73, 105-112. 
Walker, J. E., Saraste, M., Runswick, M. J., & Gay, N. J. (1982). Distantly related sequences 
in the alpha‐and beta‐subunits of ATP synthase, myosin, kinases and other ATP‐
requiring enzymes and a common nucleotide binding fold. The EMBO Journal, 1, 
945-951. 
Walsh, J. B. (1995). How often do duplicated genes evolve new functions? Genetics, 139, 
421-428.  
Wang, W., & Hecht, M. H. (2002). Rationally designed mutations convert de novo 
amyloid-like fibrils into monomeric β-sheet proteins. Proceedings of the National 
Academy of Sciences, 99, 2760-2765. 
Wei, J., & Leyh, T. S. (1999). Isomerization couples chemistry in the ATP sulfurylase-
GTPase system. Biochemistry, 38, 6311-6316. 
Wei, J., Liu, C., & Leyh, T. S. (2000). The role of enzyme isomerization in the native 
catalytic cycle of the ATP sulfurylase−GTPase system. Biochemistry, 39, 4704-4710. 
Weller, G. R., Kysela, B., Roy, R., Tonkin, L. M., Scanlan, E., Della, M., Devine, S. K., Day, 
J. P., Wilkinson, A., di Fagagna, F. D. A., & Devine, K. M. (2002). Identification of a 
DNA nonhomologous end-joining complex in bacteria. Science, 297, 1686-1689. 
Wright, P. E., & Dyson, H. J. (2009). Linking folding and binding. Current Opinion in 
Structural Biology, 19, 31-38. 
Yadid, I., & Tawfik, D. S. (2010). Functional β-propeller lectins by tandem duplications of 
repetitive units. Protein Engineering, Design & Selection, 24, 185-195. 
Yew, W. S., & Gerlt, J. A. (2002). Utilization of L-ascorbate by Escherichia coli K-12: 
assignments of functions to products of the yjf-sga and yia-sgb operons. Journal of 
Bacteriology, 184, 302-306. 
Yumerefendi, H., Tarendeau, F., Mas, P. J., & Hart, D. J. (2010). ESPRIT: an automated, 
library-based method for mapping and soluble expression of protein domains from 
challenging targets. Journal of Structural Biology, 172, 66-74. 
 169 
Zhang, J. Z. (2003). Evolution by gene duplication: an update. Trends in Ecology & 
Evolution, 18, 292-298.  
Zhang, Y., Yamaguchi, Y., & Inouye, M. (2009). Characterization of YafO, an Escherichia 
coli toxin. Journal of Biological Chemistry, 284, 25522-25531. 
Zhu, H., Sepulveda, E., Hartmann, M. D., Kogenaru, M., Ursinus, A., Sulz, E., Albrecht, 
R., Coles, M., Martin, J., & Lupas, A. N. (2016). Origin of a folded repeat protein from 




















cof 99 ihfB 27 126 
raiA 273 waaS 30 303 
yebW 258 paaH 45 303 
sad 45 udp/yegZ 57 102 
Intergenic 21 pyrL 54 75 
bolA 43 Intergenic 44 87 
waaS 365 fliE 118 483 
clpS 75 yagN 60 135 
yebW 224 yeeT 178 402 
yedN 111 yodD 24 135 
yiaG 283 Intergenic 113 396 
yevD 259 ypjC 155 414 
yciZ 81 ykfH 39 120 
yjbL 38 yedF 52 90 
rhsH 98 pbl 52 150 
cysS 152 iraD 34 186 
kdsC 46 yobF 95 141 
ynaJ 69 Intergenic 48 117 
fliN 49 nudJ 83 132 
ygeF 52 ygaQ 68 120 
yrdD 246 hisA 57 303 
cbeA 54 yneK 93 147 
Intergenic 87 rsfS 81 168 
ravA 143 Intergenic 121 264 
ilvG 66 Intergenic 36 102 
yheV 65 Intergenic 97 162 
yedN 48 intergenic 81 129 
citD 84 Intergenic 39 123 
ycgX 54 purB 42 96 
ydcX 111 trpD 105 216 
yqiB 54 yfjZ 30 84 
ydcY 47 Intergenic 55 102 
iraD 264 rffH 102 366 
yfdM 57 Intergenic 33 90 
ydfO 263 wecF 31 294 
waaS 365 fliE 118 483 
ynjA 101 fixA 34 135 
yihX 436 yegV 101 537 
ygba 61 ypjI 53 114 
csiE 41 Intergenic 133 174 
ydjO 503 Intergenic 238 741 
ydfZ 54 ycjV 66 120 
 172 
xthA 325 ynaJ 251 576 
ydhY 488 yrdD 238 726 
yafE 43 Intergenic 65 108 
pbl 185 ydcX 301 486 
waaZ 606 psiF 327 933 
dgoA 594 elaB 195 789 
yciE 255 yohJ 183 438 
yjbJ 92 Intergenic 43 135 
fabA 60 ymgE (+anmK) 121 (59) 240 
ygfS 42 ycjT 63 105 
aaeX 216 yjfI 84 300 
ygaU 79 ynjA 65 144 
yqaA 85 yebW 236 321 
yciZ 82 ykfH 38 120 
yciG 38 ydcN 97 135 
cbpM 39 ygaQ 63 102 
lit 207 iraM 156 363 
yedF 155 opgD 148 303 
yacG 118 pgaB 41 159 
Intergenic 43 Intergenic 53 96 
ebgR 94 relB 47 141 
yabI >400 psiF 251 >650 
ynfO 182 sra 43 225 
yafU 243 rmf 153 396 
tusB 284 ygaQ 55 339 
yevB 45 yaeP 57 102 
yghA 312 yecF 219 531 
yibL 66 ygeG 33 99 
rpsB 33 Intergenic 90 123 
trmH 359 atpE 223 582 
ydcH 164 ygaH 268 432 
ylcG 135 Intergenic 33 168 
cspH 39 pyrB 57 96 
yeeL 201 ygeN 39 240 
yciT 57 yecF 93 150 
gnsA 102 ykgL 132 234 
folB 76 arpB 92 168 















Parent gene 1 Parent gene 2 Reason discounted 
∆serB yaiS - No second fragment 
∆serB - - No second fragment 
∆pdxA ynaK - No second fragment 
∆pdxA pdxA - No second fragment 
∆nadC hyfJ - No second fragment 
∆nadC nadC - No second fragment 
∆panB - - Failed PCR 
∆panC - - Faled PCR 
∆panC panC ygaQ No second fragment 
∆pdxJ wbbL - No second fragment 
∆cysC cspH nudK Complete cspH gene 
∆cysN sgbE mioC N/A 
∆purK purK - No second fragment 
∆purK purK - No second fragment 
∆purK insZ purK Complete purK gene 
∆pyrD - - Failed PCR 
∆pyrC pyrC - Complete pyrC gene 
∆pyrC pyrC - No second fragment 
∆pyrC pyrC - No second fragment 
∆pyrF pyrF - Complete pyrF gene 
∆pyrF seqA marR Complete marR gene 
∆pyrE pyrE - Complete pyrE gene 
∆pyrE pyrE - Complete pyrE gene 
∆aroB pheS garR N/A 
∆purE yeiL ykfJ Complete ykfJ gene 
∆cysC rsfS - No second fragment 
∆nadC relB - No second fragment 
∆nadC anmK - No second fragment 
∆pdxB mrlA - No second fragment 
∆pdxB - - Failed PCR 
∆pdxB pdxB Intergenic Not subclonable 
∆hisB hisB - No second fragment 
∆hisB hisB - Complete hisB gene 
∆iscS wbbL - Complete wbbL gene 
∆ilvC ilvC Intergenic Complete ilvC gene 
∆ilvC tdcE ymdE N/A 
∆ilvC ilvC - No second fragment 
∆guaB ydjO guaB N/A 
∆guaB ydjO - No second fragment 
∆guaB ydjO - No second fragment 
∆argB hisB - No second fragment 
∆argB - - Failed PCR 
∆argB - - No insert 
∆thrA - - Faled PCR 
∆thrA ytfI yncH N/A 
∆thrA ulaC - No second fragment 
∆thrA ycAA yafO N/A 
∆purC yghA - Complete yghA gene 
∆purC sodA - No second fragment 
 174 
∆purC ydbD Unknown 2nd fragment 14 bp 
∆purC - - Failed PCR 
∆purH furI frlC Complete furI gene 
∆purH ygaQ - No second fragment 
∆purH sodA - No second fragment 
∆purH - - No insert 
∆argG - - No insert 
Table S2 Complete list of sequenced clones from auxotroph rescue 
 
 
Figure S3 Preliminary 1D-NMR spectra of SgbE147/MioC82. The 1D-NMR 
spectra of SgbE147/MioC82 indicates that the protein has areas of order 
indicating tertiary structure. The data was prepared by collaborators in the 









Figure S4 Purified MioC and SgbE. SDS PAGE 
gel showing protein samples of MioC and 
SgbE following affinity purification and SEC 
purification.	
 
